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Abstract 
Quantitative Susceptibility Mapping (QSM) is a relatively new Magnetic Resonance 
Imaging (MRI) technique that gives information about the relative quantities of magnetically 
active constituents of a biological system. Using phase data, not normally utilised in standard 
MRI, measurements are made of local variations in the main magnetic field, B0. This data is 
then processed to calculate a map of local magnetic susceptibility within an organ of interest. 
This map yields relatively quantitative information, and compositional inferences can be 
made regarding the organ. Thus far, the body of literature on QSM has focussed almost 
exclusively on the brain, and has been performed on clinical data. This will be a preclinical 
project, and will focus primarily on the liver.  
The first two chapters of this thesis will establish the context of the research, as well 
as the background theory of QSM, including a detailed discussion of the set of algorithms 
selected to calculate the susceptibility maps for this body of work. The implementation of 
QSM in the preclinical liver has not been performed previously, and the novelty of the 
technique and the experimental work performed necessitated optimising both data acquisition 
and processing protocols. This was done on an empirical basis, and comprises the 
experimental work detailed in chapter 3. 
Chapters 4 – 6 describe the application of QSM to a number of hepatic conditions. It 
was established in chapter 4 that QSM is sensitive to changes in the oxygen saturation of 
blood in large branches of the major hepatic blood vessels in healthy mice. Chapter 5 
discusses the application of QSM to a preclinical model of colorectal liver metastases, and 
also examines the ability of QSM to assess the efficacy of a Vascular Disrupting Agent 
(VDA), a novel chemotherapeutic drug. Finally, chapter 6 details the application of QSM to a 
model of liver cirrhosis. 
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Chapter 1 
 The aim of this thesis is to explore novel applications of Quantitative Susceptibility 
Mapping in the liver. A number of scenarios have been investigated in a preclinical context, 
and are discussed in chapters 4 – 6. The implementation of QSM in the preclinical liver 
required significant experimental work which has been detailed in chapter 3. 
 This chapter establishes the context of the research, discussing both micro- and macro 
scale liver anatomy, as well as imaging techniques currently used to image the liver, and to 
diagnose hepatic diseases. Finally, some of the advantages QSM can offer over current liver 
imaging techniques are highlighted. 
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Context of Research 
 Quantitative Susceptibility Mapping (QSM) is a novel MRI technique that uses 
variation in magnetic susceptibility as a contrast mechanism. While QSM is of relatively 
recent inception, it has spawned a rapidly growing field of research that has found a wide 
range of diverse applications – from quantifying changes in cerebral iron deposition caused 
by neurodegenerative diseases 
[1-3]
, to quantifying cerebral perfusion 
[4]
, to estimating blood 
oxygen saturation
[5-7]
. Thus far however, much of the research in the field has explored the 
application of QSM to the brain in a clinical setting. 
It is the aim of the experimental work carried out herein to implement QSM in the 
pre-clinical liver, and to investigate its subsequent application to pre-clinical models of 
human liver disease - namely colorectal liver metastases and liver cirrhosis. 
It is the purpose of this thesis to present a thorough argument in support of the 
experimental work, and to justify its undertaking. This chapter will discuss the structure and 
function of the liver under healthy conditions, and will examine some of the modalities 
currently used in clinical examination. Chapter 2 will elucidate the relevant background 
theory, and establish the case for the use of QSM in the liver. Chapter 3 will discuss the 
optimisation of the acquisition and processing pipeline, while chapters 4 – 6 will present the 
experimental work that has been carried out to test the hypotheses put forward in the previous 
chapters. Finally, there will be a general discussion of the use of QSM in the liver, and an 
outline of work that could be carried out should the project be continued. 
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Fig 1.1: Anatomical image depicting the liver in-situ [9]  
1.1 THE LIVER 
The liver is the second largest 
organ in the body, and at any one time 
contains roughly 10% of the total 
blood volume. It plays a major role in 
blood filtration, biosynthesis and 
metabolism, and is responsible for the 
storage of a number of vitamins and 
minerals, most notably iron in the 
form of ferritin. Correct functioning of 
the liver is of great importance, and 
the diagnostic procedures available for 
assessing liver health and function 
range from invasive testing in the form 
of biopsy and biochemical assay, to non-invasive imaging. The work carried out herein 
focusses exclusively on Quantitative Susceptibility Mapping, and it underpins all of the 
hypotheses presented that QSM can offer unique compositional and functional information 
that could aid in the diagnosis and monitoring of liver diseases. As such, let us begin our 
discussion with an examination of the structure and function of a healthy liver (Figure 1.1). 
Under normal circumstances, the human liver can weigh up to 1.5 kg. Despite its size 
however, the structure of the liver is relatively simple when compared to other major organs. 
On a macroscopic level, the liver is divided into 4 main lobes - the right, left, caudate and 
quadrate, but there is little in structure and function to differentiate the lobes from one 
another. This lack of regional specificity within the liver imbues the organ with a number of 
advantages. In the first instance, it allows the liver to assume roles in systems as diverse as 
the digestive, endocrine, immune and circulatory. Secondly, it means that small, regional 
insults can be absorbed with little impact on the functionality of the entire organ, allowing it 
to efficiently metabolise and expel toxins. Thirdly, the uniform functionality of the tissue 
allows significant surgical resection in the case of chronic liver diseases. 
The homogeneous structure of the liver also allows for another of its peculiar facets – 
its remarkable ability to regenerate. Unlike bone and skin which rely on stem cells, the 
regeneration of the liver tissue is due to the proliferation of existing mature cell types in the 
4 
 
Fig 1.2: Internal anatomy of the liver depicting the blood supply [9] 
intact portion of the organ 
[10]
. A complete restoration of the liver after partial hepatectomy 
can take as little as 3 – 6 months [11], so is often a useful intervention in cases of 
Hepatocellular Carcinoma or Colorectal Liver Metastases. It is known however that certain 
disease states (e.g. cirrhosis) can undermine or inhibit the liver’s restorative properties [12], 
thus precluding certain patients from this form of treatment. As such, an accurate assessment 
of the liver and its function will play a major role in determining the subsequent treatment 
pathway. 
Another 
attribute unique to the 
liver is its dual blood 
supply (Figure 1.2). 
The Hepatic Portal 
Vein delivers nutrient 
rich, partially 
deoxygenated blood 
that has passed through 
the gut and mesentery. 
It supplies roughly 75% 
of the total liver blood 
volume, but only 50% of 
the required oxygen. The 
shortfall is made up by the Hepatic Artery, which delivers richly oxygenated blood from the 
descending aorta. Both vessels enter the liver through the porta hepatis on the inferior surface 
of the liver before branching into the various lobes. The blood they carry then passes through 
the liver tissue before draining to the hepatic veins, and finally into the inferior vena cava 
(IVC). 
The liver cells are known as hepatocytes (Figure 1.3). These form hepatic plates – thin 
layers of cells roughly 1 – 2 cells thick, separated by extremely permeable capillary spaces 
called sinusoids. The hepatic plates are arranged into functional units called liver lobules, 
which consist of a large number of hepatic plates nucleated around a central vein. At the 
periphery of each lobule are portal triads – branches of the hepatic portal vein and hepatic 
artery, as well as bile canaliculi – a thin conduit through which bile is channelled from the 
hepatocytes. Blood enters the lobule through the portal triad and mixes in the sinusoids where 
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Fig 1.3a & b: Histological Anatomy of the liver
[8]
  
the structure of the hepatic plates maximises contact with the hepatocytes. Finally, the blood 
drains through the central vein, branches of which converge to form the hepatic veins. 
 
 
 
 
 
 
 
 
 
 
While an exhaustive list of vital functions in which the liver plays a role would be 
difficult to compile, some estimates put the number at several hundred 
[13]
. As such, any 
damage or condition that impedes the normal functioning of the liver can have an extremely 
serious effect on the patient in whom they manifest. Liver diseases are often asymptomatic 
until they reach an advanced stage, and even when patients seek medical help symptoms can 
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be ambiguous. This difficulty is compounded by the fact that liver lesions and tumours can 
often be mistaken as benign (or vice versa) on standard MRI and CT images 
[14]
. This may go 
some way to explain why liver disease is the only major cause of death still increasing year 
on year 
[15]
. Existing non-invasive imaging techniques provide limited information beyond 
morphology 
[16]
, and so there is a strong clinical need for improvements to be made in this 
area. Quantitative Susceptibility Mapping may go some way to filling that void. 
1.2 LIVER IMAGING 
 As mentioned, there are a number of modalities available when performing liver 
imaging. Computed tomography (CT) and ultrasound may be used to identify morphological 
abnormalities such as liver lesions that are the hallmarks of cirrhosis. Images acquired with a 
CT scanner are usually high resolution, which is important for detecting smaller lesions, but 
acquiring the image requires a high dose of ionising radiation to be administered to the 
patient. This is particularly true in the abdomen, where the effective dose of radiation is 
increased due to the air/tissue boundary at the lungs. This is not an issue in ultrasound 
imaging, but the images are extremely low resolution by comparison, and interpretation is 
heavily dependent on the operator. 
 Biopsies and serum assays give compositional and functional information 
respectively, but are limited by the fact that they are invasive, and are also open to sampling 
error. Functional information can also be derived from positron emission tomography (PET) 
but this too necessitates irradiation. Magnetic Resonance Imaging offers non-invasive, high 
resolution images, without the need for ionising radiation. As such, it is becoming the 
principal diagnostic modality for hepatic ailments, particularly for staging and re-staging 
oncological patients
 [17]
. 
 The assessment and monitoring of liver disease has benefitted greatly from the advent 
of MRI imaging. MRI has been used to measure liver fat fraction 
[18]
, gauge liver perfusion 
[19]
, or to measure elasticity of the liver tissue (to diagnose fibrosis)
 [20]
. Relaxometry can be 
further enhanced in some cases by the incorporation of exogenous contrast agents such as 
gadolinium (Gd) 
[20]
 or super paramagnetic iron oxide particles (SPIOs) 
[21]
. Diffusion 
weighted imaging (DWI) has been used to identify hepatic lesions 
[22]
. Susceptibility 
Weighted Imaging (SWI) has been used to identify haemorrhages
 [23]
, and to improve the 
identification of liver nodules that are believed to be a precursor for hepatocellular carcinoma 
(HCC) 
[24]
. Furthermore, there is a large body of work dedicated to the identification and 
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quantification of iron within the liver (see table 1 for an extensive but not exhaustive list of 
literature regarding the quantification of liver iron with MRI).
 
It is expected that the advantages offered by QSM will be extremely beneficial to the 
techniques currently used to image the liver. For instance, the measurements made on QSM 
images are independent of imaging parameters like field strength and relaxation times, 
allowing more robust comparisons between studies performed across different centres. 
Secondly, magnetic susceptibility is an intrinsic property of the tissue under examination, and 
it has been shown that the correlation between tissue iron content and susceptibility is 
stronger and more significant than with R2* 
[25]
.  Susceptibility mapping is sensitive to 
changes in the deoxyhaemoglobin content of blood 
[26]
, but unlike SWI, QSM can offer 
quantitative measurements that can be used to calculate venous oxygen saturation 
[6, 7, 27]
. 
Furthermore, the contrast in QSM images is more localised than that in SWI images, giving 
rise to a more accurate depiction of blood vessels 
[25]
. This may be particularly relevant for 
liver imaging due to the peculiar fashion in which the liver derives its blood supply, as it is 
well known that a number of pathologies can affect hepatic haemodynamics 
[16]
. Additionally, 
it is well known that both liver regeneration and the presence of cancer can both result in an 
increased demand for oxygen 
[28, 29]
 .  
 The experimental work detailed in the upcoming chapters has examined the changes 
in hepatic magnetic susceptibility brought about by the administration of a hyperoxic gas 
challenge to a healthy cohort, and has sought to apply QSM to pre-clinical models of both 
colorectal liver metastases (CRLM) and liver cirrhosis. The chapters that immediately follow 
however are a detailed discussion of the QSM background theory, and an examination of how 
implementation of QSM was optimised for application to the liver. 
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Year Author Title Journal 
1995 
Turlin, B., et 
al. 
Increased liver iron stores in patients with hepatocellular 
carcinoma developed on a noncirrhotic liver Hepatology 
1995 
Turlin, B., et 
al. 
Increased liver iron stores in patients with hepatocellular 
carcinoma developed on a noncirrhotic liver Hepatology 
1997 
Angelucci, 
E.G., A. 
Limitations of Magnetic Resonance Imaging in Measurment of 
Hepatic Iron. Blood 
2000 
Clark, P.R. 
and T.G. St 
Pierre 
Quantitative mapping of transverse relaxivity (1/T(2)) in 
hepatic iron overload: a single spin-echo imaging methodology. 
Magn Reson 
Imaging 
2000 
Clark, P.R. 
and T.G. St 
Pierre 
Quantitative mapping of transverse relaxivity (1/T(2)) in 
hepatic iron overload: a single spin-echo imaging methodology. 
Magn Reson 
Imaging 
2001 
Fenzi, A., et 
al. 
In vivo investigation of hepatic iron overload in rats using T2 
maps: quantification at high intensity field (4.7-T). 
J Magn Reson 
Imaging 
2001 
Fenzi, A., et 
al. 
In vivo investigation of hepatic iron overload in rats using T2 
maps: quantification at high intensity field (4.7-T).  
J Magn Reson 
Imaging 
2002 
Carneiro, 
A.A., et al. 
Theoretical evaluation of the susceptometric measurement of 
iron in human liver by four different susceptometers Physiol Meas 
2002 
Carneiro, 
A.A., et al. 
Theoretical evaluation of the susceptometric measurement of 
iron in human liver by four different susceptometers Physiol Meas 
2003 
Brittenham, 
G.M., et al. 
Noninvasive measurement of iron: report of an NIDDK 
workshop Blood 
2003 
Clark, P.R., 
W. Chua-
anusorn, and 
T.G.S. Pierre 
Bi-exponential proton transverse relaxation rate (R2) image 
analysis using RF field intensity-weighted spin density 
projection: potential for R2 measurement of iron-loaded liver. 
Magnetic 
Resonance 
Imaging 
2003 Sheth, S. SQUID biosusceptometry in the measurement of hepatic iron Pediatr Radiol 
2003 
Clark, P.R., 
W. Chua-
Anusorn, and 
T.G. St Pierre 
Proton transverse relaxation rate (R2) images of liver tissue; 
mapping local tissue iron concentrations with MRI  
Magn Reson 
Med 
2004 
Gandon, Y., 
et al. Non-invasive assessment of hepatic iron stores by MRI. The Lancet 
2004 
Li, T.Q., 
A.M. Aisen, 
and T. 
Hindmarsh 
Assessment of Hepatic Iron Content Using Magnetic Resonance 
Imaging. 
Acta 
Radiologica 
2005 
Wood, J.C., et 
al 
MRI R2 and R2* mapping accurately estimates hepatic iron 
concentration in transfusion-dependent thalassemia and sickle 
cell disease patients Blood 
2005 
Carneiro, 
A.A., et al. 
Liver iron concentration evaluated by two magnetic methods: 
magnetic resonance imaging and magnetic susceptometry 
Carneiro, 
A.A., et al. 
2005 
St Pierre, 
T.G., P.R. 
Clark, and W. 
Chua-
Anusorn 
Measurement and mapping of liver iron concentrations using 
magnetic resonance imaging 
Ann N Y 
Acad Sci 
9 
 
2005 
St Pierre, 
T.G., et al. 
Noninvasive measurement and imaging of liver iron 
concentrations using proton magnetic resonance. Blood 
2006 
Merkle, E.M. 
and R.C. 
Nelson 
Dual Gradient-Echo i-o phase hepatic MR imaging: A useful 
tool for evaluating more that fatty infiltration. Radiographics 
2007 
Storey, P., et 
al. 
R2* imaging of transfusional iron burden at 3T and 
comparison with 1.5T 
J Magn Reson 
Imaging 
2007 
Pakbaz, Z., et 
al. 
Liver Iron Measurement by SQUID Biosusceptometry 
Compared to Liver Biopsy: A More Accurate Definition of 
Optimal Iron Range.  Blood 
2008 
Deugnier, Y., 
P. Brissot, 
and O. Loreal Iron and the liver: update 2008 J Hepatol, 
2008 
Dereure, O., 
et al. 
Measurement of liver iron content by magnetic resonance 
imaging in 20 patients with overt porphyria cutanea tarda 
before phlebotomy therapy: a prospective study.  
Acta Derm 
Venereol 
2008 
Dujardin, M., 
et al. 
Indications for body MRI Part I. Upper abdomen and renal 
imaging Eur J Radiol 
2008 
Virtanen, 
J.M., M.E. 
Komu, and 
R.K. Parkkola 
Quantitative liver iron measurement by magnetic resonance 
imaging: in vitro and in vivo assessment of the liver to muscle 
signal intensity and the R2* methods 
Magn Reson 
Imaging 
2009 
Taouli, B., 
R.L. Ehman, 
and S.B. 
Reeder Advanced MRI methods for assessment of chronic liver disease. 
AJR Am J 
Roentgenol 
2009 
Chandarana, 
H., et al. 
Hepatic iron deposition in patients with liver disease: 
preliminary experience with breath-hold multiecho T2*-
weighted sequence. 
AJR Am J 
Roentgenol 
2009 
Olthof, A.W., 
et al. 
Non-invasive liver iron concentration measurement by MRI: 
comparison of two validated protocols. Eur J Radiol 
2009 Vag, T., et al MR imaging findings of iron overload Radiographics 
2009 
Fischer, R. 
and P.R. 
Harmatz Non-invasive assessment of tissue iron overload. 
ASH 
Education 
Program 
Book 
2010 
Lim, R.P., et 
al.,  
Quantification of hepatic iron deposition in patients with liver 
disease: comparison of chemical shift imaging with single-echo 
T2*-weighted imaging.  
 AJR Am J 
Roentgenol 
2011 
Deugnier, Y. 
and B. Turlin  Pathology of hepatic iron overload 
Semin Liver 
Dis 
2011 
Meloni, A., et 
al. 
Feasibility, Reproducibility and Reliability for the T2* Iron 
Evaluation At 3T in Comparison with 1.5T.  Blood 
2011 
Meloni, A., et 
al. 
Feasibility, Reproducibility and Reliability for the T2* Iron 
Evaluation At 3T in Comparison with 1.5T.  Blood 
2012 Lv, W., et al. 
Value of abdominal susceptibility-weighted magnetic resonance 
imaging for quantitative assessment of hepatic iron deposition 
in patients with chronic hepatitis B: comparison with serum 
iron markers.  J Int Med Res 
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2012 Hou, P., et al. 
A practical approach for a wide range of liver iron quantitation 
using a magnetic resonance imaging technique. 
Radiol Res 
Pract 
2012 
Virtanen, 
J.M., et al. 
Iron overload: accuracy of in-phase and out-of-phase MRI as a 
quick method to evaluate liver iron load in haematological 
malignancies and chronic liver disease. Br J Radiol 
2013 
Tirnitz-
Parker, J.E.E., 
et al. Iron and Hepatic Carcinogenesis 
Critical 
Reviews in 
Oncogenesis 
2013 
Trottier, B.J., 
et al. 
Association of iron overload with allogeneic hematopoietic cell 
transplantation outcomes: a prospective cohort study using R2-
MRI-measured liver iron content. Blood 
2014 
Hernando, D., 
et al. 
Quantification of liver iron with MRI: state of the art and 
remaining challenges 
 J Magn 
Reson 
Imaging 
 
Table 1.1: List of literature regarding the quantification of liver iron with MRI 
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Chapter 2 
 This chapter discusses in detail the background theory of QSM. The relationship 
between the phase of the T2*-weighted signal is established, and is followed by a discussion 
of the general processing steps required to calculate a susceptibility map from raw phase data. 
There subsequently follows a detailed description of the various algorithms that have been 
chosen in this instance to perform the necessary processing steps. Finally, there is a 
discussion of QSM in general, and an argument for its use in liver imaging. 
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Background Theory 
 Magnetic resonance imaging (MRI) uses radio-frequency (RF) magnetic waves to 
probe the physicochemical environment of hydrogen protons within a subject.  RF energy is 
absorbed and subsequently re-emitted by a subject under examination, and the emitted signals 
provide physiological information that can be used to form an image. So far, the majority of 
MRI applications involve monitoring the magnitude of the signal at each point in a region of 
interest. Differences in the rates of signal relaxation give rise to image contrast, and by 
careful selection of the acquisition parameters the resulting image can be sensitised to a 
variety of time constants that impart information on the tissues being examined. 
 The MRI signal is complex, meaning that in addition to magnitude information, the 
phase of the signal at each point is also recorded. This information is often discarded in the 
interests of efficient use of computer memory, but it has been shown recently that the phase 
of T2*-weighted data - when correctly processed - can yield useful physiological information 
[2]
. MRI phase-based imaging can produce high contrast to noise ratio (CNR) images that are 
more sensitive to some physiological information than standard magnitude MRI imaging 
[3]
. 
 The phase of the T2*-weighted gradient echo (GRE) MRI signal is sensitive to 
variations in the magnetic field induced within a subject undergoing an MRI scan 
[4]
 . These 
variations are due to changes in the magnetic susceptibility throughout the biological tissue 
under examination, as well as shim imperfections and background field effects. Recently it 
has been shown that the phase distribution can be related to the underlying magnetic 
susceptibility of the subject through a magnetic dipole kernel 
[5]
. This has led to a new field of 
research called Quantitative Susceptibility Mapping. 
 Quantitative Susceptibility Mapping is a processing technique that produces images 
with exquisite anatomical detail, and, furthermore allows the relative quantification of 
magnetic susceptibility throughout a volume of interest (VOI) 
[6]
 . From this, information 
about the composition of the tissue can be inferred, providing clinically relevant information 
based on intrinsic properties of the tissue under interrogation 
[7, 8]
. 
 So far, the majority of the research into susceptibility mapping has focussed on 
neurological applications 
[9-12]
, wherein the technique promises to be extremely useful in the 
study of a wide range of neurodegenerative disorders such as Parkinson’s disease [13], 
Alzheimer’s disease [14], and Multiple Sclerosis [15]. There are, however a large number of 
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processes and pathologies that can affect physiological magnetic susceptibility, meaning the 
technique is not confined to the brain. The iron contained in blood for example, or 
calcifications that may accompany some forms of cancer mean that susceptibility mapping 
has the potential to find a wide range of non-neurological clinical use. As such, it is the aim 
of the work undertaken hence to investigate the use of QSM in pre-clinical applications, 
focussing primarily on the liver.  
  
 
2.1 PHASE 
 Phase based MRI techniques provide a means with which to measure variations in the 
magnetic field induced in a subject undergoing an MRI scan 
[2]
. There are a number of 
magnetically active components present in biological systems. As such, for purposes 
described here, volumes of interest within the system can be thought of as susceptibility 
distributions.  
When an otherwise homogeneous magnetic field passes through a susceptibility 
distribution, it gives rise to a characteristic field pattern. The phase of a GRE signal provides 
the means with which to measure variations within the field, and susceptibility mapping 
allows quantification of the underlying susceptibility distribution based on the recorded 
phase. Inferences can then be made regarding the composition of the tissue. As such, let us 
examine the origin of MRI phase data and its relationship to magnetic susceptibility. It should 
be noted that the susceptibility effects discussed throughout this body of work pertain 
specifically to those caused by magnetically active constituents of biological tissue that result 
in distortions of the B0 field. These are distinct from susceptibility artefacts, which cause 
distortion of the linear field gradients, resulting image misregistration. 
 MRI phase imaging is performed using a T2*-weighted gradient-recalled echo 
acquisition sequence. The T2*-weighted signal contains components from two relaxation 
mechanisms – pure T2, and T2’ [16]. Pure T2 decay is caused by dipole-dipole interactions 
that result in irreversible dephasing of the transverse magnetic signal. T2’ decay is a 
reversible effect caused by physiological magnetic susceptibility variation, as well as main 
magnetic field inhomogeneity, and chemical shift 
[17]
. It is the latter that is of interest when 
performing phase imaging. Hence a gradient echo sequence is used, as a spin echo will cancel 
the T2’ effects. 
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Fig 2.1: Schematic of RF quadrature coil 
[1] 
 MRI signals are commonly detected 
in quadrature. Quadrature coils consist of 2 
concentric RF pick-up coils that are oriented 
at 90
o
 to each other (fig. 2.1). They detect 
the signal simultaneously in both the x- and 
y- directions. Magnitude MRI utilises the 
modulus of the signal: 
          Smod = √(Sx
2
 + Sy
2
)                          [1] 
Conversely, phase MRI measures the change 
in the angle of orientation of the 
magnetisation vector, and is independent of 
the magnitude response: 
           φ = arctan (Sx / Sy)                         [2] 
  
 The Larmor frequency (ω) is equal to the product of the gyromagnetic ratio of the 
protons (hydrogen in this case) and the main magnetic field: 
ω = γ. B0                                      [3] 
The phase of a T2*-weighted signal can be expressed as the product of the Larmor frequency 
and time: 
                                                                     φ = φ0 + ω. TE                            [4] 
where φ0 is the initial phase offset and TE is the echo time, i.e. the time the signal is 
measured. The difference in phase between two regions can be expressed as:  
   Δφ = φ0 + Δω. TE                                [5]  
                                                     Δω = γ. ΔB                                    [6]                 
And, (neglecting chemical shift effects): 
                                                  ΔB = g. Δχ. B0                                  [7]                
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where g accounts for the geometry of the tissue, and χ is the volume magnetic susceptibility. 
Changes in the magnetic field due to shim imperfections and air-tissue interfaces are 
neglected as they will be suppressed during post-processing 
[18]
. As such, variation in the 
phase of the T2*-weighted signal will reflect distortions of the magnetic field. 
  Recent theoretical work has shown that the magnetic susceptibility of an irregular 
object can be calculated from the magnetic field distribution that results as the response of the 
object to a static magnetic field 
[5]
. T2*-weighted phase provides a means with which to 
measure the magnetic field distribution. 
 
2.2 MAGNETIC SUSCEPTIBILITY 
  Magnetic susceptibility is the degree to which an object becomes magnetised 
when exposed to a magnetic field 
[19]
: 
                                     M = χ H   ≡   χ (B0 / μ0)                               [8]                
Paramagnetic materials – those with a susceptibility greater than one – enhance the 
strength of a magnetic field that passes through them. Diamagnetic materials, whose 
susceptibility is less than one have the opposite effect. As such, an object held in a static 
magnetic field will distort the field according to its susceptibility distribution.  
  The distorted field can be interpreted as the convolution of the susceptibility 
distribution with a unit dipole response, and its description gives rise to a complicated 
function. Convolution theorem allows this to be expressed in the Fourier domain as a simple 
point-wise multiplication 
[20]
: 
                                  ΔBz(k) = B0 χ(k)                          [9] 
where ΔBz(k) is the measured field in the z-direction in k-space, and β is the angle between 
the k-vector and the static magnetic field such that 
[5]
:  
                                            =                                 [10] 
where kz is the k-vector in the z-direction, and K is the magnitude of the k-vector. Re-writing 
eqn. 9 and solving for χ: 
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       χ(k) =  / (  )                         [11] 
This equation allows the calculation of a susceptibility distribution from a measured magnetic 
field. The simplest solutions take advantage of convolution theorem, allowing the 
deconvolution of the distribution with the dipole response to be performed as a simple point-
wise division in k-space. Taking the inverse Fourier transform of the result gives the 
susceptibility distribution in real space. 
 
2.3 CALCULATION OF SUSCEPTIBILITY MAP 
 The input data to the susceptibility calculation is T2*-weighted phase data. This gives 
a measure of the distortion of the static B0 field caused by the susceptibility distribution of the 
sample, known as a field map. As mentioned however, the distortions of the magnetic field 
are due to contributions from a number of sources 
[4]
. The field contributions of interest must 
be extracted from the raw phase data in order to calculate a useful susceptibility map. The 
raw data is further confounded by the fact that phase can only be measured between the finite 
limits of ± π. Hence, large changes in susceptibility result in aliasing that must also be 
removed from the data prior to the susceptibility calculation. As such, there are three main 
steps involved when calculating a susceptibility map: Phase unwrapping, background field 
suppression, and finally the susceptibility calculation. 
 
2.3.1 Phase Unwrapping 
 Phase unwrapping is the name given to the process of removing the aliasing caused by 
the finite limits of phase. When values of phase exceed the boundaries of ± π, they “wrap” 
back to the origin and pass through their initial value repeatedly over time. In phase images 
this results in a series of light and dark bands across the image. Phase wrapping is a 
complication in a number of disciplines and is well known problem. There are numerous 
freely available algorithms that will perform spatial phase unwrapping 
[21-23]
. Multi-echo MRI 
images can also be unwrapped temporally 
[9, 24]
.  
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2.3.2 Background Field Suppression 
 A large portion of the literature regarding susceptibility mapping has been devoted to 
separating the extraneous phase contributions from those of interest 
[6, 25-27]
. The approaches 
can roughly be divided into two main groups: Heuristic and physical. 
 The sub-division of background suppression algorithms is essentially based on 
assumptions made about the background field. The underlying assumption inherent in the 
heuristic approaches is that the background field manifests itself as large, spatially slowly 
varying phase undulations across the image. As such, removal of the low-spatial frequency 
components from the image will suppress the background field. This leaves in-tact the high 
spatial frequency components of the signal, which are assumed to be the phase variations 
caused by the susceptibility distribution throughout the regions of interest 
[4]
. 
 Physical methods are more sophisticated, and use complex algorithms to manipulate 
the mathematical properties of the signal to separate the contributions to the phase data. It has 
been shown repeatedly that the physical approaches to background field suppression supply 
data that are superior to those derived by heuristic means 
[6, 20, 25]
. Heuristic approaches can 
only remove the background field if it is spatially slowly varying, which may not be the case 
[19]
. Physical solutions remove even high spatial frequency background field components 
while preserving contrast 
[6, 20]
. Hence, as the field of susceptibility mapping progresses, 
physical approaches are becoming the standard methods of background field suppression 
[8, 14, 
28]
.  
 The resultant images - known as field maps - depict the field shifts caused by 
variation in physiological magnetic susceptibility, and provide users with a contrast 
mechanism that is independent of the magnitude of the signal. The images have a high 
contrast to noise ratio, and this type of phase imaging is a pre-cursor to SWI and 
susceptibility mapping 
[2, 29]
.  
The anatomical accuracy of the field maps is undermined by the non-local 
relationship between phase shifts and susceptibility variations 
[9]
. Secondly, the measured 
phase shifts (and hence contrast) are dependent on the angle of the anatomical feature to the 
magnetic field 
[20]
. As such, there was strong impetus to overcome these difficulties. The 
solutions were provided by susceptibility mapping. 
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2.3.3 Susceptibility Calculation 
 The calculation of magnetic susceptibility from a field map is an ill-posed inverse 
problem. The reason becomes clear from a closer look at the inversion calculation: 
                                          χ(k) =  / (  )                             [12] 
As the values on the right hand side of the denominator approach 1/3, the numerator is 
divided by values that approach zero. As such, the susceptibility values approach infinity, 
resulting in severe streaking artefacts and noise amplification in the susceptibility map 
[27]
. 
The ambiguous values of the dipole kernel lie at the “magic angle”, a conic surface in k-space 
that lies at ~54.7
o
 to B0 
[9]
. Circumventing the inverse problem has been the focus of a number 
of studies, and several solutions have been explored. 
 The most reliable way of calculating a susceptibility map is to oversample the data by 
scanning the subject at several angles with respect B0 
[11]
. The images are then co-registered, 
and any values that are ambiguous at one orientation are compensated for in the others. While 
this allows the calculation of an artefact free susceptibility map, re-orienting the subject 
within the confined space in the bore of the scanner is not always possible, particularly in 
patients with restricted movement. Furthermore the scan time is increased by the number of 
acquisitions that are needed, the accuracy of the images is dependent on the registration 
algorithm, and it is now thought that magnetic susceptibility is anisotropic 
[30]
. As such, 
multi-orientation acquisitions are not practicable solutions to the inverse problem. 
 Clinical use of susceptibility mapping will most likely depend on those calculated 
from single orientation (SO) acquisitions. As such, SO solutions to the inverse problem 
almost always involve supplying a priori information to the inversion algorithm to 
compensate for ambiguity in the inversion kernel. Image space approaches usually involve 
providing information on organ shape to impose constraints on a minimisation function 
which is then solved iteratively 
[31-33]
. These have been shown to calculate high quality 
susceptibility maps but can be computationally cumbersome, sometimes taking up to several 
hours to perform the inversion 
[27]
. 
 Alternately, there are a number of k-space based approaches to performing the 
inversion calculation 
[4, 9, 20]
. K-space inversion algorithms take advantage of convolution 
theorem which allows operations to be performed as simple point-wise multiplication or 
21 
 
division in k-space. These are the simplest approaches to performing the inversion, and differ 
from real-space algorithms in that instead of supplying spatial information, the a priori data 
attempts to mitigate the problem by correcting, substituting or removing the ill-conditioned 
regions of the data before transformation back into image space. The resulting susceptibility 
maps are of lower quality than those calculated in image space 
[27]
, and there is an inherent 
trade-off between image quality and fidelity to the measurement (contrast) when deciding the 
boundaries of the ill-conditioned data. The advantages however lie in the simplicity of the 
algorithms, and the fact that the time to perform the calculation is of the order of seconds 
[9]
. 
 
2.3.4 Algorithms 
 There is a large variety of algorithms available for performing each operation in the 
QSM processing pipeline. As mentioned previously, each comes with its own advantages and 
drawbacks, and careful selection of algorithms is necessary for each undertaking. For 
example, it has been shown that heuristic methods of background field suppression deal 
poorly with unwanted high spatial frequency contributions, and the time taken to perform 
some inversion operations may not be suitable when dealing with very large data sets. 
Conversely, heuristic background field suppression can be useful if the experiment aims to 
examine small structures, and if an extremely high quality susceptibility map is required then 
a more cumbersome inversion may be necessary. 
 The algorithms employed in the pipeline used for this body of work were a Laplacian 
based SHARP algorithm, which performs both phase unwrapping and background field 
suppression in a single step, and a Thresholded K-space Division (TKD) algorithm to 
perform the inversion calculation. These were chosen as it was found that they provided good 
quality images while minimising processing time. There follows a discussion of how each 
performs its respective operation. 
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2.3.5 SHARP algorithm 
The approach to background field suppression used throughout the experimental work 
presented here is known as the Sophisticated Harmonic Artefact Reduction for Phase images 
(SHARP), which relies on the properties of a Laplacian operator to remove the unwanted 
phase contributions within a user defined ROI 
[6]
. 
 The measured magnetic field within a region of interest can be thought of as the 
summation of contributions from external (i.e. unwanted) and internal sources: 
                                             B
tot
  = B
ext
 + B
int
                               [13] 
The internal contributions are the result of variations in magnetic susceptibility within the 
ROI. They are orders of magnitude smaller than the external contributions, and so to map the 
susceptibility within the ROI the two must be separated. SHARP background field 
suppression techniques are based on the assumption that phase contributions from outside the 
ROI are harmonic throughout the region, i.e. that they give rise to functions that satisfy that 
Laplace equation; whereas those generated by sources from within the region of interest are 
anharmonic 
[34]
. As such, the second order derivative of the external contributions (i.e. the 
background field) within the ROI (as calculated via the Laplace equation) will equal zero: 
                                                                         ∇
2
 B
ext
 = 0;                                    [14] 
where ∇
2 
is the Laplacian operator. Hence: 
                                                                       ∇
2
 B
tot
 = ∇
2 
B
int
                                [15] 
 Solving this equation can be accomplished by taking advantage of the spherical mean 
value (SMV) theorem which states that a harmonic function is preserved when convolved 
with any non-negative, radially symmetric, normalised function. This allows separation of the 
respective field contributions, and hence isolation of the field shifts of interest 
[6]
. In practice, 
this is done in three steps:  
1: Convolution of the data set with a spherical kernel; 
2:  Masking the results to define the internal and external field contributions; 
3:  Deconvolution with the spherical kernel.  
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Convolution and deconvolution are performed in Fourier space as simple point-wise 
multiplication and division respectively. 
 The edges of the region of interest can prove troublesome however, as during 
convolution the spherical kernel incorporates values from outside the defined ROI, thus 
violating the SMV theorem 
[34]
.  This results in false extreme values around the outline of the 
subject in the processed images, which are unacceptable sources of noise when performing 
susceptibility mapping. One simple solution to this problem is to erode the binary mask 
applied in the second step, thus eliminating the problem areas from the processed phase data 
[35]
. 
 A further confounding factor when performing SHARP based processing is the 
presence of anharmonic contributions to B
ext
 caused by the initial phase offset at TE = 0. 
Mitigation of this source of noise can be accomplished by relaxing the condition that states 
that the unwanted contributions to the measured magnetic field are entirely harmonic 
throughout the ROI. This is done by truncated singular value decomposition (TSVD) of the 
deconvolution 
[6]
. 
 In practice, TSVD is carried out by providing a priori information to the algorithm. 
As the values of the spherical kernel approach zero, the values of the inverse kernel used for 
deconvolution become unacceptably large. TSVD essentially truncates the inverse kernel 
such that its values are set to zero whenever they fall outside a user defined threshold 
[35]
. 
This is explored experimentally in chapter 3 (sec. 3.2.1.1). 
 
2.3.6 Laplacian phase unwrapping 
 The SHARP algorithm can be modified such that it can be applied directly to wrapped 
phase data 
[35]
, performing both phase unwrapping and background field suppression in 
tandem. To do this, the algorithm incorporates a solution offered by Schofield and Zhu 
[36]
 
that shows that the unwrapped phase can be derived directly from the wrapped phase by 
recognising certain trigonometric properties. Hence the unwrapped phase is equal to: 
                                       ∇
2
 φunwr = (cos φwr . ∇
2sin φwr) – (sin φwr . ∇
2
 cos φwr)                 [16] 
where φunwr is the unwrapped phase and φwr is the wrapped phase 
[37]
. The result of the 
calculation is then deconvolved with the Laplacian operator to yield an unwrapped, 
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background field suppressed phase image. As before, the convolution and deconvolution 
operations are carried out in k-space. 
The combination of SHARP and Laplacian phase unwrapping was carried out in this 
instance by performing the three steps required by the SHARP algorithm using the following 
3D dimensional kernel: 
First plane     Second plane    Third plane  
The construction of this operator is based on the discrete form of the Laplacian equation in 
three dimensions 
[34]
, and returns an unwrapped, background field suppressed image. 
 
 
2.3.7 Thesholded k-space Division 
The simplest inversion method is the thresholded k-space division (TKD) algorithm 
[9]
. In order to solve the inverse problem the algorithm simply removes ambiguous values 
from the inversion kernel once a user defined threshold value is reached. The values are then 
replaced with the threshold value 
[9]
. This is the fastest inversion algorithm 
[27]
 and is easy to 
implement, however the removal of information compromises the accuracy of the 
susceptibility values 
[35]
. Careful selection of the threshold is extremely important, as removal 
of too much information compromises the susceptibility values (and hence image contrast), 
but including too much ambiguity compromises the image quality by increasing the severity 
of the streaking and noise amplification 
[9, 20, 35]
 (see chap. 3, sec. 3.2.2.1) The simplicity and 
speed of the TKD algorithm makes it an attractive solution to the inverse problem, and it has 
already been used in a number of clinical studies 
[13, 38, 39]
. In addition to this, there have been 
attempts to derive a correction factor for images of the brain at 3T to counteract the systemic 
underestimation of susceptibility values caused by thresholding 
[35]
. 
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Fig 2.2 A – D: Images depicting each step of the processing pipeline. A: Magnitude Image w/ water 
reference, B: Raw Phase data w/ water reference, C: Segmented, unwrapped, background corrected field map 
(SHARP), D: Susceptibility Map (TKD inversion). Note the blood vessel (red arrow) in the susceptibility 
map is more visible than on the field map due to the localised contrast.  
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2.4 QUANTITATIVE SUSCEPTIBILITY MAPPING 
While still in relative infancy, susceptibility mapping promises to be an extremely 
beneficial addition to the clinical MRI techniques that are currently available. The non-
invasive measurement of magnetic susceptibility has been sought across a number of 
disciplines for a number of reasons. For example: biosusceptometry has been used to 
investigate liver iron stores 
[40]
, drug delivery systems 
[41]
, and in the treatment of liver 
diseases such as thalassemia  
[42]
. As such, the extension of susceptometry to MRI seems a 
natural progression. 
Susceptibility weighted imaging (SWI) is a phase based MRI technique that is seen as 
the progenitor of QSM. SWI involves the derivation of a positive or negative phase mask 
which is used to enhance contrast in magnitude images 
[3]
. It is reasonably well established as 
a clinical technique, and has been used in the brain to examine changes in cerebral iron 
deposition 
[43]
, to enhance cerebral vascular structures 
[44, 45]
, and to evaluate brain lesions 
[46]
. 
In addition to this there have been numerous studies that have implemented SWI in 
abdominal organs 
[47-49]
. While SWI is a useful clinical tool, there are a number of inherent 
drawbacks when compared to QSM. 
The phase masks used in SWI are derived from field maps, so the contrast is both 
non-local and dependent on the orientation of the object to the magnetic field 
[9, 50]
.This is 
overcome by the inversion procedure in QSM, so does not present an issue in susceptibility 
maps. Secondly, susceptibility weighted images can only show positive or negative shifts in 
susceptibility, whereas susceptibility maps can display both on the same image. This allows 
differentiation between blood products and calcifications for example 
[8]
. Thirdly, 
susceptibility weighted images are not quantitative, and so while they can highlight 
differences in deoxyhaemoglobin concentrations in the blood, or iron in the brain, 
comparison between cohorts is far less precise. 
There have been a number of clinical applications explored with QSM. Initial 
investigations focussed on quantifying the changes in focal iron deposits in the brain 
associated with a variety of neurodegenerative disorders, including Parkinson’s [51] and 
Alzheimer’s disease [14]. Some of these studies have since progressed to mid-sized (~50 
patients) longitudinal clinical trials 
[52, 53]
. 
27 
 
It has been shown that QSM is sensitive to changes in myelination that are associated 
with the onset of Multiple Sclerosis (MS), and it has even been suggested that QSM may be 
more sensitive than R2* at the earliest stages of the disease 
[51]
. More recently, there has been 
a degree of interest generated in using QSM to estimate changes in the deoxyhaemoglobin 
content of blood. It is known that the susceptibility of blood is linearly related to its 
deoxyhaemoglobin content 
[54]
, and that changes in deoxyhaemoglobin are directly indicative 
of changes in blood oxygen saturation.  
Deoxyhaemoglobin (dHb) is paramagnetic, however when oxygen binds to 
haemoglobin it has a profound effect on the magnetic signature of the molecule, turning 
paramagnetic dHb into diamagnetic oxyhaemoglobin (Hb). QSM has afforded a novel way to 
exploit this difference, and has given rise to a number of studies attempting to estimate 
changes blood oxygen saturation (SO2) from measured differences in susceptibility. For 
example, it has been shown recently that QSM can differentiate between cerebral venous 
blood under normoxic and hyperoxic conditions, which could play a role in detecting 
differences brought about by neurological pathophysiology 
[39, 55]
. Other studies have sought 
to use QSM to quantify the Cerebral Metabolic Rate of Oxygen (CMRO2) on a global and 
regional basis - an important tool for assessing metabolic changes associated with strokes, 
tumours, and some neurodegenerative disorders 
[56-58]
. It is this area of research that is of 
particular interest for application to the liver. Table 1 at the end of the chapter contains an 
extensive but not exhaustive list QSM literature. 
 
2.5 QSM in the liver 
The use of phase imaging in the liver is not a new phenomenon. SWI has been the 
subject of a number of papers that have aimed to examine a diverse range of disease states. 
For instance, it was found in a feasibility study that decreases in the liver-to-muscle signal 
intensity ratio as measured on a susceptibility-weighted image correlated strongly with 
increasing grades of liver fibrosis 
[59]
. In another study it was found that SWI was better at 
identifying certain morphological features that are associated with hepatocellular carcinoma 
(e.g. pseudo-capsules, haemorrhage) than conventional MR imaging 
[60]
, and in a study 
focussing on liver cirrhosis it was found that SWI provided the most sensitive method to 
detect the siderotic regenerative nodules associated with the disease 
[61]
.  
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The aim of the work carried out in this thesis focusses entirely on pre-clinical models. 
While there have been attempts to implement QSM in the pre-clinical kidney, the work was 
ex-vivo 
[62]
. Implementation of QSM in an in-vivo pre-clinical liver has never been performed 
before, and will offer a number of advantages over clinical imaging. Firstly, pre-clinical 
imaging can be carried out at high field strengths, allowing high resolution images to be 
acquired with excellent SNR. All of the experiments conducted presently were performed 
using a 9.4T MRI scanner. Secondly, models of human diseases can be induced in pre-
clinical subjects, allowing a thorough comparison of healthy and disease cohorts. Thirdly the 
burden of ethics is significantly lower for performing pre-clinical trials, allowing far more 
experimental procedures to be carried out on the test subjects. The latter is particularly 
prevalent when attempting to implement and develop the application of novel imaging 
techniques. 
We are particularly interested in the ability of QSM to quantify changes in blood 
oxygen saturation. As discussed, the liver derives its blood supply in a unique manner, and 
under normal conditions there is a balance between the blood supplied by the portal vein and 
hepatic artery. Disruption of this balance is well known to be indicative of a number of 
disease states 
[63, 64]
, and deterioration of hepatic homeostasis is associated with a high 
morbidity rate. We believe that this creates an opportunity to study liver pathologies using 
QSM, as it has been shown that QSM correlates more strongly with iron than comparable 
techniques such as R2* imaging 
[9]
. Furthermore, the quantitative nature of QSM allows not 
only the observation of changes in blood oxygen, but also the calculation of changes in the 
absolute value of SvO2 that show good agreement with invasively measured values. This has 
been shown in cerebral blood the literature 
[55]
, and will be shown here in chapter 4 (sec 
4.2.4.). 
Colorectal liver metastases (CRLM), for example, are secondary cancers that have 
spread from the colon. The condition is associated with poor prognosis, and there have 
previously been a number of MRI studies focussed on CRLM. Haemodynamic response 
imaging (HRI) for example has explored the use of endogenous contrast in the form of 
BOLD imaging to improve the diagnosis of CRLM 
[65]
, as well as to assess the changes in the 
vascular profile of tumours 
[66]
. The advantage offered by QSM in this instance is that 
susceptibility mapping is independent of imaging parameters such as field strength, and 
overcomes the directional dependence of R2* mapping and SWI. It has been shown that as 
the tumours grow, they receive blood primarily from the hepatic artery 
[63, 67]
. It will be 
29 
 
shown that the difference in the deoxyhaemoglobin concentration of blood in the portal vein 
and hepatic artery means that it is possible to differentiate between tumours and healthy liver 
tissue, and, furthermore, that it is possible to use QSM in conjunction with a gas challenge to 
assess the vascularity and oxygenation status of the tumours (chapter 5). 
Similarly, liver cirrhosis is caused by a chronic scarring of the liver tissue. This 
reduces the functionality of the hepatocytes, and causes a deterioration of the elasticity of the 
tissue. As a result, the blood pressure in the portal vein is rendered insufficient, and the blood 
cannot enter the hepatic plates. In order to prevent hypoxia, the blood supplied by the arterial 
source is increased, thus increasing the amount of oxygenated blood supplied to the liver. 
Furthermore, hepatic siderosis is a known facet of cirrhosis 
[61]
. The ability to use QSM to 
assess the extent of cirrhosis based on changes in liver iron and tissue oxygenation will be 
investigated in chapter 6. 
The sensitivity of phase-based MR imaging techniques to variations in physiological 
susceptibility means that they are well placed to examine hepatic diseases, and it is thought 
that QSM can offer a number of further advantages. For example, it has been shown that 
QSM correlates more strongly with iron stores than R2* measurements 
[9]
, and the localised 
nature of the contrast means that the images aren’t beset by the blooming artefacts known to 
affect SWI and R2* images 
[9]
. Furthermore, it has been shown in the literature that the 
quantitative nature of QSM allows the calculation of venous oxygen susceptibility (SvO2) 
[55]
. 
While cerebral SvO2 has been the focus of a number of experiments, it is relatively underused 
in the liver, even though several studies have shown it to be an eminently useful parameter 
[68-70]
. On this basis it is hypothesised that QSM will prove to be an advantageous addition to 
existing hepatic imaging techniques. The latter half of this thesis contains a number of novel 
applications of QSM, however the highly experimental nature of the work necessitates 
extensive optimisation of both data acquisition and QSM image processing. This will be the 
focus of the upcoming chapter. 
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Author Year Title Journal 
Liu, T. 2010 
Unambiguous identification of superparamagnetic iron oxide particles 
through quantitative susceptibility mapping of the nonlinear response to 
magnetic fields 
Magn Reson 
Imaging 
Li, W. 2011 
Quantitative susceptibility mapping of human brain reflects spatial 
variation in tissue composition Neuroimage 
Klohs, J. 2011 
Detection of cerebral microbleeds with quantitative susceptibility mapping 
in the ArcAbeta mouse model of cerebral amyloidosis 
J Cereb Blood 
Flow Metab 
Schweser, F. 2012 
Quantitative susceptibility mapping for investigating subtle susceptibility 
variations in the human brain Neuroimage 
Liu, J. 2012 
Morphology enabled dipole inversion for quantitative susceptibility 
mapping using structural consistency between the magnitude image and 
the susceptibility map Neuroimage 
Langkammer, 
C. 2012 
Quantitative susceptibility mapping (QSM) as a means to measure brain 
iron? A post mortem validation study Neuroimage 
Bilgic, B. 2012 
MRI estimates of brain iron concentration in normal aging using 
quantitative susceptibility mapping Neuroimage 
Liu, T. 2012 
Accuracy of the morphology enabled dipole inversion (MEDI) algorithm for 
quantitative susceptibility mapping in MRI 
IEEE Trans Med 
Imaging 
Wong, R. 2012 
Visualizing and quantifying acute inflammation using ICAM-1 specific 
nanoparticles and MRI quantitative susceptibility mapping 
Ann Biomed 
Eng 
Wang, S. et. al. 2013 
Hematoma volume measurement in gradient echo MRI using quantitative 
susceptibility mapping Stroke 
Deistung, A. 2013 
Quantitative susceptibility mapping differentiates between blood 
depositions and calcifications in patients with glioblastoma PLoS One 
Acosta-
Cabronero, J. 2013 In vivo quantitative susceptibility mapping (QSM) in Alzheimer's disease PLoS One 
Xie, L. 2013 
Quantitative susceptibility mapping of kidney inflammation and fibrosis in 
type 1 angiotensin receptor-deficient mice NMR Biomed 
Zheng, W. 2013 
Measuring iron in the brain using quantitative susceptibility mapping and 
X-ray fluorescence imaging Neuroimage 
Lim, I. A. 2013 
Human brain atlas for automated region of interest selection in 
quantitative susceptibility mapping: application to determine iron content 
in deep gray matter structures Neuroimage 
Deistung, A. 2013 
Toward in vivo histology: a comparison of quantitative susceptibility 
mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high 
magnetic field strength Neuroimage 
Wang, S. 2013 Noise Effects in Various Quantitative Susceptibility Mapping Methods 
IEEE Trans 
Biomed Eng 
Li, W. 2014 
Integrated Laplacian-based phase unwrapping and background phase 
removal for quantitative susceptibility mapping NMR Biomed 
Balla, D. Z. 2014 Functional quantitative susceptibility mapping (fQSM) Neuroimage 
Xu, B. 2014 
Flow compensated quantitative susceptibility mapping for venous 
oxygenation imaging 
Magn Reson 
Med 
Liu, C. et. al. 2015 
Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical 
Applications Tomography 
Ozbay, P. S. 2015 
Effect of respiratory hyperoxic challenge on magnetic susceptibility in 
human brain assessed by quantitative susceptibility mapping (QSM) NMR Biomed 
Sun, H. 2015 
Validation of quantitative susceptibility mapping with Perls' iron staining 
for subcortical gray matter Neuroimage 
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Zhang, J. 2015 
Quantitative mapping of cerebral metabolic rate of oxygen (CMRO2 ) using 
quantitative susceptibility mapping (QSM) 
Magn Reson 
Med 
Xu, B. 2015 
Quantification of cerebral perfusion using dynamic quantitative 
susceptibility mapping 
Magn Reson 
Med 
Wang, Y. 2015 
Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue 
magnetic biomarker 
Magn Reson 
Med 
Sun, H. 2015 Quantitative susceptibility mapping using single-shot echo-planar imaging 
Magn Reson 
Med 
Sharma, S. D. 2015 
Quantitative susceptibility mapping in the abdomen as an imaging 
biomarker of hepatic iron overload 
Magn Reson 
Med 
Dimov, A. V. 2015 
Joint estimation of chemical shift and quantitative susceptibility mapping 
(chemical QSM) 
Magn Reson 
Med 
Deng, W. 2015 
Iterative projection onto convex sets for quantitative susceptibility 
mapping 
Magn Reson 
Med 
Haacke, E. M. 2015 Quantitative susceptibility mapping: current status and future directions 
Magn Reson 
Imaging 
Barbosa, J. H. 2015 
Quantifying brain iron deposition in patients with Parkinson's disease using 
quantitative susceptibility mapping, R2 and R2 
Magn Reson 
Imaging 
Liu, C. 2015 
Susceptibility-weighted imaging and quantitative susceptibility mapping in 
the brain 
J Magn Reson 
Imaging 
Dong, J 2015 
Simultaneous phase unwrapping and removal of chemical shift (SPURS) 
using graph cuts: application in quantitative susceptibility mapping 
IEEE Trans Med 
Imaging 
Reichenbach, 
J. R. 2015 Quantitative Susceptibility Mapping: Concepts and Applications 
Clin 
Neuroradiol 
Schweitzer, A. 
D. 2015 
Quantitative susceptibility mapping of the motor cortex in amyotrophic 
lateral sclerosis and primary lateral sclerosis 
AJR Am J 
Roentgenol 
Murakami, Y. 2015 
Usefulness of quantitative susceptibility mapping for the diagnosis of 
Parkinson disease 
AJNR Am J 
Neuroradiol 
Schweser, F. 
et. al. 2016 
Foundations of MRI phase imaging and processing for Quantitative 
Susceptibility Mapping (QSM) Z Med Phys 
Hsieh, M. C. 2016 
Quantitative Susceptibility Mapping-Based Microscopy of Magnetic 
Resonance Venography (QSM-mMRV) for In Vivo Morphologically and 
Functionally Assessing Cerebromicrovasculature in Rat Stroke Model PLoS One 
Du, G. 2016 Quantitative susceptibility mapping of the midbrain in Parkinson's disease Mov Disord 
Zhang, Y. 2016 
Longitudinal change in magnetic susceptibility of new enhanced multiple 
sclerosis (MS) lesions measured on serial quantitative susceptibility 
mapping (QSM) 
J Magn Reson 
Imaging 
Chang, S. 2016 
Quantitative Susceptibility Mapping of Intracerebral Hemorrhages at 
Various Stages 
J Magn Reson 
Imaging 
Kudo, K. 2016 
Oxygen extraction fraction measurement using quantitative susceptibility 
mapping: Comparison with positron emission tomography 
J Cereb Blood 
Flow Metab 
Moon, Y. 2016 
Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's 
Dementia Using Quantitative Susceptibility Mapping Imaging 
J Alzheimers 
Dis 
Stuber, C. 2016 
Iron in Multiple Sclerosis and Its Noninvasive Imaging with Quantitative 
Susceptibility Mapping Int J Mol Sci 
van Bergen, 
J.M.G. 2016 
Quantitative Susceptibility Mapping Suggests Altered Brain Iron in 
Premanifest Huntington Disease 
American 
Journal of 
Neuroradiology 
Xie, L. 2016 
Dynamic contrast-enhanced quantitative susceptibility mapping with 
ultrashort echo time MRI for evaluating renal function 
Am J Physiol 
Renal Physiol 
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Zhang, Y. 2016 
Quantitative Susceptibility Mapping and R2* Measured Changes during 
White Matter Lesion Development in Multiple Sclerosis: Myelin 
Breakdown, Myelin Debris Degradation and Removal, and Iron 
Accumulation 
AJNR Am J 
Neuroradiol 
Tan, H. 2016 
Quantitative Susceptibility Mapping in Cerebral Cavernous Malformations: 
Clinical Correlations 
AJNR Am J 
Neuroradiol 
Wei, H. 2017 
Joint 2D and 3D phase processing for quantitative susceptibility mapping: 
application to 2D echo-planar imaging NMR Biomed 
Santin, M. D. 2017 
Reproducibility of R2 * and quantitative susceptibility mapping (QSM) 
reconstruction methods in the basal ganglia of healthy subjects NMR Biomed 
Lauzon, M. L. 2017 
Quantitative susceptibility mapping at 3 T: comparison of acquisition 
methodologies NMR Biomed 
Sharma, Samir 
D. 2017 
MRI-based quantitative susceptibility mapping (QSM) and R2* mapping of 
liver iron overload: Comparison with SQUID-based biomagnetic liver 
susceptometry 
Magnetic 
Resonance in 
Medicine 
Straub, S. 2017 
Suitable reference tissues for quantitative susceptibility mapping of the 
brain 
Magn Reson 
Med 
Hsieh, M. C. 2017 
Investigating hyperoxic effects in the rat brain using quantitative 
susceptibility mapping based on MRI phase 
Magn Reson 
Med 
Straub, Sina 2017 
Potential of quantitative susceptibility mapping for detection of prostatic 
calcifications 
Journal of 
Magnetic 
Resonance 
Imaging 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.1: Non-exhaustive list of QSM literature. 
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Chapter 3 
 Chapter 3 outlines the implementation of QSM in the preclinical liver, and is divided 
into two sections. The first section (3.1) pertains to the acquisition of the data, detailing the 
various parameters selected for the acquisition sequence, as well as modifications to the 
sequence such as flow compensation, that were found to be necessary. Chapter 3.1 also 
contains some preliminary experimental work, including susceptibility maps calculated from 
data acquired from a pre-clinical liver in-vivo, as well as a justification for acquiring 2D vs 
3D data in the experiments exploring novel applications that follow. Finally there is a brief 
discussion of the influence of liver fat on QSM images in this context. 
 The second section (3.2) pertains to the processing of the data, and outlines the 
experimental work undertaken to empirically optimise the series of algorithms required to 
calculate a susceptibility map from raw T2*-weighted phase data, and, furthermore, 
characterises the impact that the interaction between the algorithms has on the final image. 
Lastly, a novel method to compensate for the inherent underestimation of susceptibility 
values calculated using the selected inversion algorithm is presented. 
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OPTIMISATION 
3.1 Acquisition 
 With the exception of a handful of papers 
[3, 4]
, research into the use of susceptibility 
mapping has so far focussed exclusively on the brain, and there are even fewer studies 
exploring preclinical models 
[5-7]
. The novelty of the work undertaken as part of this thesis 
necessitated a degree of optimisation before QSM could successfully be implemented in a 
preclinical liver. For example, it was found that the large vessels and high degree of blood 
flow in the liver required modification of the acquisition sequence to mitigate artefacts. 
Secondly, while the particular processing pipeline selected for the main experiments that 
follow has been shown to yield clinically relevant data in the brain 
[8, 9]
, implementation in a 
preclinical liver at high field strengths required a degree of calibration of the various 
algorithms. As such, the following chapter aims to justify the data acquisition procedure and 
processing pipeline that was be used for the remainder of the experiments detailed in the 
upcoming chapters. 
 
3.1.1 Acquisition parameters 
The fidelity of a susceptibility map to the physiological environment it represents 
relies on the input of high quality data to the inversion algorithm. This is particularly true 
when using TKD inversion, as it is prone to noise amplification which can have deleterious 
effects on the measurements derived from the images. It is, however equally important to 
minimise the length of time each animal is under anaesthetic. As such, selection of 
acquisition parameters must strike a careful balance between maximising SNR and 
minimising acquisition time. Some parameters need to be tailored to individual mice or 
specific studies, but others can be standardised for all experiments. There follows a brief 
discussion of the acquisition parameters employed in the experiments that follow. 
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3.1.1.1 Echo Time 
 Quantitative Susceptibility Maps are derived from the phase (φ) of GRE data, which 
is equal to:  
                                  φ = φ0 + γ. B. TE                         [1] 
where φ0 is the initial phase offset,  γ is the gyromagnetic ratio of the (hydrogen) protons, B is 
the local magnetic field, and TE is the echo time. Of these, the first two are a constants and 
the second is effectively the measurand, so from a data acquisition standpoint the echo time is 
the experimentally defined parameter which enables control of the signal. 
 Optimising the echo time is an important consideration when performing QSM, as 
contrast in the final image will depend on the extent of the distinction between tissues based 
on their respective phase. Phase evolves over time, and increasing the time between 
excitation and acquisition will allow small differences in susceptibility to become apparent. 
Conversely, for reasons that will be discussed below, it is imperative that the field map has a 
high signal to noise ratio (SNR). When magnitude SNR is greater than ~3, the noise in a 
phase image is inversely proportional to the magnitude SNR 
[10]
. As such, it is also desirable 
to minimise the echo time in order to boost SNR. There is general agreement in the literature 
that an echo time equal to the T2* value of the tissue offers the optimal compromise 
[11]
.  The 
T2* value of a healthy mouse liver was measured using a multi-GRE technique. Briefly, a 
multi-echo image of a healthy mouse liver was acquired at 9.4T. A T2* map of the liver was 
calculated by first calculating the logarithm of the exponential T2* decay at each point in the 
image. A linear fit was then performed on a voxel-wise basis, and the slope of the linear fit 
was taken to be the T2*-value at each point. The mean value in a region liver tissue was then 
taken as the T2* value of the tissue, and was found to be ~4ms at 9.4T. This process is 
depicted in figure 3.1. This is the echo time used for all of the main experiments that follow. 
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3.1.1.2 Respiratory gating 
All in-vivo acquisitions were respiratory-gated. This was done by monitoring the 
animals breathing rate with a pressure sensitive respiratory monitor (SA Instruments, Stony 
Brook, NY, USA) while they were in the scanner. Data were acquired only during a flat 
region of the respiratory cycle (i.e. between breaths) in order to avoid respiratory related 
motion artefacts in the image. 
 
 
 
 
 
Figure 3.1: Calculation of liver T2* 
relaxation at 9.4T. The graph in A shows the 
T2* decay in a single voxel as echo time 
increases. B depicts the calculated logarithm 
of the T2* decay, as well as the linear fit. C 
shows a T2*-map of the liver of a healthy 
mouse acquired at 9.4T (axial orientation). 
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3.1.1.3 Repetition Time & Flip Angle 
The T1 of the liver at 9.4T is relatively long (>1s) 
[12]
 compared to lower field 
strengths. In order to minimise T1 influence on the acquired images, each was acquired at a 
repetition time of 1s. In order to maximise magnitude SNR a flip angle of 70
o
 was chosen as 
it is close to the Ernst angle for the above TR and T1 values. 
 
3.1.1.4 Resolution & Averages 
Only the z-component of the magnetic field will differ significantly from zero in 
response to the susceptibility distribution 
[13]
. As such, the number of sampling points will be 
specified by the number of slices in an axial oriented acquisition. These must be sufficiently 
numerous to give a reasonable facsimile of the distorted field. It was found that 60 – 100 
slices of 200 µm thickness (mice), or 300 µm thickness (rats) would cover the entire liver at a 
sufficient resolution. These slice thicknesses was chosen as they are the upper limit of 
resolution achievable with this scanner under these circumstances. 
It was shown in a phantom experiment detailed in the literature that a voxel aspect to 
slice thickness ratio above 1:2 resulted in a deviation from the expected susceptibility, which 
was ascribed to partial volume effects
[14]
. As such, the matrix size in the phase and frequency 
encode directions employed throughout the experimental work were selected such that the 
voxels were isotropic, and were tailored to the FOV required to ensure each individual animal 
was entirely contained within the image. 
The number of signal averages acquired for the animals in each study was dependent 
on their tolerance of the anaesthetic. As such, signal averages were limited to 4 for disease 
cohorts. This was doubled for healthy young animals. 
 
3.1.2 FLOW COMPENSATION 
Flow compensation is a well-known modification of MRI acquisition sequences that 
improves the quality of images when first order laminar flow is present in an area under 
examination. During a standard acquisition, a signal is excited with a resonant RF pulse. 
Magnetic gradients are applied for spatial localisation (i.e. phase encoding and read 
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dephasing), and a “readout” gradient is then applied at a predetermined time such that the 
isochromats rephase, and the echo is realised. This however is true only in the case of static 
isochromats. Any non-stationary spin packet, e.g. those within the blood vessels, will not 
rephase upon read-out, resulting in magnitude signal loss.  
The effect is equally detrimental to phase images. The phase of the GRE signal is 
essentially a measure of the extent of the precession of the isochromats at a given (echo) 
time. Isochromats accumulating extra phase as they move through magnetic gradients will 
distort local field estimations, leading to erroneous susceptibility measurements. Flow 
compensation involves modifying the acquisition sequence by adding extra gradients that are 
designed to ensure all of the isochromats rephase upon readout. 
Initial applications of QSM were mostly concerned with assessing changes in the 
focal centres of iron in the brain, and so were not affected by blood flow. Advances in the 
field however have given rise to a number of QSM applications for which flow compensation 
has been crucial. For instance, QSM venography has been applied to a preclinical model of 
stroke 
[7]
, which involved the detection of small cerebral blood vessels. The image distortion 
caused by blood flow would most likely prove detrimental in this scenario. Equally, there 
have been a number of studies attempting to quantify cerebral venous oxygen saturation 
(SvO2) through susceptibility measurements 
[9, 15, 16]
. Accurate estimation of SvO2 depends on 
the linear relationship of deoxyhaemoglobin content and magnetic susceptibility, and in the 
presence of uncompensated flow this linearity is severely undermined 
[16]
. 
 The blood vessels contained within the liver are extremely abundant and large relative 
to those in the brain, meaning that there are large volumes of blood entering, leaving and 
passing through the liver during the acquisition sequence. As such, a series of short 
experiments were carried out to assess the necessity of flow compensation in the liver. There 
follows a brief discussion of the implementation of flow compensation in this instance, and 
an analysis of its effect on the Quantitative Susceptibility Maps derived thereafter. 
 
3.1.2.1 Implementation 
The effect a gradient has on the precession of an isochromat during the course of a 
pulse sequence can be described by its moment. Positive and negative gradients will have 
opposing effects, and the extent to which they do will depend on their strength and duration. 
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In order to ensure all spins rephase at the desired echo time, the area under the positive and 
negative curves described by each gradient waveform must sum to zero. Gradient Moment 
Nulling (GMN) refers to the technique that ensures that this condition is met. 
Gradient moments can be nulled to varying degrees, referred to as orders. Zeroth-
order moment nulling ensures that all stationary spins rephase at the desired echo time, and is 
included in virtually all pulse sequences. The situation becomes more complex when a ROI 
contains both stationary and moving spins, and it is the objective of higher order moment 
nulling to ensure that the total phase dispersion is zero for all spins at the echo time whether 
they are stationary or not. As such, first-order nulling is pertinent to spins that move through 
the gradient at a constant velocity, second order nulling refers to spins moving at a constant 
acceleration, and so on. GMN is performed by including extra lobes on a gradient waveform 
of sufficient strength, duration and polarity such that all spins up to the desired order will 
rephase upon read-out.  
In the interests of clarity, let us examine a velocity compensated slice select gradient, 
where lobe 1 is the refocussing gradient, and lobe 2 is the velocity compensating gradient (fig 
3.1). 
 
 
Fig 3.2: A velocity compensated slice select gradient
[1]
. 
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The amplitude and duration of the slice select gradient are represented by Gs and Ts 
respectively, the widths of the lobes are w1,2, and rs is the gradient ramp time. The goal of the 
exercise is to calculate the widths, amplitudes and shape of the unknown lobes 1 & 2, such 
that the net area under the waveform is equal to zero, i.e. that: 
                                         A1 = A2 + As                                         [2] 
where A denotes the absolute value of the area under each lobe, and As is the area 
from the RF isodelay point to the end of the slice selection lobe (i.e. t = 0).  
Manipulation of the gradient waveform requires modification of the programme that 
dictates the sequence protocol. Each gradient is treated separately, so compensation can be 
applied to each cardinal direction individually, or any combination thereof. To ensure the 
extra lobes are of the appropriate size etc., they are described by a series of equations that 
incorporate information from the sequence protocol, and calculate the required amplitude and 
duration accordingly. So, for example, A2 in eqn. 1 can be calculated using the equation (as 
derived in Bernstein)
[1]
: 
 
                                   [3] 
 
where h is the maximal gradient amplitude, r is the minimal rise time from 0 to h, and ms is 
the absolute value of the first moment of the slice select lobe. The variables h, r, are directly 
calculated during the execution of the sequence, and both ms and As can be calculated from 
sequence parameters. The variables A2 and As can then be used to calculate A1 (eqn. 1), and 
the gradients of lobes 1 & 2 can be calculated such that their net area sums to zero, thus 
nulling the 1
st
 moment of the sequence. Similar equations allow the calculation of gradients 
that will null the first moment of the frequency and phase-encode gradients. For the 
experimental work below, flow compensation was applied in all three directions, so the 
sequences are said to be fully first-order flow compensated. 
The Agilent scanner used for these experiments offers two possible options when 
implementing GMN. The first is to programme the acquisition such that the individual 
gradient waveforms run in a sequential fashion. While this is easy to implement from a 
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programming point of view, the extra lobes come with a time penalty that may increase the 
echo and repetition times to an unacceptable degree.  
The second option is to take advantage of the gradient kernel programming capability 
built into the Agilent paradigm. Instead of running each gradient sequentially, this removes 
the blocking constraints imposed on the sequence, and allows individual waveforms to 
arbitrarily overlap. The individual waveforms are combined into a single compound gradient 
shape, which has the effect reducing the minimum echo and repetition times. Upon 
implementation it was found that the required echo time necessitated programming the 
acquisition sequence in kernel form. 
Implementation of flow compensation was done in two stages. The first stage was 
conducted entirely on a flow phantom, as this allowed on-line sequence development without 
the use of animals. Once it was established that the sequence could successfully compensate 
for laminar flow, in-vivo animal data was acquired with and without flow compensation in 
order to gauge the effect on the subsequent susceptibility maps. 
 
3.1.2.2 Stage I – Flow Phantom 
The flow phantom was constructed in-house, and consisted of a 15 ml falcon tube 
filled with agar (figure 3.3). A hole was cut in the top and bottom of the falcon tube, through 
which a thin flexible plastic pipe was inserted such that the direction of the pipe was parallel 
to that of the falcon tube. The pipe was connected at either end to a water bath and pump that 
were outside the scan room so that when the pump was turned on water flowed at a constant 
rate in a closed system. 
The tube was positioned in the scanner such that the flow was perpendicular to the 
main magnetic field. The dataset consisted of 3 GRE acquisitions: 
Acq 1: No flow, no flow compensation 
Acq 2: Flow, no flow compensation 
Acq 3: Flow, flow compensated sequence. 
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The acquisition parameters were as such: B0 = 9.4T, TR = 1000 ms, TE = 8.9 ms, FA = 70
o
, 
FOV = 30 x 30 x 23 mm, Matrix = 128 x 128 x 50, Voxel = 234 x 234 x 460 µm, bandwidth 
= 50 kHz, average = 1. 
 Susceptibility maps were calculated from the raw phase data of each acquisition using 
the SHARP and TKD algorithms discussed in chapter 2. Images were examined by visual 
inspection, and susceptibility was measured in the agar and in the pipe. The susceptibility 
shift is quoted in ppb, and is the difference in susceptibility between the two regions. The 
standard deviation of the susceptibility within the pipe is also compared as a measure of the 
success of the flow compensation. 
 
 
 
 
 
 
 
 
Figure 3.3: Photograph of flow phantom. 
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3.1.2.2.1 Stage I – Results 
 
 
 
. 
Figure 3.4 shows a trio of images from each dataset. Columns 1 – 3 are populated by 
Acq. 1- 3 respectively. The top row contains magnitude images, the second row contains the 
corresponding phase images, and the bottom row contains the subsequent susceptibility maps. 
All images are shown in sagittal orientation 
In the magnitude image with no flow, the water is hyperintense from the top to the 
bottom of the image with respect to the agar. In the image with no flow compensation the 
water and the agar are of almost the same intensity, while in the image with flow 
compensation the water is also hyperintense, but the contrast seems to drop off slightly at the 
top and bottom of the image. 
Figure 3.4 A- I: Images from data acquired with no flow (A, D, G), flow but no compensation (B, E, H), and 
flow with compensation (C, F, I). The top row contains magnitude images from each acquisition, the second 
row is the raw phase data, and the third row contains the corresponding susceptibility maps. 
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The raw phase images are contained in the second row (D - F). As discussed in 
chapter 2 section 2.3.1 the pixel values in a raw phase image are expressed between the finite 
limits of ± π. As such, when the values of phase exceed this limit, they “wrap” back to the 
origin, resulting in a series of bright and dark bands throughout the image. The effect is 
clearly visible in figure 3.4, and a comparison of the phase wraps gives an insight into the 
effectiveness of the flow compensated sequence. In the first image (D), in which there is no 
flow, the phase wraps form a continuous band across the entirety of the phantom, as 
expected. In the second, uncompensated image (E), there is a break in the phase wraps as 
they pass through the section of the phantom that contained the flowing water. The reason for 
this is that the isochromats contained in the water pipe did not rephase at the echo time, as 
they have accumulated extra phase while passing through the various gradients. Conversely, 
in the compensated phase image (E), the phase wraps manifest as unbroken lines that pass 
across the entire phantom, as the modification to the sequence has resulted in the correct 
rephasing of the majority of the isochromats at the correct time. 
The resultant susceptibility maps are contained in the third row (G – I). In the no-flow 
image (G), the susceptibility of the water in the pipe is slightly hypointense with respect to 
the agar that surrounds it (see figure 3.5). By comparison, the water in the susceptibility map 
calculated from the uncompensated data is hyperintense. Again this is attributed to the 
distortion of the phase as the moving isochromats passed through the various imaging 
gradients. As expected, the water in the compensated image (G) is hypointense, in reflection 
of the first image. The water in image G however is slightly more hypointense than in the 
first image. This may be attributed to non-laminar flow at the edges of the pipe that has not 
been entirely compensated for by the sequence. 
The graph in figure 3.5 A shows the shift in measured susceptibility between the 
water and agar for each acquisition. The susceptibility of the water in the uncompensated 
image is measured as paramagnetic (i.e. > 0), while in the others it is diamagnetic. The 
susceptibility of the water in the flow compensated image is slightly more diamagnetic than 
the water in the no flow image. According to the literature, the magnetic susceptibility of 
both water and agar is very similar 
[17]
, so it is unclear why in this instance the water appears 
to be slightly diamagnetic by comparison. The difference is ~30 ppb, and it may be that the 
water in the phantom contains some impurities (i.e. calcium) which would explain the 
discrepancy. 
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 The graph in figure 3.5B shows the standard deviation of the susceptibility measured 
in the water in each data set. As expected, the standard deviation in the uncompensated image 
is the highest. The SD in the compensated image is slightly higher than that in the image with 
no flow. The differences between the compensated and no flow images may be due to non-
laminar flow that is not compensated for by first order gradient moment nulling. 
 
 
 
 
3.1.2.2.2 Stage I – Conclusions 
It is clear from the above that the presence of flow during the acquisition will have a 
noticeable effect on the resultant images, and a detrimental effect on the susceptibility maps 
and the values measured therein. It is also shown that first-order flow compensation was 
successfully implemented, and that it goes some way to mitigating the errors introduced by 
flow. It must be noted however that the compensation is imperfect; some residual flow 
artefact remains, which may be a systemic source of error throughout the experiments. 
Inclusion of higher order compensation would however push the echo time to an 
unacceptable value, so it was decided that first order compensation was the optimal choice.  
 
 
Figure 3.5 A & B: Graphs depicting the contrast measured in each of the susceptibility maps displayed in 
figure 2 (A) and the standard deviation of the susceptibility measured in the water in the same images (B). 
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3.1.2.3 Stage II – In-vivo acquisition 
Once the efficacy of the flow-compensated acquisition sequence was established, in-
vivo data was acquired to determine the effect of flow compensation on a susceptibility map 
that was more representative of data that would be acquired during the main experiments in 
the upcoming chapters. 
GRE data was acquired from a healthy CD1 mouse (6 -8 weeks old). The subject was 
anaesthetised using 4% isoflurane in 100% O2. During scanning, respiratory rate was 
monitored and maintained at ~50 - 70 breaths p/m by varying isoflurane concentration 
between 1.5 and 3%. Data were acquired while the mouse was administered medical air, by 
means of a respiratory gated sequence on a 9.4T scanner (Agilent Technologies). 
The acquisition parameters were as such: Flow compensated acquisition: TR = 1000 
ms, TE = 4 ms, FA = 70
o
, FOV = 25.6 x 25.6 x 16 mm, Matrix = 128 x 128 x 80, Voxel = 
200 µm isotropic, bandwidth = 50 kHz, average = 4. Standard acquisition: TR = 1231 ms, 
TE = 4.712 ms, FA = 70
o
, FOV = 25.6 x 25.6 x 16 mm, Matrix = 128 x 128 x 80, Voxel = 
200 µm isotropic, bandwidth = 50 kHz, average = 4.  
 Data was manually segmented using ITK-snap
[18]
 and susceptibility maps were 
calculated from raw phase data using the SHARP and TKD algorithms. Images were assessed 
by visual inspection, and the magnetic susceptibility was measured in a large blood vessel, 
and in the liver tissue. The difference in susceptibility between each region was taken as a 
measure of image contrast, and the standard deviation of the measured susceptibility in the 
blood vessel quoted as a measure of image quality. 
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3.1.2.3.1 Stage II – Results 
 
 
 
 
Figure 3.6 (top row) shows single slice magnitude images of the mouse liver (sagittal 
orientation) acquired with (left) and without (right) flow compensation. The second row 
contains maximum intensity projections (MIP) over 2 mm (10 slices) of the susceptibility 
maps calculated from the same data set.  
 The image quality of the magnitude image acquired with the flow compensated 
sequence is superior to the image acquired with the standard sequence as evidenced by the 
fact that contrast in the liver volume is more homogeneous, and there is less signal dropout, 
particularly towards the superior section of the organ. Additionally, the large blood vessel 
Figure 3.6 A- D: In-vivo images of mouse liver (sagittal orientation) acquired with (A, C), and without (B, D) 
flow compensation. The top row contains magnitude images, and the bottom row contains Maximum Intensity 
Projections over a 2 mm area of the corresponding susceptibility maps. The red arrow draws attention to the 
prominence of a large blood vessel in the uncompensated image. 
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that is visible on the right hand side of the uncompensated image (red arrow) is less 
conspicuous in the flow compensated image. This is because the acquisition sequence has 
reduced signal drop out due to flow artefact. 
 The MIPs displayed in the second row of figure 3.6 also display obvious differences. 
The delineation of the blood vessels in the flow compensated image is far superior to that in 
the uncompensated image. Furthermore, the vessels in the uncompensated image appear more 
diffuse, which will have implications for the susceptibility measured not only in the blood 
vessels, but also in the surrounding tissue. 
 Figure 3.7 shows a series of graphs that depict differences in the susceptibility 
measured in the blood vessel and liver tissue. Graph A shows that the contrast between the 2 
regions is higher in the flow compensated image due to the superior delineation of the blood 
vessels – when the signal from the blood vessels is diffuse, it contaminates the signal from 
the adjacent regions thus undermining the measurement. Graph B shows that the standard 
deviation is higher in the susceptibility in the blood vessel in the uncompensated image. This 
is as expected, and is due to flow artefact.  
 
 
 
 
  
Figure 3.7 A & B: Graphs depicting a comparison between the contrast (A) and the standard deviation of the 
susceptibility measured in a large blood vessel (B) in images acquired with and without flow compensation. 
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3.1.2.3.2 Stage II – Conclusions 
 It is clear from the above that first order flow compensation improves the quality of 
QSM images and measurements. The delineation between the blood vessels and tissue is 
vastly improved, as is image contrast. Additionally, the susceptibility measured in the blood 
vessels is less noisy when flow compensation is included in the imaging sequence. This is 
highly desirable, as susceptibility changes are of the order of parts per billion, and so could 
easily be obscured by noise. 
 From this set of experiments it is concluded that first order flow compensation is 
extremely beneficial when performing in-vivo QSM on the liver. As such, all results 
discussed in the remainder of the thesis will be derived from images acquired with a first 
order flow compensated sequence. 
 
3.1.3 2D vs 3D images 
 When performing susceptibility mapping in the brain, it is usual to acquire data using 
a 3D GRE acquisition sequence, the reasons cited in the literature being that 3D acquisitions 
offer superior SNR, and that 2D acquisitions may introduce phase inconsistencies among 
adjacent slices 
[19]
. It is also noted in the same review however that 2D data are also 
compatible with QSM, and it has been suggested in an SWI study of the liver that a 3-
dimensional acquisition sequence is not suitable for abdominal imaging, due to the long 
acquisition times and the large B0 variations encountered when doing so
[20]
.  
 There are a number of recent examples in which the application being explored has 
necessitated calculating susceptibility maps from 2D GRE data. These are instances which 
require fast acquisitions, such as in the case of functional QSM 
[21]
 or for use in patients that 
are unable to remain still for the duration of the scan 
[22]
. The latter is particularly prevalent, 
as the most well developed application of QSM is to assess changes in focal iron deposition 
in the brains of Parkinson’s or Huntington’s disease sufferers. 
 In order to assess the suitability of each acquisition sequence for use in the preclinical 
liver, 2D and 3D GRE data was acquired of an excised mouse liver at 9.4T. As mentioned, it 
is important to minimise the time each subject spends in the scanner, and optimisation of the 
acquisition parameters selected must involve a trade-off between maximising SNR and 
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minimising scan time. As such, the acquisition parameters of the 3D sequence were 
manipulated to ensure that the scan time required by both sequences was the same, such that 
a comparison can be drawn between the (magnitude) SNR in both images, and the quality of 
the susceptibility maps calculated from each data set. 
 
3.1.3.1 Methods 
 2D and 3D GRE data was acquired from a non-fixed, freshly excised mouse liver that 
was immersed in Fomblin. The acquisition parameters were as such: 
2D: B0 = 9.4T, TR = 1000 ms, TE = 4 ms, FA = 70
o
, FOV = 25.6 x 20 x 16 mm, Matrix = 
128 x 100 x 80, Voxel = 200 x 200 x 200µm, bandwidth = 50 kHz, average = 8, acquisition 
time: 13m 20s. 
3D: B0 = 9.4T, TR = 100 ms, TE = 4 ms, FA = 8
o
, FOV = 25.6 x 20 x 24 mm, Matrix = 128 x 
100 x 100, Voxel = 200 x 200 x 200µm, bandwidth = 100 kHz, average = 8, acquisition time: 
13m 20s. 
The masks required for QSM processing, and regions of interest were manually 
segmented on the magnitude images using ITK-snap
[18]
. ROIs consisted of a region of liver 
tissue that did not contain any obvious large blood vessels, and a region of the image within 
the FOV but outside the sample in order to measure the image noise. 
Susceptibility maps were calculated from raw phase data using the SHARP and TKD 
algorithms. Signal to noise was calculated using the following equation: 
                                 SNR = 0.655∙S/σ                                  [4] 
Where S is the magnitude signal in a region of the object being imaged, and σ is the 
standard deviation of the noise, measured in the aforementioned region. The standard 
deviation of the susceptibility measured in the liver tissue is also quoted as a measure of 
image quality. 
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3.1.3.2 Results 
Figure 3.8 shows the magnitude SNR measured in the 2D and 3D datasets 
respectively. Unsurprisingly given the acquisition parameters, the SNR in the 2D image 
(37.92) is higher than in the 3D image (31.74). Increasing the receive bandwidth lowers the 
acquisition time but increases the amount of noise sampled with the signal. Secondly, the flip 
angle with which the 3D data was acquired was not the at the Ernst angle (~25
o
 at this TR for 
tissues with this T1), also contributing to reducing the SNR by reducing the signal. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9 shows the T2*-weighted magnitude, raw phase, field maps, and 
susceptibility maps acquired with both 2D (left) and 3D (right) acquisition sequences. For the 
purposes of display, the raw phase data has been masked such that only the sample is 
displayed.  
 
Fig 3.8: Graph depicting difference in Signal to Noise ratio as measured in 2D and 3D magnitude data. 
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Fig 3.9 A- H: T2*-weighted magnitude images (A,B), raw phase (C,D), frequency maps (E,F), and 
susceptibility maps (G,H), of 2D (left hand column), and 3D (right hand column) data. The red arrows in 
(H) indicate the streaking artefact caused by noise in the data supplied to the TKD algorithm. 
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As expected, the signal in the 2D magnitude image (A) is far superior to that in the 3D 
image (B) due to the reasons discussed in the previous paragraph. A comparison of the raw 
phase data (C & D) shows that the phase lines are more dense and numerous on the 2D image 
(C). It is unclear why this is the case, but may have something to do with the differences in 
which the data is acquired. During 2D acquisitions, each slice is excited in isolation, and the 
data from that slice is then acquired. During 3D acquisitions, the entire image volume is 
excited, and an extra phase encoding gradient is applied in the “slice” direction such that it is 
spatially encoded. The difference in how each of these gradients are applied during their 
respective acquisition sequence may explain the differences in phase wraps in the raw 
images. In any case, this will not have any effect on the susceptibility map calculated from 
either data set as the phase wraps will all be removed during processing. More importantly, 
there was no evidence in the 2D image of any broken, or “open-ended” fringe lines that may 
be indicative of phase inconsistencies, and can adversely affect the phase unwrapping 
process
[23]
.  
The frequency maps displayed in E & F show that in both cases the phase wraps and 
background field contributions have been successfully removed by the SHARP algorithm. 
The dipole patterns that are visible in the images are due to the presence of blood vessels. The 
tissue visible between the dipoles in each image is less homogeneous in the 3D data. This 
may be due to increased noise. 
The quality of the susceptibility map calculated from the 2D data (G) is superior to 
that from the 3D data (H). The streaking artefact caused by the TKD algorithm is more 
prominent in the 3D susceptibility map (red arrows). This is most likely due to the increased 
noise in the image, and will negatively impact any quantitative measurements. 
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The negative impact of the artefacts in the susceptibility is confirmed numerically in 
figure 3.10, which displays the standard deviation on a measurement taken in the liver tissue 
of each image, which is quoted as a measure of image quality. It is clear that the SD on the 
measurement of the 3D image (50.88) is greater than that of the 2D image (43.66). 
 
 3.1.3.3 Discussion 
 The results of this experiment are borne out of a very preliminary dataset acquired in 
the early stages of the project. Nevertheless, the results are broadly indicative of the 
differences between 2D and 3D susceptibility maps in the context of pre-clinical abdominal 
imaging. As the data was ex-vivo, the B0 inhomogeneities caused by the large air-tissue 
interfaces in the abdomen were not encountered, allowing the study to focus explicitly on the 
trade-off between SNR and acquisition time. 
 As mentioned, noise in a phase image is proportional to the noise in the corresponding 
magnitude image
[10]
. While it would be possible to optimise the 3D acquisition sequence used 
here - by reducing the receive bandwidth for example, improving data acquisition to the point 
at which the SNR in the 3D dataset was significantly higher than in the 2D dataset would 
Fig 3.10: The standard deviation in ppb on the measurement of susceptibility taken from the 2D and 3D images 
respectively. The higher SD in the 3D image is caused by more prominent streaking artefacts in the 
susceptibility map. 
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almost certainly involve a time penalty, particularly so if respiratory-gating is introduced to 
the sequence.  
 The reduction in scan time brought about by 2D acquisitions is an attractive prospect 
for many applications. For instance, QSM-fMRI has been the subject of investigation
[21]
, and 
recently a processing method has been developed that allows the calculation of QSM images 
from 2D-EPI data
[24]
. In that instance it was shown that quantitative results derived from 2D 
susceptibility maps are consistent with those derived from 3D susceptibility maps. 
Additionally, reduced scan time allows a higher throughput when dealing with cohorts of 
multiple subjects, which is advantageous in both research and clinical scenarios. 
 
3.1.3.4 Conclusion 
 The scan time required to acquire 3D data can be reduced by adjusting some 
acquisition parameters, but this comes at the expense of reducing the SNR in the magnitude 
images, which negatively impacts the subsequent susceptibility maps.  
Based on the above, it was deemed that 2D acquisitions provide data that is of 
sufficient quality to perform susceptibility mapping in the pre-clinical liver at high fields, and 
any improvement in SNR that could be brought about by a lengthy 3D acquisition is less 
desirable than reducing the scan time required for each animal. 
 
 
3.1.4 Mouse liver fat fraction 
 The influence of fat is a topic not usually discussed in the context of QSM images, the 
reason being that the majority of applications focus on the brain. When performing QSM in 
organs outside the head however, the contribution of fat to the MRI signal must be 
considered.  
 Chemical shift is a well-known phenomenon in MR imaging, and refers to the 
difference in resonant frequencies of two nuclei due to their local environments. It is most 
commonly seen in regions that contain fat. Chemical shift is electronic in nature, and occurs 
when the electron cloud around protons contained in a fat molecule produce a local, induced 
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magnetic field that opposes B0. As such the electron cloud produces a shielding effect that 
reduces the magnetic field experienced by the protons, effectively resulting in a diamagnetic 
response to the applied field. 
Less well known however is the effect that fat will have on QSM images. The contrast 
in images derived from T2*-weighted phase data is brought about by differences in the phase 
angle of the magnetic vector of the acquired signal at each point in the image. These 
differences are due to local variations in the main magnetic field (B0) caused by regional 
susceptibility differences in the tissue under examination. As such, if a voxel contains both 
water and fat, it is probable that the fat will have the effect of undermining the susceptibility 
shift caused by paramagnetic components of the tissue that may be of interest (e.g. iron), or, 
conversely, causing an overestimation of the contribution of any diamagnetic substances that 
may be present. 
In order to ascertain the levels of fat present in the livers of the mice examined in later 
chapters, the histological images obtained as part of the respective studies were visually 
inspected for the presence of fat (figure 3.11). These were compared to images from a study 
in the literature that focussed on mouse models of non-alcoholic fatty liver disease (NAFLD), 
in which large lipid droplets are clearly visible 
[2]
 (figure 3.12). In addition, another study that 
aimed to compare a variety of MRI fat quantification techniques found histologically that the 
liver fat content of wild type mice was 0.53 ± 0.19 %, compared to 23.03 ± 2.59% found in 
obese mice 
[25]
. Furthermore, upon visual inspection no mis-registration artefacts, indicative 
of the presence of fat, were visible on any of the acquired magnitude images. 
At time of writing, there have been two papers published that have sought to address 
the problem of chemical shift in the context of QSM imaging, both of which have involved 
complex modifications of the processing protocol. As the amount of fat present in the livers 
of the mice examined was negligible, implementing a chemical shift correction in the data 
processing protocol was deemed unnecessary.  
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Fig 3.12 A & B: Images taken from literature
[2]
. H & E stained histological histological images of livers 
from a healthy mouse (A) and a mouse fed a high fat/fructose diet (B). Large lipid droplets are clearly 
visible in the second image, indicating the presence of a high degree of fat in the liver.  
Fig 3.11 A & B: H & E stained histological images of livers from a healthy mouse (A) and a mouse with 
tumours (B) from the studies described in chapter 4 and chapter 5 respectively. No lipid droplets are visible 
in either image. 
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3.2 Processing 
 As discussed in chapter 2, calculation of a susceptibility map requires three main steps 
– phase unwrapping, background field suppression, and inversion. There are a number of 
algorithms that can perform each stage of the process, and it was decided that the experiments 
conducted herein would employ a SHARP algorithm to perform both phase unwrapping and 
background field suppression, and a TKD algorithm to perform the inversion calculation. 
 This particular processing pipeline was chosen because it has been previously been 
shown to work well in practice
[26]
, it is relatively easy to implement and optimise for novel 
applications, and it can generate a susceptibility map from raw data in a matter of seconds
[8]
. 
To the best of our knowledge, implementing QSM to study the pre-clinical liver has never 
before been performed. Within each processing pipeline there are a number of variables that 
must be matched to the application. For example, it was found upon initial implementation 
that the combination of high field strength and the unique geometry of the liver – in particular 
the location and size of the air/tissue interfaces of the abdomen – required careful calibration 
of the SHARP algorithm. By the same token, all inversion algorithms require optimisation 
upon initial implementation. This process was performed on an empirical basis, and the speed 
with which these algorithms perform their respective functions allowed an exploration of the 
effect that each of these variables – and their interaction - had on the resultant susceptibility 
map. Once established, this pipeline had the added advantage of allowing large volumes of 
data to be processed relatively quickly.    
 The following section highlights the steps taken to optimise the selected processing 
pipeline for calculating an in-vivo susceptibility map from raw GRE phase data acquired 
from a mouse liver at 9.4T. The first experiment details a comparison of a heuristic and 
physical (homodyne and SHARP) background field suppression algorithms discussed in 
chapter 2 (sec. 2.3.2) in order to bolster the argument that the SHARP filter is more suitable 
for liver imaging. The second step was incremental adjustment of the TSVD threshold of the 
SHARP algorithm such that the raw data is unwrapped and the background field 
contributions are sufficiently suppressed. It was also necessary at this point to mitigate the 
artefacts at the edge of the image by adjusting the erosion of the binary mask. The second 
step was to adjust the threshold of the TKD algorithm such that the resulting susceptibility 
maps retained a reasonable degree of contrast, but displayed minimal inherent streaking 
artefact. 
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The data selected for the first experiment (sec. 3.2.1) is human brain data acquired at a 
very preliminary stage of the project. Otherwise, the data selected for the optimisation 
procedure was that of a healthy mouse, considered to be broadly representative of the data 
acquired for the main experiments that follow. The acquisition parameters are as such: B0 = 
9.4T, TR = 1000 ms, TE = 4 ms, FA = 70
o
, FOV = 32 x 32 x 12 mm, Matrix = 160 x 160 x 
60, Voxel = 200 µm isotropic, bandwidth = 50 kHz, average = 8. The acquisition sequence 
was respiratory gated and first order flow compensated in all directions. Binary masks were 
manually drawn in ITK-SNAP
[18]
, and all post processing was performed in Matlab (version 
2015b, The MathWorks, Natick, MA). As all of the main experiments involve administering 
a hyperoxic gas challenge, it was necessary to consider images acquired under both medical 
air and pure oxygen in the optimisation procedure. 
 
3.2.1: Heuristic vs Physical Background Field Suppression 
This first experiment investigates the argument that physical background field 
removal algorithms are superior to heuristic algorithms when preparing data that is to be 
input to the susceptibility algorithm. Field maps will be calculated from human brain data, 
and comparisons will be drawn between data processed with a homodyne filter (heuristic), 
and a SHARP based algorithm (physical). 
The same raw T2*-weighted phase data will be processed with both algorithms. The 
resultant field maps will be compared visually, and the mean frequency values from different 
brain regions will be compared to each other and to literature values. 
There follows first a brief description of the background theory of the homodyne 
filter. For the theory regarding the SHARP algorithm, the reader is referred to chap. 2 sec. 
2.3.5. 
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3.2.1.1 Homodyne filtering 
 Homodyne filtering is a type of synchronous detection, and falls into the heuristic 
category of approaches to background field suppression. The underlying assumption of the 
technique is that the complex T2*-weighted signal can be interpreted as consisting of high 
spatial frequency components that we wish to examine, modulated by an undesired low 
spatial frequency background. To extract the component that is of interest the signal must be 
demodulated, requiring a demodulation reference. This can be isolated from the original 
signal by low pass filtering (LPF), such that the reference will encompass the low spatial 
frequency background field. Demodulation is then carried out by performing complex 
division of the original by the filtered signal.  This removes the unwanted low spatial 
frequency component, but leaves in-tact the high spatial frequency phase variations of 
interest. In addition to this, as the calculation is carried out in the complex plane, phase wraps 
are also removed 
[27]
.  
 There is a trade-off involved when performing homodyne filtering: The band-pass of 
the filter must be of sufficient width that the demodulation reference is an adequate 
representation of the unwanted phase variation, while at the same time narrow enough to 
preserve the contrast between large structures. This trade off becomes readily apparent when 
trying to mitigate the problems associated with phase imaging. It can be seen from eqn. 4 
(chap. 2 sec. 2.1) that the contrast in a phase image is dependent on field strength, and can be 
manipulated by careful selection of echo time. Equally, both phase wraps and background 
field effects are exaggerated by increases in field strength or echo time, becoming higher 
spatial frequency components of the image. This increases the overlap between wanted and 
unwanted signal, making the respective contributions harder to separate. Hence an increase in 
echo time will necessitate filter with a wider bandwidth, however the contrast gained by 
virtue of the increased echo time can in some cases compensate for this. 
 K-space is filled such that the high spatial frequency components of the image that 
make up the sharp details, such as the edges, are mapped to the outside of k-space. 
Conversely, the low-spatial frequency components – those responsible for contrast - are 
mapped to the centre. As such, filtering was carried out by performing a Fourier transform of 
the image, and then multiplying the result by a 3D Gaussian function. This preserved the 
values at the centre of k-space, while minimising the values in the outer region. The data was 
then inverse Fourier transformed to yield a low pass filtered image, and the demodulation 
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was carried out by complex division in the image domain. Finally, the homodyne filtered 
images were multiplied by a sufficiently eroded binary brain mask to remove edge effects. 
The brain mask was extracted from the magnitude data using the BET tool in the FSL 
package 
[28]
. 
 The bandpass of the filter can be discussed in terms of the full width half maximum 
(FWHM) of the Gaussian function. It is quoted in terms of the number of points in the x-
direction of k-space (kx) as Δkx = FOVx
-1
. The filter has been designed such that it will act on 
the same spatial frequencies in all three directions in k-space.  
 A FWHM of 60 voxels in the kx direction was used to filter the complex data. The 
filter width was determined empirically by visual inspection of the filtered images 
[27]
. 
 
3.2.1.2 Data Acquisition 
 Scans were performed on a 3T scanner (Magnetom, Siemens Healthcare, Germany). 
A multi-echo (5) T2*-weighted 3D GRE coronal acquisition was performed. The image 
acquired at TE4 (19.68 ms) was chosen for examination as it has been determined in a 
previous experiment on the same data set (not shown) that this image provides the best 
balance between SNR and contrast after filtering. Parameter values are presented in table 3.1 
Parameter Value 
TR / TE1 / TE5 (ms) 30 / 4.92 / 24.6  
ΔTE (ms) 4.92 
Flip Angle (
o
) 20 
FOV (mm) 178.86 x 192 x 220  
Voxel size (mm) 0.859 x 2 x 0.859  
Number of averages 1 
Receiver BW (Hz/px) 400  
 
Table 3.1: Acquisition parameters for sec. 3.2.1 
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3.2.1.3 ROI 
 Regions of interest (figure 3.13) were placed in: 
- White matter in the primary motor area 
[29, 30]
. 
- Grey matter in the primary motor area 
[29, 30]
. 
- The putamen, an iron rich structure in the base of the forebrain 
[31]
. 
- CSF in the ventricles 
[31]
. 
 These regions were chosen as they are often used throughout the literature to gauge 
the usefulness of phase based images. Briefly, grey matter (GM) has been shown to contain 
more iron than white matter (WM). WM contains myelin, which is slightly diamagnetic. As 
such, the mean frequency shift between grey and white matter has been used as a measure of 
contrast in field maps 
[29, 30]
. The putamen is an iron rich deep brain structure, so will be 
readily apparent on a calculated susceptibility map. As the calculated susceptibility maps 
contain no areas of known absolute susceptibility, the measured susceptibility values must be 
quoted relative to a reference. CSF is thought to contain very little iron, and so will have a 
susceptibility close to that of water. As such, it is often used as the reference for susceptibility 
measurements in the literature 
[31]
. Susceptibility values are quoted as the difference in 
measurements. ROIs were hand drawn on the magnitude image acquired at the first echo 
using ITK-SNAP 
[32]
. 
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A: Motor region of cortex 
 
B: Close up of motor region delineating white 
(yellow) and grey (green) matter 
  
  
 
C: Putamen 
 
 
D: CSF in the ventricles 
 
Fig 3.13: Regions of interest, as drawn on magnitude T2*-weighted images. 
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3.2.1.4 RESULTS 
The images displayed in figure 3.14 and 3.15 show the magnitude, raw phase, 
homodyne and SHARP filtered field maps in coronal and axial planes. It is clear from the 
field maps that phase based imaging provides contrast of iron rich areas of the brain that is 
not evident on the magnitude data. The highlighted region in the SHARP field map in figure 
3.14 is where we would expect to find the red nucleus and substantia nigra, two iron rich 
deep brain nuclei. It is also clear however that the contrast is non-local and depends on the 
orientation of the structure to the main magnetic field. 
 
T2*-weighted magnitude image 
 
Raw phase data (rads) 
   
 
 
 
 
Field map – Homodyne filter (ppm) 
 
Field map – SHARP (ppm) 
 
 
Fig 3.14: Coronal images. Magnitude, raw phase and field maps calculated with a homodyne filter and SHARP 
algorithm respectively. The highlighted region in the SHARP derived field map shows the region that contains iron 
rich structures 
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T2*-weighted magnitude image 
 
Raw phase data (rads) 
   
  
 
Field map – Homodyne filter (ppm) 
 
Field map – SHARP (ppm) 
 
Fig 3.15: Axial images of the data displayed in fig. 3.14. The highlighted region in the raw phase image shows 
phase discontinuities in the area adjacent to the sinus. 
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Both homodyne and SHARP algorithms removed phase wraps and suppressed the 
background field to an extent that is sufficient for susceptibility calculation, but it is equally 
clear that the field maps derived by the SHARP algorithm provide superior contrast to the 
homodyne filtered images. Both algorithms struggled to remove the unwanted field effects in 
the area that is adjacent to the sinuses (figure 3.15). This area is known to cause particular 
difficulty when processing phase images due to the steep susceptibility gradient at the tissue / 
air interface. The effect can even be seen as a slightly darker region of the magnitude image. 
In this data set, this region appears to cause particular difficulty for the processing algorithms 
due to the presence of phase discontinuities (highlighted region in figure 3.15). Phase 
discontinuities are incomplete phase wraps and are thought to be caused by the algorithm 
responsible for the combination of the multi-channel phase data
[33]
. It is thought these can be 
mitigated by using the SENSE rather than the GRAPPA algorithm
[33]
. 
 The graphs in figure 3.16 display the absolute field shift between grey and white 
matter in the motor region. Graph 3.16 A confirms that the measured field shift and hence 
image contrast is superior in the SHARP filtered image. Graph 3.16 B compares the field 
shift measured in the SHARP images to similar values from the literature measured on 
systems with different field strengths 
[29, 30]
. As expected, the contrast increases with field 
strength. 
 
71 
 
 
 
Fig 3.16 A & B: Graph A displays the measured absolute field shift between the grey and white matter in the 
motor region. Graph B shows the measured field shift in the SHARP processed data compared to values from 
the literature measured at different field strengths[29, 30] . 
72 
 
3.2.1.5 CONCLUSIONS 
It was shown that physical approaches to data processing produce superior input data 
for the susceptibility algorithm, but that useable susceptibility maps can be calculated from 
the data derived via heuristic means. 
 
 
3.3.1 : SHARP algorithm 
 Figure 3.17 shows the magnitude image of the area within the subject’s liver that 
contains the region of interest (red box). Figures 3.17 B & C show the corresponding raw 
phase image (for display purposes masked such that only the liver is shown) and SHARP 
processed field map, the latter of which will be the subject of the measurement. Figure 3.17 C 
depicts the regions of interest in green (tissue) and red (vessel), and has been scaled to Hz, 
such that image contrast – measured as the mean frequency shift between the liver tissue and 
a large vessel - could be discussed in terms of the optimisation protocol. All images shown 
were derived from the data set acquired while the subject was breathing pure O2, as the 
observed background field was much more pronounced under these conditions. It is thought 
that this is because O2 is a paramagnetic molecule, so its administration may have had a 
greater effect on the susceptibility gradient between the lungs and the liver. 
Previous studies have implemented this pipeline in the brain with TSVD threshold 
values that range from 0.016
[8]
 to 0.2
[9]
. For this work, the TSVD threshold was incrementally 
increased from 0.006 – 0.04. The resulting field maps were visually inspected to determine 
sufficient suppression of the background field
[31]
 . The number of times the mask was eroded 
was then increased incrementally from 1 – 3 until the edge artefacts were deemed adequately 
removed (see below).  
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Figure 3.17 A – C: (A)T2*-weighted magnitude image of in-vivo mouse liver (coronal orientation). The 
highlighted area containing the ROIs is magnified in the bottom row. (B) Corresponding region of raw phase 
image. (Image has been masked for clarity during display) (C) Corresponding field map displaying vessel (red) 
and liver tissue (green) regions of interest. 
 
 
 
 
 
 
 
74 
 
3.3.1.1: SHARP results 
 As mentioned in chapter 2 (sec. 2.3.2), background field effects most obviously 
manifest as large scale contrast undulations throughout the image. As such, it can be seen 
from figure 3.18 that the characteristic hypo- and hyperintensities (yellow arrows) indicative 
of external field contributions to the image are reduced as the TSVD threshold is increased. 
Conversely, the edge effects (green arrows) – caused by an idiosyncrasy of the SHARP 
algorithm (chap. 2 sec. 2.3.5) - remain largely unchanged. These are eliminated as the mask is 
eroded to a greater degree. 
  
 
 
 
 
 
 
 
Figure 3.18: Field map of mouse liver (axial orientation) calculated using the SHARP algorithm. Series 
shows the reduction in background field contributions (yellow arrows) and edge effects (green arrows) as the 
TSVD regularisation threshold and degree of mask erosion are increased respectively. 
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The graphs in figure 3.19 show the image contrast and standard deviation within each 
ROI as the algorithm is optimised. Image contrast increased with the TSVD threshold. The 
reason for this is that as the relatively large contributions to the image that constitute the 
background field are removed, the underlying contrast brought about by field shifts within the 
organ of interest is revealed. There is a slight reduction in contrast as the number of times the 
mask is eroded is increased due to the removal of the extreme values around the edge of the 
image. 
  
 
Images were visually assessed in all instances. The criteria for acceptance was 
removal of any large scale contrast undulations that are indicative of background field effects. 
Equally, the removal of edge effects was deemed sufficient when there were no obvious signs 
of abrupt contrast changes around the edges of the liver in the images. The progression of this 
removal process is depicted in figure 3.18. It was deemed that a TSVD threshold of 0.04 with 
a mask eroded 3 times resulted in adequate suppression of the background field effects and 
removal of edge artefacts from the field map. As such, raw data processed with these 
thresholds was used as the input data for the susceptibility algorithm.   
 
Figure 3.19: Graphs depicting the measured contrast (left) and standard deviation in the ROIs (right) as 
the SHARP algorithm is optimised 
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Figure 3.20: Quantitative Susceptibility Map of mouse 
liver (coronal orientation), displaying large blood vessel 
(red) and liver tissue (green) ROIs. 
3.2.3: Thresholded K-space (TKD) Algorithm 
 There is also a large degree of 
variability in the regularisation threshold 
value selected for the TKD algorithm in 
previous studies. Values ranging from 
0.2 – 0.5 were found agreeable in the 
literature 
[26]
. Presently, the threshold 
was incrementally increased from 0.008 
to 1. Images were examined by visual 
inspection, and the difference in mean 
susceptibility between the liver tissue 
and a large vessel (figure 3.20) was used 
to numerically gauge image contrast in 
terms of the optimisation procedure. 
Additionally, and in similar fashion to previous studies, the standard deviation of the 
susceptibility within the tissue ROI was used to assess the severity of the streaking artefact 
inherent to the TKD algorithm 
[26]
.  
 
3.2.3.1: TKD results 
Figure 3.21 shows a series of representative susceptibility maps calculated with 
increasing thresholds. As expected, there is a strong positive correlation between image 
quality and TKD threshold. This is due to the fact that as the threshold is lowered it allows 
more ambiguity into the susceptibility calculation, resulting in greater noise amplification. 
Conversely, as the threshold is increased more a priori information is supplied to the 
calculation, resulting in a decrease in image contrast. 
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This is confirmed numerically in figure 3.22. The graph in 3.21 A shows an almost 
linear decrease in image contrast as the TKD threshold is increased. Equally, 3.21 B shows an 
almost linear decrease in the standard deviation of the values within the liver tissue ROI as 
the threshold is increased. Optimisation of the TKD algorithm requires striking a balance 
between reducing the image artefact while retaining adequate contrast. In this instance, a 
TKD threshold value of 0.2 was deemed to meet these criteria. 
 
Figure 3.21: Series of Quantitative Susceptibility Maps depicting changes in image quality and contrast as the 
TKD threshold is increased 
Figure 3.22: Graphs depicting image contrast (A) and SD in the liver tissue ROI (B) as the TKD threshold is 
increased 
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3.2.4: Interaction between Algorithms 
 In order to ensure a thorough analysis of the processing pipeline, an investigation was 
carried out on the impact that the interaction between the SHARP and TKD algorithms have 
on the final susceptibility map. The same raw data was processed with the SHARP algorithm 
three times with variations in the TSVD threshold and degree of mask erosion: 
Field Map 1: TSVD = 0.04, # mask erodes = 1; 
Field Map 2: TSVD = 0.04, # mask erodes = 3; 
Field Map 3: TSVD = 0.08, # mask erodes = 3; 
Susceptibility maps were then calculated from each field map using the TKD algorithm with 
the same range of regularisation thresholds examined in the previous section (i.e. 0.008 - 1). 
Images were subject to visual inspection, and contrast was calculated as before. Again, the 
SD of the susceptibility values in the tissue ROI was used to gauge the severity of the 
streaking artefact. 
 
3.2.4.1: Results 
Figure 3.23 shows a representative susceptibility map calculated from each dataset 
and a graph showing the how image contrast in each changes as the TKD threshold is 
increased. There is little difference in contrast between each of the data sets, however the data 
processed with the highest TSVD threshold consistently has the lowest contrast of the three. 
Of the other 2, the data set subject to a greater degree of mask erosion displayed higher 
contrast at low values of the TKD threshold. Contrast in each image decreases by an average 
of 11.99 ± 3.39%, 12.74 ± 2.35% and 12.95 ± 2.52% per 0.1 increment of the TKD threshold 
for field maps A, B, and C respectively.  
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The graphs in figure 3.24 depict the progression of the measured susceptibility values 
in the liver tissue and blood vessel respectively as the TKD threshold is increased. The 
susceptibility values measured in the blood vessel decrease gradually with each increment of 
the TKD threshold, but there is little difference between the values measured in each image at 
each point. As expected, each tends to zero as the regularisation value is increased. As before, 
the values in the image processed with the highest TSVD threshold is consistently the closest 
to the zero point. 
 
 
 
Figure 3.23: Top: Series of 
quantitative susceptibility maps of 
mouse liver (coronal orientation) 
depicting the differences to the final 
image brought about by changes in 
input data to the inversion 
calculation. Images calculated with 
TKD algorithm, threshold = 0.2. 
Bottom: Graph depicting changes 
in image contrast measured in 
susceptibility maps for each field 
map, as the TKD threshold is 
increased. 
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The susceptibility measured in the liver tissue is more sensitive to the number of times 
the mask has been eroded than to the TSVD threshold when the TKD regularisation is at a 
low value (i.e. < 0.2). As the TKD threshold is increased however the values from the data set 
with the same TSVD threshold are almost identical. Again, the values in the image processed 
with the highest TSVD threshold are consistently the closest to the zero point. As the TKD 
threshold is increased, the contrast in all images is increasingly undermined. The convergence 
of all susceptibility values on the zero point is demonstrative of this. 
The graph in figure 3.25 shows the progression of the SD measured in the liver tissue 
as the TKD threshold is increased, and is presented as a measurement of the streaking artefact 
in the susceptibility maps. As expected, the SD has an inverse relationship with the 
regularisation threshold, and there is virtually no difference between data sets for most 
increments. At low values of the TKD threshold the data set processed with the highest 
TSVD value is higher than the others, indicating a slight sensitivity of the TKD algorithm. 
 
 
Figure 3.24: Graphs depicting the changes in measured susceptibility in the blood vessel (left) and liver 
tissue (right), for each input data as the TKD threshold is increased. 
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3.2.4.2: Conclusions 
 The above experiment explored the interaction between the various algorithms that 
are to be used to process the data for the main experiments carried out as part of this body of 
work. Image quality (given by the standard deviation on measurements from ROIs), and 
image contrast were examined. The expected trade-off between image quality and fidelity 
was observed. It was found that the TSVD threshold and number of times that the mask was 
eroded during the SHARP processing step have some effect on image contrast, however it 
was also found that the factor most affecting image contrast was the amount of information 
supplied to the inversion algorithm via the threshold value. 
 
 
Figure 3.25: Graph depicting changes in the standard deviation of the susceptibility values measured in the liver 
tissue for each field map as the TKD threshold is increased. 
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3.2.5: TKD Systemic Underestimation 
While it is true that the derivation through careful processing of a pristine field map 
from raw data is a crucial component of the susceptibility mapping process, it can be seen 
from the above that the differences in measured susceptibility values calculated from the 
various field maps is of the order of tens of parts per billion. It is equally clear that once a 
field map has been deemed a suitable substrate for inversion, the largest influence on the 
susceptibility measurements when using the TKD method is the TKD regularisation 
threshold. 
The systemic underestimation of susceptibility values in images calculated using the 
TKD method is a well-known problem 
[8, 26]
, and is an inherent property of the algorithm. As 
shown above, each 0.1 increment of the regularisation threshold results in a ~12% change in 
susceptibility values. This comes about because the regularisation of the algorithm involves 
replacing very small values of the deconvolution kernel with a value equal to the 
regularisation threshold. As such, the division of the field map in k-space is performed in this 
region with inflated values 
[8]
. 
The effect is almost linear with the TKD threshold, and is consistent across the entire 
image. As such, one simple solution to the problem is the inclusion of a simple multiplicative 
factor when carrying out the inversion calculation 
[8]
. The study in which this solution was 
presented detailed a rigorous comparison between a TKD susceptibility map and a one 
calculated from multi-echo data via the COSMOS method. This enabled the derivation of a 
curve that expressed the degree of underestimation for each increment of the TKD 
regularisation threshold (figure 3.27 B). This was then compared to theoretically predicted 
values of underestimation. While it was shown that this successfully mitigated the 
underestimation engendered by the algorithm, the purpose of the exercise was to demonstrate 
its applicability to human brain imaging, and as such may not be pertinent at high field 
strength in a preclinical liver. 
The solution to the underestimation issue proposed herein is to perform linear 
regression on the series of values measured within an ROI as the TKD regularisation 
threshold is increased. As such, the intercept of the fitted line will be the mean susceptibility 
within the ROI if the regularisation threshold was 0. This can then be used to estimate the 
underestimation of susceptibility values, and to subsequently calculate a correction factor for 
the image.  
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The data selected was that used in previous sections. The raw data was processed with 
the SHARP algorithm (TSVD threshold = 0.04, #msk erodes = 3). TKD threshold values 
were incrementally increased from 0.008 – 1, and the mean susceptibility measured in the 
blood vessel ROI (figure 3.20) was selected as the measurement on which to perform the 
regression.  
 
3.2.5.1: Results 
The graph in figure 3.26 shows the progression of the measured value as the TKD 
threshold is increased, and the results of the linear least squares fit. The intercept of the 
regression line with the y-axis was observed at a value of 185.81 ppb. Figure 3.27 shows the 
projected underestimation plotted against the TKD regularisation threshold as derived from 
the results of the linear regression, and the graph depicting the same from Scheweser 2013
[8]
. 
The table 1 shows the calculated correction factor for each increment of the TKD threshold. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.26: Graph depicting changes in susceptibility measured in the blood vessels within the liver as the 
TKD threshold is increased, and the results of a linear regression performed on the measured values. The y-
intercept of the regression indicates the predicted susceptibility value in the ROI when the TKD threshold is 
0. 
84 
 
Figure 3.27: (A) Graph depicting the projected underestimation for each TKD threshold value as calculated 
from the results of the linear regression. (B) Graph depicting the projected underestimation from Schweser 
(2013) 
 
 
 
 
 
 
 
 
 
 
 
 
 
TKD 
threshold 
Underestimation 
0.008 1.138798 
0.02 1.048383 
0.05 0.954739 
0.1 0.884237 
0.2 0.786287 
0.3 0.694796 
0.4 0.585544 
0.5 0.491362 
0.6 0.412787 
0.7 0.353049 
0.8 0.31107 
0.9 0.276088 
1 0.248641 
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Figure 3.28: Quantitative Susceptibility Maps calculated from identical field maps using TKD inversion. 
Image on the right has been calculated with algorithm including the correction factor. Note the difference in 
contrast between the images. 
Figure 3.28 shows an image from a susceptibility map calculated with an inversion 
threshold of 0.2, with and without the inclusion of the correction factor. There is an 
improvement in contrast in the image in which the underestimation has been mitigated. This 
is confirmed numerically in the graph shown in figure 3.29, which depicts the progression of 
the mean susceptibility value measured within the blood vessel as the TKD threshold is 
increased in the corrected and uncorrected susceptibility maps respectively. As expected, the 
negative correlation between susceptibility values and TKD regularisation threshold has been 
mitigated. 
 
 
 
 
 
 
 
Figure 3.29: Graph 
depicting the difference in 
susceptibility values 
between the corrected and 
uncorrected images 
measured in the blood 
vessel as the TKD 
threshold is increased. 
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3.2.5.2: Discussion and Conclusions 
While there were no explicitly reported numerical values accompanying the graph in 
the Schweser et. al. (2013), there appears to be good agreement between the underestimation 
calculated by both methods. It has been shown previously that the correction factor derived 
from the curve in the literature can compensate for the systemic underestimation inherent to 
the TKD algorithm 
[8]
. This has been confirmed numerically above (figure 3.29). 
There are a number of advantages to using the TKD algorithm when calculating a 
susceptibility map by comparison to other inversion algorithms. For example, it has been 
shown that iterative inversion methods can take up to several hours to perform the necessary 
calculations
[34]
. The speed of the TKD algorithm means that it is well suited to investigating 
novel applications of QSM, and it has been shown that the images derived by means of TKD 
inversion retain the advantages that QSM has over other similar techniques
[34]
.  
While the correction factor derived above shows good agreement with that in the 
literature, it should also be noted that the underestimation values in the literature were 
derived by using a multi-orientation (MO) acquisition susceptibility map as a gold standard 
(i.e. the COSMOS method). While this is a common practice when performing susceptibility 
mapping, it is known that there are limitations to the accuracy of the images calculated via 
the COSMOS method (see chapter 2). While no measurement is absolutely perfect, any 
thorough study that employs TKD must at the very least acknowledge the shortcomings of 
the algorithm, and would preferably make an attempt to mitigate the problem. As such, the 
appropriate correction factor as estimated above will be included in the inversion calculation 
for the experiments performed henceforth. The acquisition and processing factors with which 
QSM will be performed in the following chapters is contained in table 2 below. 
Quantitative Susceptibility Mapping is a rapidly developing, and relatively new field 
of research which can broadly be split into two main groups – those that seek to improve the 
accuracy of the processing pipeline, and those that endeavour to discover new applications. 
As with any field of research, both pathways will develop in tandem, informing and 
encouraging each other. The work carried out hence is of the latter variety. 
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Acquisition 
 
 
 
Parameter 
 
Value 
 
 
B0 (T) 9.4 
 
 
TR (ms) 1000 
 
 
TE (ms) 4 
 
 
FA 70 
 
 
FOV (mm) TBC (as discussed) 
 
 
Matrix TBC (as discussed) 
 
 
Vox (µm) 200 isotropic 
 
 
BW (kHz) 50 
 
 
#avg TBC (as discussed) 
Processing 
 
Algorithm 
 
Variable 
 
Value 
 
SHARP 
 
TSVD Threshold 
 
0.4 
 
SHARP 
 
Mask Erosion 
 
X 3 
 
TKD 
 
TKD threshold 
 
0.2 
 
TKD 
 
Algorithm Correction Factor 
 
185.81 ppb 
Table 2: Summary of empirically derived acquisition and processing parameters that will be used for the 
remainder of the experimental work presented in this thesis 
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Chapter 4 
 Chapter 4 presents the first implementation of QSM in the mouse liver with the 
optimised acquisition and data processing protocols. This chapter contains two experiments. 
The aims of the first experiment were to establish the case for using an external susceptibility 
reference, to examine a variety of regions of interest in the liver in terms of susceptibility, and 
to demonstrate the robustness of the acquisition and processing protocols. 
 The aims of the second experiment were to examine the use of QSM to assess 
changes in venous oxygen saturation in the portal and hepatic veins, as modulated by a 
hyperoxic gas challenge. Data was acquired from a cohort of health mice (n = 10) under both 
normoxic and hyperoxic conditions. Susceptibility was measured on QSM images in the 
aforementioned regions, and was used to calculate the venous oxygen saturation in both. 
Finally, the values calculated from the susceptibility of the hepatic vein were compared to 
invasively measured values. 
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4.1 QSM with optimised pipeline 
 
4.1.1 Introduction 
 Once it had been ascertained that calculating a susceptibility map of a pre-clinical 
liver was feasible, data from a small cohort of healthy mice were acquired and processed with 
the optimised protocols established in the previous chapter. The aim of this experiment was 
threefold – to establish the case for the use of an external reference against which 
susceptibility values could be measured; to explore the suitability of various regions of 
interest from a QSM standpoint; and to demonstrate the robustness of the imaging protocol 
by examining the precision of the measurements made within a cohort. 
 
4.1.1.1 Susceptibility Reference 
Susceptibility mapping is said to be a semi-quantitative technique, as the phase (φ) of 
a GRE signal from which the image is calculated, is equal to: 
                                 φ = φ0 + γ B TE                    [1] 
where φ0 is the initial phase value, γ is the gyromagnetic ratio of the protons, B is the local 
magnetic field, and TE is the echo time. The initial phase value, also referred to as the 
induction field offset, is an unknown property, and, as such, the values derived from the 
image are not absolute, so must be discussed as being relative to a reference point common to 
all images in a dataset.  
When performing QSM in the brain it is generally agreed that susceptibility values 
should be quoted relative to the cerebrospinal fluid (CSF) located in the ventricles
[1]
, though 
other references are also used (e.g. white matter). These are imperfect solutions however. In 
the first instance, it is impossible to quantify intra-subject variability, though it is highly 
likely that this will be a source of error
[1]. Secondly, reference ROI’s are often manually 
segmented, so can be mistakenly contaminated by values from non-reference tissues (e.g. the 
choroid plexus
[2]
). Furthermore, it has been shown recently that the susceptibility of the 
reference tissue can be affected by the independent variables of the experimental protocol 
(e.g. administration of gases 
[3]
). 
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Fig. 4.1: Magnitude image, axial 
orientation, healthy mouse with water 
reference. 
 Performing QSM in the liver presents challenges for identifying a reference ROI. In 
comparison to the brain, the liver is an amorphous structure, and is relatively homogeneous. 
As such it is difficult to select an internal reference that is conspicuous enough not only to be 
identified repeatedly in the same animal, but is clear and unambiguous in an entire study 
cohort. This difficulty is compounded by the fact that the anatomical position of the liver 
results in significant movement over the course of the respiratory cycle.  
The solution suggested here is the inclusion of a sample of distilled water in the 
scanner with each subject (figure 4.1). This has the advantage of being easily identified, 
eliminates intra-subject and intra-experiment variability, and, although the ROI is still 
manually segmented, the large homogeneous nature of the sample reduces dramatically the 
possibility of contamination by human error. 
 
4.1.1.2 Regions of interest 
 The homogeneous nature of the liver also presents challenges when first attempting to 
identify regions for examination. Unlike the brain which contains well-defined focal points of 
accumulated iron (e.g. red nuclei, substantia nigra etc.), there is no clear, recognisable 
differentiation between regions of the liver. It has been shown previously however that QSM 
is sensitive to fluctuations in the deoxyhaemoglobin content of blood
[3-5]
. As such, it was 
decided that the most obvious areas to focus on were the major blood vessels of the liver, and 
a section of liver tissue. The regions of interest that were selected for examination were the 
Portal Vein (PV), the Hepatic Vein (HV), the Hepatic Artery (HA), and a region of liver 
tissue that did not contain any obvious blood vessels. 
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4.1.1.3 Precision and Robustness 
The calculation of a susceptibility map involves processing raw data with a series of 
complex algorithms, each of which must be optimised according to the requirements of the 
application and anatomical location. Once the acquisition protocol and processing pipeline 
had been optimised for use in the pre-clinical liver, it was decided that image quality and the 
precision of susceptibility measurements must be assessed before the technique could be 
reliably applied to disease models. As such, data were acquired and susceptibility maps were 
calculated using the protocols that have been discussed in chapter 3. 
 
        4.1.2 Materials and Methods 
4.1.2.1 Animal Preparation 
  All animal studies were performed in accordance with the UK Home Office Animals 
Science Procedures Act (1986). 5 healthy CD1 mice (female 8 – 12 weeks) were scanned 
with a 9.4T MRI scanner (Agilent Technologies, Santa Clara, CA, USA) using a 39-mm-
diameter bird cage coil for signal transmission and reception (RAPID Biomed, Rimpar, 
Germany). 
Each animal was anaesthetised using 4% isoflurane in 100% O2. Data were acquired 
while each subject was administered a mixture of pure O2 and isoflurane at a rate of 0.5 ltr / 
min. for the duration of the scan. Respiratory rate was constantly monitored using a pressure 
pad (SA instruments, Stony Brook, NY USA) and maintained at ~40 - 80 breaths per minute 
by varying isoflurane concentration between 1.5 and 3%. Rectal temperature was maintained 
at 37.5 ± 0.5
o
C using a warm water circulation system. 
 
4.1.2.2 Data Acquisition 
 The data acquired were single echo, fully first order flow compensated, respiratory 
gated, T2*-weighted 2D GRE acquisitions. Scan parameters were as follows: 
B0 = 9.4T, TR = 1000 ms, TE = 4 ms, FA = 70
o
, Voxel = 200 µm isotropic, bandwidth = 50 
kHz, average = 8.  
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FOV was adjusted to accommodate each animal, and the matrix size was adjusted to ensure 
the voxel dimensions were as above. 
 
4.1.2.3 QSM processing 
Quantitative susceptibility maps were calculated from the raw phase data. A binary 
mask was manually drawn around the entire liver in each magnitude image using ITK-
SNAP
[6]
. The corresponding phase data were unwrapped and background field suppression 
was performed using the SHARP algorithm
[7]
 (TSVD threshold = 0.04, # mask erode = 3).  
Susceptibility inversion was carried out using the Thresholded K-Space Division 
(TKD) algorithm
[8]
. The threshold of the TKD kernel was set to ± 0.2, such that absolute 
values outside of this range were set to the threshold value with the appropriate sign 
depending on the position of the voxel within the kernel. A correction factor of 1.26 (i.e. 1 / 
0.786) was included in the deconvolution operation of the TKD algorithm, as previously 
discussed. All post processing was performed in Matlab (version 2015b, The Math Works, 
Natick, MA). 
 
4.1.2.4 External Reference 
In order to establish the homogeneity and precision of the measurement taken from 
the water reference in the susceptibility map, an ROI was manually segmented from each 
magnitude image using ITK-SNAP
[6]
. The standard deviation of the voxels in each ROI was 
examined, as well as the mean value and SD for the entire set of measurements. For 
comparison, similar measurements were taken from a region of liver tissue located as far as 
possible from any large vessels. 
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4.1.2.5 Regions of interest 
 Regions of interest were manually segmented on each magnitude image using ITK-
SNAP
[6]
, and corresponded to large branches of the portal vein (PV), the hepatic vein (HV), 
and the hepatic artery (HA). A segment of liver tissue that was as remote as possible from 
any large veins was also included for examination. 
Each region of interest was identified as follows: 
Hepatic vein (figure 4.2 A & B): Branches of the hepatic veins are quite large, and as they 
carry blood with a high concentration of deoxyhaemoglobin usually appear hypointense on 
GRE magnitude images. As such, they are relatively easy to identify, and if visually traced 
through the image volume will connect to the inferior vena cava (IVC), which is itself easily 
identifiable as the largest vessel in the image. 
Portal Vein (figure 4.3 A & B): Branches of the portal vein are smaller than the hepatic vein, 
and are slightly more difficult to identify. As they are supplying blood to the liver, the vessel 
walls are usually much thicker than those of the hepatic vein, and they can be identified as 
hyperintense areas on the GRE magnitude image. When visually traced through the image 
volume they connect to the main branch of the portal vein, which is the second largest vessel 
in the image, and is located close to the IVC. 
Hepatic artery (figure 4.4 A, B & C):  The hepatic artery is extremely small with respect to 
the other vessels, and at the resolution of the images examined here is often the size of a 
single voxel in the x-y plane. It appears as a small, hypointense dot towards the inferior 
portion of the image, and can be identified as it branches off the coeliac trunk, located below 
the liver and perpendicular to the direction of the hepatic artery (i.e. it lies upon the y-axis of 
an axial image).  
It was found that the hepatic artery was more easily identifiable if the magnitude 
image is inverted (i.e. each voxel is multiplied by -1), such that the vessel appears as 
hyperintense. During segmentation, image contrast can be manipulated such that the HA can 
be easily identified and traced through the image volume. 
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Fig 4.2: Magnitude image of a healthy mouse liver in sagittal (A) and axial (B) orientation, displaying branches of 
the hepatic vein and the IVC. 
Fig 4.3: Magnitude image of a healthy mouse liver in sagittal (A) and axial (B) orientation, displaying branches of 
the portal vein and the main portal vein 
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4.1.2.6 Precision and Robustness 
All images were visually assessed in order to gauge their quality and to detect any 
artefacts. Magnetic susceptibility was measured in the aforementioned regions of interest, and 
is quoted as the susceptibility shift with respect to the water sample. Lastly, the standard 
deviation of each ROI is taken as an indication of the precision of each measurement
[9]
. The 
precision of each measurement will also be the criteria used to gauge the suitability of the 
regions of interest that have been selected for examination.  
 In addition to MRI data, histology was performed on a selection of liver samples to 
assess the iron content of the liver tissue. 
 
 
Fig 4.4 A, B & C: Magnitude image of a 
healthy mouse liver in axial orientation, 
displaying the coeliac trunk (A), the hepatic 
artery (B), and an inverted image (C) 
displaying the hepatic artery as hyperintense 
with respect to the rest of the liver 
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4.1.2.7 QSM in blood vessels 
Taking measurements from blood vessels can be problematic in QSM images. Gibbs 
ringing, caused by the under-sampling of high spatial frequencies in the image causes an 
oscillation of contrast at sharp signal intensity transitions in the image. This is known to 
happen at the interface between blood vessels and tissue in susceptibility maps. This is 
depicted in fig 4.5 A 
[10]
, which shows a 2 dimensional profile plot across a cylinder – 
representative of a blood vessel - in a numerical phantom. It can be seen that the artefact 
causes erroneous negative values at the boundary of the object, noted in the study to be up to 
±85% of the input susceptibility value. In reality, this manifests as a ring of negative values 
around blood vessels in a susceptibility map (fig 4.5B). 
 
 
 
 
The difficulty is compounded by partial volume effects. In the voxels that lie at the 
vessels boundary, the phase inside and outside the vessel will be integrated across the voxel. 
In the magnitude image this leads to blood vessels appearing thicker than they are - the so- 
called “blooming” artefact. This can be problematic when segmenting ROIs within the blood 
Fig 4.5 A & B: (A) Taken from Haacke et. al. (2010)
[1]
 Displays the results of a numerical susceptibility 
phantom that has been subject to inversion. The cylinder in the image represents a blood vessel, and the image 
is demonstrates the artefact that arises due to Gibbs ringing when areas of sharp contrast are inverted. (B) 
Susceptibility map taken from one of the data sets examined here, depicting a large branch of the hepatic vein 
featuring the negative susceptibility values that surround it. 
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vessel, and also means that the phase in these voxels will be an inaccurate estimate of the true 
value. 
One solution put forward in the literature is to only accept susceptibility values within 
blood vessels that are in the top 20
th
 percentile of those within the region of interest
[11]
, thus 
reducing the chances that the measured values lie at the border between the blood vessel and 
tissue, and so confounded by either error. As such, this will be the criteria of acceptance of a 
measured value within a blood vessel region. 
 
4.1.2.8 Histology 
Animals were culled immediately after scanning. Livers were excised and stored in 
10% neutral buffered formalin. Standard Perl’s iron staining was carried out on livers from 
three subjects in order evaluate the iron content of the liver tissue. 
 
4.1.3 Results 
4.1.3.1 External Reference 
 Figure 4.6 shows the mean and standard deviation of the individual measurements 
taken from the QSM images in regions of the external water reference and liver tissue 
respectively. As discussed, values measured on a susceptibility map necessitate a reference 
against which to be measured. As such, the mean values quoted below are themselves 
meaningless, but the variation measured within each ROI (i.e. SD) gives a measure of the 
homogeneity of the measured susceptibility within each region, and the SD of the mean 
values of each ROI within the dataset allows evaluation of the precision of the measurement. 
The susceptibility measurements made in experiments rely heavily on both of these 
parameters. Inhomogeneities brought about by the acquisition or processing procedures will 
introduce noise in subsequent measurements. As the expected changes are of the order of 
parts per billion, erroneous variation could obscure changes in susceptibility that are 
indicative of experimentally dependent variables. Equally, imprecise measurements could 
undermine differences between cohorts. 
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The values taken from the water reference in each image are -0.0319 ± 10.1 ppb, 
0.0254 ± 11.3 ppb, 0.0356 ± 10.3 ppb, 0.1950 ± 9.6 ppb,-0.1860 ± 10.6 ppb. Conversely, the 
values taken from the liver tissue are 4.8663 ± 34.17 ppb, -2.0963 ± 37.65 ppb, 2.0269 ± 41.8 
ppb, -4.2519 ± 30.98 ppb, 2.2597 ± 45.8 ppb. 
 Figure 4.7 shows the mean and standard deviation of the above values. The standard 
deviation is quoted as a measure of the precision of the measurement. The mean and standard 
deviation of the values are 0.0076 ± 0.1372 ppb, and 0.5609 ± 3.66 ppb for the water and 
liver ROIs respectively. 
 
 
 
 
 
 
 
 
Fig 4.6: Comparison of the standard deviation of susceptibility measurements measured in regions of the 
external water reference (left) and liver tissue (right). This is given as a measure of the homogeneity of the 
values in each region. 
Fig 4.7: Comparison of the 
standard deviation of the 
mean susceptibility values 
measured in the water 
reference and liver tissue. 
This is given as a measure 
of the precision of the 
measurement. There is 
greater variation in the 
values measured in the liver 
tissue, assumed to be due to 
compositional variation 
between subjects. 
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4.1.3.2 Precision and Robustness 
Figure 4.8 shows representative slices of the magnitude (A), raw phase data (masked 
for display purposes, such that only the liver is visible in the FOV) (B), frequency map (C), 
and susceptibility map (D). The images are from the dataset of a single subject.  
 
 
 
 
Fig 4.8 A- F: Representative images taken from the dataset of one subject. All images are taken from the 
same region. (A) T2*-weighted magnitude image. (B) Raw phase data (masked for display purposes). (C) 
Frequency map. (D) Susceptibility map. (E) Maximum Intensity Projection (MIP) of susceptibility map (12 
slices, 2.4 mm segment). (F) MIP of magnitude image taken from same region as (E). 
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All images were visually inspected at each point in the processing pipeline. Inspection 
of the magnitude and raw phase images showed that the data had been successfully 
reconstructed. Furthermore, there were no obvious artefacts in the phase data that indicated 
any phase distortions or inconsistencies which may have had a negative impact of the 
subsequent processing steps. Inspection of the field map (C) showed that the SHARP 
algorithm had successfully unwrapped the raw phase data, and that the background field had 
been removed to an adequate degree. Again, there were no obvious artefacts that would have 
had a negative impact on the inversion calculation. The susceptibility map was inspected 
upon completion of the inversion. The streaking artefact was minimal, and there were no 
obvious signs of artefacts or excessive noise which may have influenced the images or the 
quantitative values that were to be measured. This procedure was carried out for the data 
from all subjects.  
Once it had been ascertained that the calculation of the susceptibility map had been 
successful, a maximum intensity projection (MIP) of a region of the susceptibility map (12 
slices, 2.4 mm segment, coronal orientation) was composed is displayed in figure 4.8 E. To 
allow a comparison of the information offered by susceptibility maps and magnitude data, a 
MIP over the same region of the magnitude image is shown in figure 4.8 F.  
In order to demonstrate the precision of the quantitative measurements taken from the 
images, as well as the suitability of the regions of interest, the mean susceptibility and 
standard deviation of each set of measurements are displayed in figure 4.9. Values from each 
region are quoted as relative to the water reference. Mean values in each region were as 
follows: PV:  226.4 ± 65.44 ppb, HV: 293.33 ± 46.92 ppb, HA: 274.4 ± 188.9 ppb, tissue: 
0.55 ± 3.79 ppb.  
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Figure 4.10 shows a series of representative images of a histological sample at 
increasing magnification. Also included for comparison is a reference image from the 
literature that has been subject to the same stain
[12]
. The reference image is taken from a 
mouse model of haemochromatosis, a disorder that is characterised by excess iron deposition 
in the liver parenchyma. The difference in terms of iron deposition between the healthy and 
reference images is quite pronounced, to the extent that the healthy samples contain very little 
iron by comparison. 
 
 
Fig 4.9: Graph displaying mean susceptibility values and standard deviation measured in each of the regions 
of interest. The variation in measurements from each region are used as a criteria by which to gauge the 
suitability of the region for examination 
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Fig 4.10 A - D: Representative 
images of histological samples 
from healthy mouse livers 
subject to Perl’s iron stain. 
Images are from the same 
sample displayed at increasing 
magnification – x2.43 (A), 
x13.35 (B), and x35.15(C). 
Also included is a reference 
image from the literature to 
allow comparison to an iron 
overloaded image (D). It should 
be noted that there is a marked 
difference in the staining of the 
healthy and reference samples 
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4.1.4 Discussion 
The variability of the reference against which susceptibility is measured in QSM 
experiments is often not discussed in the literature, however it is widely acknowledged that 
there will be a degree of variability between subjects, and even individual scans. It has been 
shown recently that the variability of the reference value depends on the reference tissue that 
is chosen. In the (human) brain, CSF has been shown to have the smallest variability (mean 
susceptibility 10 ± 14 ppb), while in the same study, the mean susceptibility of the white 
matter ranged from 6 ± 20 ppb to 28 ± 23 ppb depending on the location in which it was 
measured
[1]
. As such, standardisation of the susceptibility reference is an important factor 
when trying to maximise the benefit of the quantitative nature of QSM. 
In that regard, the external reference used in this experiment was a successful 
inclusion to the experimental set-up. As discussed in the literature, the reference against 
which susceptibility is measured should be independent of experimental variables, easy to 
depict and delineate, and easily identifiable across a wide range of subjects
[1]
. The external 
reference meets all of the criteria. Furthermore, the sample displays excellent homogeneity 
and precision when compared to the liver tissue as measured here, but also by comparison to 
the CSF measurement in the study cited above. 
The inclusion of the reference into the set-up is extremely simple; however the 
drawback is that the FOV must be increased to accommodate its inclusion in the image. This 
should not present too great a problem however - the sample used here was quite large 
relative to the subject but could easily be made smaller depending on the constraints of the 
experiment. While the CSF may be a suitable reference when performing cerebral QSM in 
humans, the expansion of the field into abdominal imaging will require the use of an easily 
identifiable reference that gives rise to repeatable measurements. The external water 
reference included here provides one possible solution. 
The images displayed in figure 4.8 exemplify the steps taken to calculate a 
susceptibility map, and the rigour of the inspection of the images that takes place at every 
point during the process. Improper reconstruction of the images can result in aberrations in 
the raw phase data such as open-ended fringe lines which are detrimental to the unwrapping 
process, thus undermining the final susceptibility map. Equally, the frequency maps that are 
the result of the SHARP algorithm must be inspected for any residual phase wraps, 
background field contributions or edge effects that would introduce excessive noise in the 
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final susceptibility map. Finally, the susceptibility map is inspected for any artefacts that may 
have occurred during the inversion, including excessing streaking which may undermine the 
measurements taken from the images. The purpose of performing this experiment was to 
discern whether the protocols that were optimised in the previous chapter could be applied to 
a number of datasets such that high quality susceptibility maps could be calculated repeatedly 
and consistently. In that regard the exercise was a success. 
The blood vessels displayed in 4.8 (E) are the hepatic veins. Hepatic veins carry a 
relatively high proportion of deoxyhaemoglobin so are paramagnetic, and, hence, 
hyperintense with respect to the liver tissue. As such, they feature prominently on the MIP of 
the susceptibility map. Conversely, the portal veins are hyperintense relative to the 
surrounding liver tissue due to the thickness of the vessel walls (as discussed sec. 4A.2.5). As 
such, the portal veins feature more prominently on the MIP of the magnitude image. This 
shows that susceptibility mapping can provide information that is not available on a standard 
GRE magnitude image. 
The susceptibility of the blood in the hepatic vein is more paramagnetic than that in 
the portal vein (fig. 4.9), which is indicative of the fact that the blood being carried away 
from the liver (i.e. in the hepatic vein) contains a higher concentration of deoxyhaemoglobin 
than the blood entering the liver. It was expected that the difference in susceptibility between 
the two on this basis would have been more pronounced, but this may be because the blood in 
the portal vein already contains an appreciable concentration of dHb, having already passed 
through the gut and mesentery. Furthermore, the blood in the HV contains a mixture of 
contributions from the portal and hepatic veins, so trying to predict a relationship between the 
portal and hepatic vein without considering the hepatic artery may be difficult. 
 The susceptibility of the blood in the hepatic artery appears more paramagnetic than 
that in the portal vein. This was not expected, as arteries carry richly oxygenated blood. As 
such, it is expected that the susceptibility of the arterial blood would register as diamagnetic 
with respect to that in the portal vein. As mentioned above, the hepatic artery is an extremely 
small vessel, with a diameter that is often the size of a single voxel under this imaging 
protocol. As such, it may be the case that partial volume effects at the edge of the vessel – 
unavoidable at the resolution of the images – may have resulted in erroneous values with 
relatively large variation between subjects. 
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It would be an interesting experiment in any future work that lead on from this thesis 
to attempt to use the aorta as a reference against which to measure the susceptibility of the 
large hepatic veins. Given the linearity of the relationship between susceptibility and blood 
deoxyhaemoglobin content this may allow the calculation of a decrease in blood oxygen 
concentration without the use of an external standard. This would however necessitate the 
assumption that the blood in the aorta was 100% oxygenated, which may not be the case in 
each animal, and so could introduce systematic errors. Furthermore, measuring the 
susceptibility in the aorta would require both cardiac and respiratory gating, thus introducing 
additional complexity into both data acquisition and image reconstruction, as well as 
increasing the required scan time for each subject. 
 The magnetic susceptibility of the tissue is almost identical to that of the water 
reference. It was expected that the iron in the liver would have resulted in the liver tissue 
registering as paramagnetic with respect to water, but as is indicated by the histology it would 
appear that there is very little iron present in the livers of the subjects examined. Taking this 
into consideration it is conceivable that the liver tissue is of roughly the same susceptibility as 
water, as that will be the main magnetically active constituent of the organs composition. An 
interesting proof of concept experiment would be a comparison between the susceptibility 
measured in the liver tissue of healthy subjects and those from a disease model that resulted 
in liver iron overload (e.g. haemochromatosis). The lack of availability of such a model in our 
lab would have required implementing the disease model ourselves, requiring ethical and 
licensing approval, and as such was outside of the realistic time limits of the PhD. This could 
however be considered as an experiment in future, now that QSM acquisition and processing 
pipelines are established for use in a pre-clinical model. 
 The precision of the measurements across the cohort is illustrated by the standard 
deviation in each ROI. This is taken as an indication of the suitability of each region for 
examination with QSM under the imaging protocol employed here. The SD of the 
measurements in the portal and hepatic veins are lower than that in the hepatic artery. Again, 
this is due to the size of the various ROIs, and the ease with which they can be segmented. 
The PV and HV are much larger, and values can be quoted with a greater degree of 
confidence that the measurements are not contaminated by values from outside the intended 
ROI, or are affected by partial volume effects that are present at the vessel wall. This is not 
possible with the HA, and is reflected in the relatively high standard deviation of the 
measurement across the cohort. Based on the results presented here, it appears that the HA is 
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not a suitable region of interest for study under this imaging protocol. It may be possible if 
the resolution of the images was increased, but this would come at a cost to scan time and/or 
SNR. 
The robustness of the experimental protocol would have benefitted from scanning the 
same mouse a number of times in succession, and measuring the susceptibility in the same 
area to assess the repeatability of the measurement. This is difficult in the liver however, as it 
moves and it’s amorphous nature makes it difficult to examine precisely the same region 
again and again. This difficulty could have introduced systematic errors into the measurement 
and undermined the exercise. 
 
4.1.5 Conclusion 
The water reference that accompanied each animal in the scanner was a successful 
addition to the imaging protocol. It provided a robust reference point against which to 
measure the susceptibility values, it was easily identifiable each image, and as it is external 
was not influenced by the experimental protocol. As such it will be included in all of the data 
sets examined hence. 
It is shown above that it is possible to calculate high quality susceptibility maps of a 
healthy pre-clinical liver that allows repeatable measurements in a number of differentiable 
regions. Based on the evidence presented herein, it is shown that the portal and hepatic veins, 
as well as the liver tissue are suitable regions for examination under this imaging protocol, 
however the hepatic artery is not.  
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4.2: Hyperoxic Gas Challenge 
4.2.1 Introduction 
It was shown in the previous section that it is possible to use Quantitative 
Susceptibility Mapping to estimate the magnetic susceptibility of blood in large branches of 
the liver vasculature. It was also shown in figure 4.8 (E) that hepatic veins feature more 
prominently than portal veins on MIPs of QSM images. The reason for this is that as the 
blood passes through the liver, oxygen is being metabolised, meaning the deoxyhaemoglobin 
content of the blood is higher as it leaves the liver through the hepatic vein. The susceptibility 
of the blood is linearly related to its deoxyhaemoglobin content
[1]
, which, in turn, is indicative 
of the oxygen content of the blood. 
The assessment of venous blood susceptibility using QSM has been the focus of 
several studies in recent years, as the measurement can be used to calculate Venous Oxygen 
Saturation (SvO2)
[2-4]
.  Studies have been performed in both pre-clinical
[4]
 and clinical 
scenarios
[2, 3]
. It has been shown that QSM is sensitive to changes in deoxyhaemoglobin 
brought about by a hyperoxic gas challenge
[3, 4]
, can be used to measure the Cerebral 
Metabolic Rate of Oxygen Consumption (CMRO2)
[1]
, and can even quantify regional venous 
oxygenation in the brain
[2]
. To date however, all of the work has been carried out in the 
cerebral vasculature. It is the hypothesis explored here that this can be extended to the liver. 
Hepatic Venous Oxygen Saturation (ShvO2) is an indicator of the hepatic oxygen 
supply-demand ratio
[5]
, and has been the focus of a number of studies. Several in particular 
have investigated ShvO2 in patients that have undergone surgical procedures, as this may 
have important implications for their postoperative care
[6]
. For instance, it was found that 
after Fontan operations – a palliative procedure performed on children – monitoring ShvO2 in 
the immediate post-operative period could predict the occurrence and severity of subsequent 
acute liver dysfunction
[7]
. Furthermore, it was shown in a preclinical study that ShvO2 in rats 
that have undergone partial hepatectomy could be used to gauge the regeneration status of the 
remnant portion
[6, 8]
. 
Previously, measurement of ShvO2 has been performed invasively by means of 
catheterisation. This increases the risk of infection and thrombosis, making it unsuitable for 
some patients. Quantitative Susceptibility Mapping may offer the ability to assess ShvO2 
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non-invasively, which could have a positive impact on the post-operative care and assessment 
of those who have undergone treatment. 
To test the hypothesis, a hyperoxic gas challenge was administered to a cohort of 
healthy mice, such that the deoxyhaemoglobin content of the blood was manipulated in a 
controlled fashion. Susceptibility was measured in a large branch of the hepatic vein in each 
subject under both normoxic and hyperoxic conditions. Susceptibility measurements were 
then used to calculate ShvO2 under each condition. Magnetic susceptibility and SvO2 were 
also measured and calculated respectively in a branch of the portal vein, as it is expected that 
the differences brought about by the gas challenge will also manifest here. The magnitude of 
the change brought about by the gas challenge should be the same in both blood vessels 
provided the rate of oxygen metabolism remains the same under each condition. This is 
assumed to be the case. Finally, venous oxygenation was measured invasively in the inferior 
vena cava in order to provide validation for the calculations. 
 
4.2.2 Theory 
4.2.2.1 Magnetic susceptibility of blood 
The magnetic properties of the haemoglobin molecule are dependent on its 
oxygenation state
[9]
. Haemoglobin consists of 4 globin subunits, each of which contains a 
haem molecule consisting of iron (Fe(II)) surrounded by a porphyrin ring
[10]
. Both molecular 
O2 and Fe(II) contain unpaired electrons, and as such are paramagnetic. When Oxygen binds 
to haemoglobin however, the product is a singlet state with an equal number of spin up and 
spin down electrons, and so is diamagnetic. Upon dissociation both revert to their previous 
state, and are once again paramagnetic
[11]
.   
Venous blood oxygen saturation is, effectively, the percentage of haemoglobin 
binding sites that are occupied, and so is directly measurable by susceptometry. While there 
is also a small amount of O2 dissolved in the plasma (~2% under resting conditions), and it is 
possible for carbon-monoxide to bind to haemoglobin, these are negligible under normal 
circumstances, and so have little impact on the overall susceptibility of the blood. 
Carbominohaemoglobin – the compound that forms when CO2 binds to haemoglobin, 
accounting for ~10% of CO2 transported by the blood – is also paramagnetic, so will not 
result in an underestimation of ShvO2. 
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4.2.2.2 Calculating ShvO2 
The susceptibility difference between blood and water can be related to SvO2 by the 
following: 
                             Δχ blood – water
 
 = Δχdo . Hct . (1 – SvO2)                    [1] 
where Δχdo
 
= 2.26 ppm (SI) is the difference in susceptibility between fully oxygenated and 
deoxygenated blood
[12]
, and Hct is the fraction of blood composed of haematocrit, assumed in 
this instance to be 0.4
[4]
. 
 In the study cited above the equation relates SvO2 to the susceptibility shift between 
the vein and surrounding tissue. As shown in the previous section the difference in 
susceptibility between liver tissue and the water reference is negligible, but as the water 
reference is less likely to be confounded by inter-subject variability, all calculations will be 
performed using the water sample as the reference point. 
 
4.2.3 Methods 
4.2.3.1 Animal Preparation 
 All animal studies were performed in accordance with the UK Home Office Animals 
Science Procedures Act (1986). 10 healthy CD1 mice (female 8 – 12 weeks) were scanned 
with a 9.4T MRI scanner (Agilent Technologies, Santa Clara, CA, USA) using a 39-mm-
diameter bird cage coil for signal transmission and reception (RAPID Biomed, Rimpar, 
Germany). 
Gasses were administered through a nose cone at a rate of 0.5 ltr/min. Images were 
acquired under normoxic conditions as the subject was administered medical air (21% 
O2/balance Nitrogen), and again under hyperoxic conditions as the subject was administered 
100% O2. 10 minutes were allowed between gasses to allow the animal to acclimatise. All 
other animal preparation was as discussed in chapter 4.1. 
Data acquisition, QSM processing and ROI segmentation were all performed as 
discussed previously. 
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4.2.3.2 Blood Gas Measurement 
In order to quantify the degree of hyperoxia induced by the gas challenge, blood gases 
were measured invasively in 3 mice with a blood gas analyser. Mice were anaesthetised and 
blood was extracted from a portion of the inferior vena cava (IVC) within the liver, under 
ultrasound guidance. The procedure was carried out under normoxic and hyperoxic 
conditions for each mouse. Data were acquired on a RAPIDLab 348EX blood gas system 
(Siemens), and 10 minutes were allowed following a change in administered gas to allow the 
animal to acclimatise before sampling. Samples were transferred from the syringe to a 2 µl 
heparinised glass tube, and then to the blood gas analyser. 
 
4.2.3.3 Statistical Analysis 
Parameter estimates were compared using a Wilcoxon matched-pairs signed rank test, 
in which a difference was considered statistically significant for p < 0.05.  
 
4.2.4 Results 
Figure 4.11 depicts an array representative images from a single subject. Shown are a 
single slice of the magnitude, the corresponding raw phase (masked for display), the 
frequency map, and the susceptibility map. Each image depicts the same slice from each 
image. Both normoxic (left column) and hyperoxic (right column) states are shown. 
In the magnitude images (A & B) the hepatic veins feature less prominently on the 
hyperoxic images. The reason for this is that the administration of pure O2 reduces the 
deoxyhaemoglobin content of the blood. This in turn reduces T2* dephasing and associated 
signal loss. Additionally hyperoxia is known to have a vasoconstrictive effect, so it may also 
be the case that the blood vessels themselves are less dilated. There were no obvious artefacts 
in any of the magnitude images that would have indicated adverse conditions for performing 
susceptibility mapping. 
The phase images (C & D) acquired under either state are very similar to each other – 
both contain the same number of phase wraps, which appear in broadly the same place in the 
image. Again there was no indication of phase inconsistencies (e.g. broken phase wraps) that 
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Fig 4.11 A - H: Magnitude images (A, B), raw phase (C, D), frequency maps (E, F) and susceptibility maps 
(G, H) from data acquired under normoxic and hyperoxic conditions. Both portal and hepatic veins feature 
on the QSM images (blue and green arrows respectively), while only the hepatic vein appears on the 
normoxic magnitude image and only the portal vein appears on the hyperoxic magnitude image. 
 
may have indicated improper data reconstruction or uncompensated blood flow artefacts 
which may impact negatively on the susceptibility maps. 
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The frequency maps calculated from the raw phase data are depicted in E & F. Blood 
vessels appear more prominently in the normoxic image (E), than in the hyperoxic image. 
This is due to the fact that the greater deoxyhaemoglobin content of the blood under 
normoxic condition causes a greater perturbation of the B0 field, resulting in a more 
prominent manifestation on the phase image. The bright and dark areas which are particularly 
obvious in (E) are the characteristic dipole patterns of susceptibility variations on phase 
images, and exemplify the orientation dependence and non-local contrast of phase imaging. 
The normoxic and hyperoxic susceptibility maps are shown in images (G) and (H) 
respectively. As expected, the blood vessels feature more prominently on the normoxic 
image. Interestingly, branches of both the portal vein (blue arrows) and hepatic vein (green 
arrows) are visible on the QSM images, whereas on the magnitude images, the hepatic vein is 
only prominent on the normoxic image, and the portal vein is only prominent on the 
hyperoxic image. There were no obvious artefacts on the susceptibility maps. 
The change in susceptibility brought about by the gas challenge is highlighted in 
figure 4.12, which features maximum intensity projections of a segment of the susceptibility 
maps (11 slices, 2.2 mm segment.) As expected, the blood vessels appear more prominently 
on the normoxic image. 
 
 
 
Fig 4.12: Maximum Intensity Projections over 2.2 mm segment of a representative mouse liver under 
normoxic and hyperoxic conditions. Large branches of the hepatic and portal veins are clearly visible in each 
image. Note that the vessels are brighter with respect to the liver tissue in the normoxic image compared 
with the hyperoxic image, indicating a more paramagnetic susceptibility. This is due to the increased 
concentration of deoxyhaemoglobin in the blood under normoxia. 
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Figure 4.13 illustrates the changes in magnetic susceptibility in the hepatic (A) and 
portal (B) veins under both normoxic and hyperoxic conditions respectively. A significant 
diamagnetic shift in mean susceptibility (p < 0.01) was detected in the hepatic vein under 
hyperoxic conditions. Susceptibility decreased from 427.9 ± 161.2 ppb to 234.5 ± 80.5 ppb 
under normoxic and hyperoxic conditions respectively. Similarly, the mean susceptibility in 
the portal vein decreased significantly from 383.6 ± 134.3 ppb under normoxia to 248.7 ± 
161.8 ppb under hyperoxia (p < 0.05).  
A significant increase in venous oxygen saturation was detected in both vessels under 
hyperoxic conditions. This is depicted in figure 4.14. In the hepatic vein (A), mean ShvO2 
increased by 21.39% from 52.67 ± 17.83% to 74.06 ± 8.9% (p < 0.01), and in the portal vein 
(B) SpvO2 increased by 14.93% from 57.57 ± 14.85% to 72.5 ± 17.9%. 
Figure 4.15 shows a comparison of ShvO2 as calculated from the QSM data, and the 
blood gas measured invasively via the IVC. The invasive measurement showed a mean 
increase of 26.14% in blood oxygenation, from 52.83 ± 9.78% to 78.97 ± 11.45%. The 
difference was not statistically significant. 
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Fig 4.13 A & B: Graphs showing the change in susceptibility (ppb) in the portal (A) and hepatic (B) veins. 
There is a statistically significant shift in susceptibility in response to hyperoxia in both regions (* p<0.05 
– PV, **p<0.01 - HV). 
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Fig 4.14 A & B: Graphs showing the change in venous oxygen saturation in the portal (A) and hepatic (B) 
veins. There is a statistically significant increase in response to hyperoxia in both regions. (* p<0.05 – 
PV, **p<0.01 - HV). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
118 
 
Fig 4.15: Graphs showing the change in venous oxygen saturation in the hepatic vein - calculated from the 
QSM data, and the IVC – measured invasively from using the blood gas analyser. The difference measured 
invasively is not statistically significant but there is excellent agreement between the two datasets. 
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4.2.5 Discussion 
 The ability to non-invasively perform venous oximetry in the liver could have 
important clinical implications. For instance, thanks to improvements in diagnostic radiology, 
patient selection and operative technique, partial hepatectomy has increasingly become a 
more viable treatment option in cases of hepatic lesions, both malignant and benign. It is 
known that the regenerating liver places an increased metabolic burden on patients that have 
undergone the procedure, and it has been shown previously that ShvO2 reflects the metabolic 
status of the remnant liver
[6, 8]
. The advent of QSM means that the ability to relate magnetic 
susceptibility to ShvO2 offers a way to asses this in a non-invasive and repeatable fashion. 
In the present study, we employed QSM to assess changes in hepatic venous oxygen 
saturation modulated by a hyperoxic gas challenge. This is the first report that examines the 
ability of QSM to assess oxygen changes in the major hepatic vessels, and it is shown that it 
is possible to detect statistically significant differences in blood oxygenation in response to 
hyperoxia. 
It is known that exposure to hyperoxic conditions will reduce the deoxyhaemoglobin 
concentration of venous blood. This has been confirmed presently by invasive measurement. 
QSM uses deoxyhaemoglobin as a native contrast agent, so it logically follows that under 
hyperoxic conditions there would be a reduction in contrast between the hepatic vein and the 
surrounding tissue when compared to an image acquired under normoxia. This is shown in 
figures 4.11 (G & H) and 4.12. 
The diamagnetic shift in response to the gas challenge shown in figure 4.13 
substantiates the effect depicted in figure 4.11 (G & H). The difference in susceptibility 
brought about by the gas challenge in both the portal and hepatic vein is statistically 
significant, but there is also a high degree of variability between subjects. This is most likely 
due to natural variation in metabolic rates between subjects. 
The SvO2 changes in figure 4.14 are within realistic physiological boundaries. 
Previous studies that have calculated SvO2 from QSM measurements in the cerebral 
vasculature have reported a ~10% increase from ~88% to ~99% in response to hyperoxia
[4]
. 
The absolute values measured here are much lower. It should be noted however that the blood 
from which these measurements have been taken has already passed through the gut and 
mesentery before reaching the liver, so it is expected that blood oxygenation would be lower 
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than that measured in the brain. Furthermore, the effect of the gas challenge measured here is 
greater than that measured in the brain, but again, this may be a function of the fact that the 
venous blood the liver receives is partially deoxygenated, and so the effects of hyperoxia on 
hepatic blood may be greater than in the brain. 
There is no statistically significant difference between the portal and hepatic veins in 
terms of SvO2 under hyperoxic or normoxic conditions. As the hepatic vein is downstream 
from the portal vein it was expected that the deoxyhaemoglobin concentration would be 
higher than in the PV, and that this relationship would remain constant over the course of the 
experiment. There are reports in the literature of the effective arterialisation of portal venous 
blood in rats in response to hyperoxia – i.e. SpvO2 increased from ~53% under normoxia to 
~93% under hyperoxia in healthy control animals
[13]
. While the nomoxic SpvO2 value is 
comparable to the measurement made in our experiment, the increase under induced 
hyperoxia is far greater than we have observed, but may go some way to explaining the 
relationship between blood oxygenation between the two vessels under hyperoxia. It is 
difficult to draw any conclusions from this however without data from the hepatic artery. 
The ability to non-invasively perform venous oximetry in the liver could have important 
clinical implications. Hepatic venous oxygen saturation is an eminently useful metric, and has 
been used to assess hepatic oxygen kinetics in studies with respective focusses as diverse as 
haemodialysis 
[22]
, acute and chronic heart failure 
[23]
, and hepatic ischemic/reperfusion 
injuries 
[24, 25]
. Furthermore, thanks to improvements in diagnostic radiology, patient selection 
and operative technique, partial hepatectomy has increasingly become a more viable 
treatment option in cases of hepatic lesions, both malignant and benign. It is known that the 
regenerating liver places an increased metabolic burden on patients that have undergone the 
procedure, and it has been shown previously that ShvO2 reflects the metabolic status of the 
remnant liver 
[15, 17]
. The advent of QSM means that the ability to relate magnetic 
susceptibility to ShvO2 offers a way to assess this in a non-invasive and repeatable fashion. 
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4.2.6 CONCLUSIONS 
The present study clearly demonstrates that it is possible to measure changes in blood 
oxygen saturation in the portal and hepatic veins on the basis of susceptibility. Furthermore, it 
has been shown that the susceptibility measurement can be used to calculate venous blood 
oxygen saturation in the major hepatic vessels, and that the calculated values reflect 
physiologically realistic ones. Venous oxygen saturation calculated from measurements of 
susceptibility in the hepatic vein have been validated by invasive blood gas measurements, 
and there was good agreement between the measurements. 
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Chapter 5 
 Chapter 5 details two experiments. The first demonstrates the first application of 
QSM to a preclinical model of colorectal liver metastases (CRLM). Data was acquired in a 
cohort of mice that had been inoculated with CRLM (n = 10). Magnetic susceptibility was 
measured in both the healthy liver tissue and in the liver tumours. Secondly, a comparison 
was made between the susceptibility of the liver tumours under normoxic and hyperoxic 
conditions. Thirdly, the venous oxygen saturation was calculated from susceptibility 
measurements taken from the hepatic vein under normoxic conditions, and was compared to 
that of a cohort of healthy mice. 
 The aim of second experiment was to determine the ability of QSM to assess the 
efficacy of a Vascular Disrupting Agent (VDA), a novel chemotherapeutic agent. A cohort of 
mice (n = 10) that had been inoculated with SW1222 colorectal cancer cells were scanned 
immediately before, and 72 hours after the drug was administered to half of the animals. 
Hyperoxia was induced in all mice during both scanning sessions, and susceptibility maps 
were calculated under both hyper- and normoxic conditions. Susceptibility was measured in 
the healthy liver tissue and tumours under normoxic conditions, and in the tumours under 
both hyper- and normoxic conditions, at both time points. A comparison was also made 
between the venous oxygen saturation of the hepatic vein, as calculated from the measured 
susceptibility of both groups at both time points. 
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5.1 QSM and Colorectal Liver Metastases 
5.1.1 Introduction 
 Though still considered a novel technique, Quantitative Susceptibility Mapping has 
shown considerable potential in terms of clinical use. As discussed in chapter 2, the 
application of QSM has been investigated in the context of a broad assortment of clinical 
conditions, ranging from neurodegenerative disorders 
[1-4]
, to volumetric measurement of 
haematomas 
[5]
, to a variety of experiments examining various facets of cerebral venous 
oxygenation 
[6-10]
. To date however, the application of QSM to cancer research has been 
limited to a handful of studies, and within those has been confined to the identification of iron 
and calcium deposits in tumour volumes 
[11, 12]
.  
In the previous chapter, the differences between oxygenated and partially 
deoxygenated blood were discussed in terms of magnetic susceptibility, and it was shown that 
QSM could differentiate between normoxic and hyperoxic blood in both the portal and 
hepatic veins. It is well known that cancer cells require a rich supply of oxygenated blood to 
service their enhanced metabolic requirements 
[13]
, and in this chapter the hypothesis will be 
extended to investigate the application of QSM to a preclinical model of colorectal liver 
metastases.  
Colorectal cancer is the 4
th
 most common cancer in the UK, accounting for 12% of all 
new cancer diagnoses 
[14]
. It is most common in older age groups, and the median 5-year 
survival rate for those diagnosed between the ages of 60 – 69 is ~67%, a figure which 
decreases with age. It is estimated that of those diagnosed, between 50 - 70% will develop 
secondary tumours in the liver, known as colorectal liver metastases (CRLM). CRLM have a 
negative effect on prognosis, reducing the 5 year median survival rate to ~5% 
[15]
. As with all 
cancers, early detection and intervention are critical for improving outcome. 
Hepatic resection, often in combination with either pre- or post-surgical 
chemotherapy is the only curative treatment available for CRLM 
[16]
.  As few as 20% of 
patients diagnosed with CRLM will qualify for surgical intervention, but of those that do, 5-
year survival has been reported to range from 37 – 58%. The remaining patients must be 
assessed for palliative care options.  Imaging plays a vital role in the diagnosis and 
assessment of patients with CRLM, and there are a number of modalities available at each 
stage of the treatment cycle. 
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Ultrasound (US), for example, has been shown to improve tumour detection intra-
operatively, identifying additional tumours in 16% of patients in one study 
[17]
. The limited 
size of the visual field however generally precludes US imaging from pre-operative 
assessment 
[18]
. Similarly, FDG-PET can identify malignant lesions with extremely high 
accuracy 
[19]
, but its diagnostic value can be undermined by the increased uptake of FDG by 
tissues suffering from inflammation 
[20]
. High resolution, contrast enhanced, computed 
tomography (CT) is the most widely used modality for pre- and post-operative assessment 
and monitoring of CRLM, however it has been shown that MRI has a higher sensitivity to 
sub-centimetre lesions 
[21]
, and it is generally recommended that CT findings should be 
integrated with those from other imaging modalities before any significant changes to 
therapeutic strategy are introduced
[20]
. As such, it is clear from the literature that no one 
imaging modality can act as a panacea. 
Beyond identification and morphological assessment of CRLM, there are some 
techniques that give information concerning the haemodynamics and vasculature of tumours. 
Gadolinium and iodinated contrast agents can be intravenously administered during MRI and 
CT protocols respectively to assess tumour blood flow, and there have been attempts in the 
literature to characterise the vascular profile of liver tumours using BOLD MRI in 
conjunction with gas challenges 
[13]
. 
The ability to assess changes in tumour oxygenation has important implications for 
the selection of oncological treatment pathways, and a non-invasive technique that produces 
reliable and reproducible results could find broad use in a clinical setting. Hyperoxia is a 
well-known tumour radiosensitiser that works by increasing the amount of dissolved oxygen 
in plasma in order to allow the diffusion of oxygen into chronically hypoxic regions of 
tumours 
[22]
. It was shown in the previous chapter that QSM could provide functional 
information regarding changes in blood oxygenation in the branches of the major hepatic 
blood vessels. In this chapter, the hypothesis is extended to ascertain information regarding 
the oxygenation status of colorectal liver metastases. 
This study aimed to test three hypotheses in a preclinical (mouse) model of colorectal 
liver metastases. The first was that it is possible to differentiate between healthy liver tissue 
and tumours on the basis of susceptibility, as the tumours receive greater amounts of 
oxyhaemoglobin from the hepatic artery than normal liver tissue 
[13, 23, 24]
. The second was 
that QSM can be used to detect changes in the susceptibility of the tumours that are indicative 
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of changes in oxygenation status. In order to test this, the susceptibility of the tumours was 
measured under the administration of pure O2. This was then compared to baseline 
susceptibility measured under normoxic conditions. Finally the third hypothesis was that the 
increased metabolic demand placed on the liver by the tumours will manifest in the hepatic 
venous oxygen saturation (ShvO2). To examine this, ShvO2 was calculated from the 
susceptibility measured in the hepatic vein of the mice with tumours, and was compared to 
that of the healthy mice examined in the previous experiment. Data acquired from a small 
cohort of mice of the same species as the disease cohort that had not been inoculated with 
cancer cells was also included for completeness. 
 
 
5.1.2 Materials & Method 
5.1.2.1 Animal Preparation 
All animal studies were performed in accordance with the UK Home Office Animals 
Science Procedures Act (1986). Severe combined immunodeficiency (SCID) mice (n = 10) 
were inoculated with 1x10
6 
SW1222 CRLM cells via intrasplenic injection
[25]
. A splenectomy 
was then performed immediately post-injection. Mice were scanned 19 days post-surgery. 
The healthy cohort were CD1 wild type mice (WT, n = 10), and the third cohort were 
uninoculated SCID mice (n = 2). The small size of the third cohort precluded their inclusion 
in any statistical analysis. 
Gasses were administered through a nose cone at a rate of 0.5 ltr/min. Normoxic data 
was acquired as the subjects were administered medical air (21% O2/balance Nitrogen), 
while hyperoxic data was acquired under the administration of 100% O2. 10 minutes were 
allowed between gasses to allow the animal to acclimatise. All other animal preparation was 
as discussed in chapter 4. 
 
5.1.2.2 Data Acquisition 
 The data acquired were single echo, fully first order flow compensated, respiratory 
gated, T2*-weighted 2D GRE acquisitions. Scan parameters were as follows: 
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B0 = 9.4T, TR = 1000 ms, TE = 4 ms, FA = 70
o
, Voxel = 200 µm isotropic, bandwidth = 50 
kHz, average = 4.  
FOV was adjusted to accommodate each animal, and the matrix size was adjusted to ensure 
the voxel dimensions were as above. 
QSM processing (sec. 4.1.2.3), venous oxygen saturation (SvO2) calculations (sec. 
4.2.2.2) and statistical comparisons (sec. 4.2.3.3) were as performed previously. 
 
5.1.2.3 Regions of Interest 
Liver tumours were identified as hyperintense regions on the T2*-weighted magnitude 
data (figure 5.1 - highlighted). Multiple tumours were identified in each animal and were 
manually segmented en masse in each image, such that the values quoted for the tumours 
represent the combined mean value measured in all identified tumours for each animal. 
Regions of healthy liver tissue were also segmented manually from areas that were as remote 
as possible from tumours or large branches of the hepatic vessels. All other ROI’s were 
identified and segmented as discussed previously (sec. 4A.2.5).  
 
 
 
 
 
 
 
 
 
 
Fig 5.1: Representative 
coronal (top) and sagittal 
(bottom) orientation T2*-
weighted magnitude images 
displaying the liver tumours 
(red arrows) that appear as 
hyperintensities relative to the 
healthy liver tissues. 
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5.1.3 Results 
The images in figure 5.2 are a representative slice from a magnitude image (A), the 
corresponding raw phase image (masked for display purposes) (B), the corresponding 
frequency map (C), and the corresponding susceptibility map (D), from a single mouse with 
tumours. There was nothing in the magnitude image that would have indicated any 
respiration, flow, or reconstruction artefact that could have negatively impacted on the 
subsequent processing procedure. The raw phase data showed no evidence of artefacts or 
phase discrepancies that could have undermined the unwrapping and background field 
removal process that they were to be subjected to. The SHARP algorithm successfully 
unwrapped the phase image, and removed the background field contributions to the measured 
magnetic field (C). In the particular frequency map displayed there are still some visible edge 
effects that were not removed by the mask erosion process (red arrows). It was expected that 
these would not have any major impact on the susceptibility map. Upon carrying out the 
inversion this proved to be the case, and there were no major streaking artefacts visible in the 
susceptibility map (D). It was found that the contrast from the blood vessels was entirely 
localised, as expected. The images displayed are representative of the entire cohort, and the 
inspections that they have been subjected to were carried out for each image of every subject. 
Fig 5.2 A - D: T2*-weighted magnitude image (A), corresponding raw phase image (B), frequency 
map (C) and calculated susceptibility map (D) of a single mouse, representative of the entire dataset 
examined here. 
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Some of the tumours displayed in figure 5.2 have been highlighted in the magnitude 
and corresponding susceptibility map (green arrows A & D). As mentioned, these appear as 
hyper-intense on the T2*-weighted magnitude images, however on susceptibility maps appear 
as slightly hypo-intense regions relative to the healthy liver tissue, and are difficult to detect. 
The reason for this is that relative to other regions (e.g. venous blood vessels), the B0 field 
perturbation caused by the tumours is quite small, and so they generate little contrast on QSM 
images. 
The graph in figure 5.3 depicts the difference in mean susceptibility between the 
healthy liver tissue and the tumours of all of the subjects under normoxic conditions. The 
susceptibility of the tissue and tumours is 1.38 ± 2.76 ppb and -33.54 ± 18.5 ppb respectively. 
The tumours are significantly more diamagnetic that the surrounding healthy liver tissue (p < 
0.0001), thus confirming the first experimental hypothesis. It is expected that this is due to 
the increased amount of oxyhaemoglobin received by the tumours due to their increased 
arterial blood supply. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 5.3: Graph displaying the difference in mean susceptibility (ppb) between healthy liver tissue and liver 
tumours. Tumours are significantly more diamagnetic that the liver tissue. This is ascribed to the increased 
arterial component of their blood supply. 
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Figure 5.4 illustrates the behaviour of the tumours under hyperoxic and normoxic 
conditions as measured on a susceptibility map, and shows that the tumours are significantly 
more paramagnetic under hyperoxic conditions (p < 0.01). The susceptibility under hyper- 
and normoxia is -15.63 ± 10.72 ppb and -33.54 ± 18.5 ppb respectively. The result is counter-
intuitive, as it was shown in the previous experiment (chap. 4.2) that the administration of 
pure O2 results in a diamagnetic shift in the susceptibility of the blood in the blood vessels, 
and it was expected that the same effect would be observed in the tumours. This suggests that 
the susceptibility of the tumours is not entirely governed by the deoxyhaemoglobin content of 
the blood. 
 
 
 
 
 
 
 
 
 
 
The images in figure 5.5A & B show the effect of the administration of pure O2 as 
detected by the T2*-weighted magnitude images (A) and the corresponding susceptibility 
maps (B). Normoxic images are included for comparison, and hyperoxic and normoxic 
images are indicated in each by H & N respectively. Also included are magnified images of a 
single tumour (magnified areas indicated by blue boxes). There is a clear increase in 
magnitude signal intensity in response to the administration of oxygen relative to the 
normoxic images. The effect was observed in both the healthy liver tissue and the tumour. 
This was as expected. 
Fig 5.4: Graph displaying the mean 
susceptibility of the liver tumours under 
both hyperoxic and normoxic conditions. 
The administration of pure O2 results in a 
significant paramagnetic shift from 
normoxic susceptibility. 
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Conversely, there was little change in signal intensity in response to hyperoxia 
observed in the susceptibility maps (5.5B). Again, the tumours are difficult to detect and are 
indicated by blue arrows in the close up image. The images of the tumours are slightly more 
hypo-intense when acquired under normoxic conditions, confirming that they are more 
paramagnetic under O2 administration. There is little difference in the signal intensity of the 
liver tissue, however the blood vessels are more hyperintense in the normoxic image due to 
the increased levels of deoxyhaemoglobin. 
 
 
 
 
 
 
Fig 5.5A: Coronal orientation T2*-weighted magnitude images of the liver of a representative mouse with 
tumours, under hyperoxic (H) and normoxic (N) conditions. The left had column contains magnified images of 
a single tumour (highlighted by the blue box in the left hand images). The administration of pure O2 results in 
enhancement of the T2* weighted signal in both the healthy liver tissue and liver tumours. 
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The graphs in figure 5.6 shows the venous blood saturation measured under normoxic 
conditions in the portal (A) and hepatic (B) veins of the mice with tumours and the healthy 
cohort from the previous chapter. Also included is the SvO2 of the uninoculated mice. There 
was no significant difference between the cohorts measured in the portal vein, however the 
oxygen saturation of the blood in the hepatic vein was significantly lower in the mice with 
tumours when compared to the wild types (p < 0.05). As the effect was not observed in the 
portal vein, this would indicate that the effect is not systemic, and is instead caused as the 
blood passes through the liver. It is expected that this can be attributed to the increased 
metabolic requirements of the liver tumours. Although statistical analysis was not possible 
for the uninocculated mice, the mean oxygen saturation in both regions was higher than that 
in the other groups. While it is difficult to draw any meaningful conclusion from a cohort of 
Fig 5.5B: Coronal orientation susceptibility maps calculated from the corresponding phase data of the 
magnitude images in 5A. The administration of oxygen has little effect on the contrast visible in the liver 
tissue. In addition, the tumours are difficult to detect relative to the magnitude images, however appear as 
slightly hypointense regions, indicating that they are diamagnetic with respect to the surrounding liver tissue. 
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two mice, this lends credence to the argument that the diminished oxygen observed in the 
mice with tumours is related to the increased oxygen needs of the tumours. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 5.6 A & B: Graphs displaying the difference in venous blood oxygen saturation between the mice with 
tumours, healthy wild type, and uninoculated (uninc) SCID mice as calculated from susceptibility measured 
in the blood in the portal vein (A) and the hepatic vein (B). The blood in the hepatic vein of the mice with 
tumours contained significantly less oxygen than the healthy cohort. This is attributed to the tumour burden 
of the liver. 
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5.1.4 Discussion 
Hypoxia is known to be one of the main limiting factors in the efficacy of cancer 
treatment for a number of reasons. For instance, oxygen molecules stabilise the DNA damage 
caused by the reactive oxygen species that result from the radiolysis of water molecules 
[26]
. 
In the absence of oxygen the damage is readily reversible, meaning a higher dose of radiation 
is required to ensure adequate effect. Secondly, a well oxygenated tumour is indicative of a 
healthy blood supply, which increases the likelihood that chemotherapeutic agents will reach 
their intended target. Thirdly, it is well known that hypoxia results in genotypic mutations in 
tumour cells, increasing their malignant potential 
[27]
.  
As recently as the 1990s, tumour hypoxia was assessed in clinical studies by means of 
polarographic needles, and, while useful in demonstration, the invasive nature of the 
procedure prevented its inclusion in regular clinical assessment 
[26]
. Improvements in imaging 
in recent decades however have meant that hypoxia can now be measured using alternative, 
non-invasive approaches, which has opened the possibility of routine assessment of tumour 
oxygenation. 
The inclusion of hypoxia imaging in regular diagnostic protocol brings with it a 
number of advantages. Firstly, the non-invasive nature of imaging allows longitudinal 
monitoring of individual patients. Secondly, previous clinical analyses have shown that there 
is a large degree of heterogeneity among tumours, and even within and between the same 
tumour types 
[27]
. Hypoxia imaging allows customisation of treatment plans – for instance in 
the form of conformal radiotherapy, or combinations of radio- and chemotherapy. 
Furthermore, hypoxia imaging would allow assessment of methods designed to alleviate 
hypoxia. In this study, QSM has been successfully applied to a preclinical model of colorectal 
liver metastases. It has been shown that it is possible to derive clinically relevant information 
regarding blood oxygenation in the context of liver cancer from QSM images, and is the first 
such application of Quantitative Susceptibility Mapping. 
The graph shown in figure 5.3 displays the difference in susceptibility between the 
healthy liver tissue and the tumours under normoxic conditions. The tumours are significantly 
more diamagnetic than the healthy liver tissue, and this has been ascribed to arterial blood 
supplied to the tumours. While it is possible that the susceptibility of the tumours relative to 
the surrounding tissue may be due to physical differences between the regions – for example 
tumours are known to be far less vascular than normal tissue, and the cells of which the 
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tumours are composed are of a different type to liver cell – this seems unlikely, as it has been 
shown in the literature 
[13, 23, 24]
 that CRLM derive blood predominantly from the hepatic 
artery, and is show in fig. 4.13 and fig. 5.4 that the susceptibility of both blood and tumours 
can be manipulated by the administration of oxygen. As such, it is thought that the 
susceptibility of the tumours is predominantly affected by the blood that is supplied to them. 
It has been shown repeatedly that the effect of oxygen administration manifests in 
T2*-weighted magnitude images of healthy liver tissue and tumours as an increase in signal 
intensity. This is clearly visible in the images displayed in fig. 5.5A, and has been well 
documented in the literature 
[28-31]
. The reason given for this is that the administration of O2 
reduces the presence of paramagnetic deoxyhaemoglobin, and, by extension, the local B0 field 
inhomogeneities that increase the rate of T2* relaxation 
[22]
.  
As such, the effect of O2 administration on the susceptibility of the tumours observed 
here is somewhat counter-intuitive. It was expected that the decrease in deoxyhaemoglobin 
brought about by hyperoxia would have resulted in a diamagnetic shift in susceptibility in the 
tumours, whereas the opposite was observed. It may be, however, that the paramagnetic shift 
observed here indicates the presence of O2 that is unbound, i.e. dissolved in the plasma.  
As discussed previously (sec 4B.2.1), oxygen, when bound to haemoglobin, results in 
a diamagnetic molecule, and, as shown in the previous chapter, the administration of O2 
causes a diamagnetic shift in the susceptibility of venous blood due to a systemic decrease in 
deoxyhaemoglobin. Arterial blood on the other hand is almost entirely saturated. As such, 
inducing hyperoxia results in an increase in the amount of O2 dissolved in the plasma 
[22, 32]
. 
Unbound O2 is a paramagnetic molecule, and, as the tumours examined here receive a large 
proportion of blood from the hepatic artery, it may be the case that the paramagnetic shift in 
susceptibility observed in response to hyperoxia is due to the increased influx of unbound O2 
that diffuses into the tumour. 
The discrepancy between the magnitude and QSM results is intriguing, as the two 
seem to directly contradict each other. One possible explanation however may be related to 
mechanistic differences between phase and magnitude image contrast. It is noted in the 
literature that bulk susceptibility (as measured by QSM) is more directly related to tissue 
composition than T2* (or R2*) measurements, as changes in the latter can more accurately be 
thought of as measures of local field inhomogeneities 
[33]
. It is noted elsewhere that the 
dephasing which results in the T2* effect only occurs when a phase dispersion exists across a 
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voxel, and that tissues that have uniform distributions of susceptibility will exhibit a phase 
effect but no T2* response 
[34]
. As such, it may be the case that hyperoxic gasses have a 
uniform effect across the tumours to the extent that field inhomogeneities are reduced (thus 
increasing T2*), but still result in an increase in the delivery of (paramagnetic) O2. If this is 
the case, it further exemplifies one of the advantages QSM has over standard magnitude 
imaging i.e. that QSM can differentiate between para- and diamagnetism, whereas T2* is only 
sensitive to field (in)homogeneity, and as such tissue composition by proxy. 
The difference in hepatic venous blood saturation between the mice with tumours and 
healthy wild type mice from the previous chapter could have significant clinical potential. 
The images in both cases were acquired under normoxic conditions so their acquisition 
necessitates little more than a single standard T2* scan. Future experimental work could be to 
perform a longitudinal study in order to characterise the correlation between tumour burden 
and ShvO2. Once this is established, it opens the possibility of using QSM to non-invasively 
diagnose or monitor liver cancer, differentiate between benign and malignant lesions, or even 
to gauge the efficacy of treatment regimes. 
 The main drawback of QSM in the context of liver cancer as observed here is the 
difficulty with which tumours are identified on the susceptibility maps. As such, QSM can 
only provide complimentary information to the magnitude data, however the breadth and 
clinical potential of the functional information derived from susceptibility maps more than 
compensated for this shortcoming. 
 
5.1.6 Conclusions 
 The results presented here have shown that QSM can differentiate between healthy 
liver tissue and liver tumours in a preclinical model of colorectal liver metastases. It has also 
been shown that QSM is sensitive to changes in tumour oxygenation brought about by the 
administration of pure O2 in the same model. Lastly, it was shown that QSM measurements 
can be used to detect changes in hepatic venous blood oxygenation that are indicative of liver 
cancer. 
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5.2 VDA EXPERIMENT 
5.2.1 Introduction 
 Colorectal liver metastases (CRLM) are, by definition, a secondary cancer. As such, 
treatment strategies are complex and multi-faceted 
[18]
. Ultimately, the only available 
treatment that will allow long-term survival is removal by surgical resection 
[35]
, however 
surgery can only be performed in the context of the entire treatment regime 
[16]
. For example, 
treatment of the primary cancer will require intervention in the form of surgery, chemo- or 
radiotherapy, or some combination thereof, and may take place before or after treatment of 
the metastases. Secondly, patients may present with tumours that are initially unresectable, 
requiring pre-operative chemo- or radiotherapy to downstage the tumours to resectable status 
[16]
. Furthermore, only a relatively small percentage of patients will qualify for surgical 
intervention, but those that do not can still benefit from palliative care designed to inhibit 
growth, and minimise the spread of further tumours. 
 Imaging plays a vital role during the treatment of CRLM. CT is the most commonly 
used modality for assessing the treatment response of metastatic liver tumours, due to its 
wide availability and excellent spatial resolution. Traditionally, morphological changes (i.e. 
shrinkage) of the tumour have been used to assess treatment efficacy. As therapies become 
more sophisticated however, there is a growing body of evidence to suggest that tumour size 
does not always adequately correlate with treatment outcome 
[36]
. Bevacizumab, for example, 
is an anti-vascular endothelial growth factor (anti-VEGF) antibody which works by inhibiting 
the growth of new blood vessels, but does not immediately lead to the reduction of tumour 
mass. In situations such as these, functional imaging plays a much more important role. 
It is possible to derive functional information from both CT and MR techniques 
through the use of contrast agents. Iodine or gadolinium based agents (for CT and MRI 
respectively) can be administered intravenously prior to imaging, in order to assess the 
vascular characteristics of tumours
[37]
. Furthermore, there are myriad MRI techniques such as 
diffusion-weighted and BOLD MRI that can impart information regarding pathophysiology, 
heterogeneity, and may also predict clinical outcomes
[36]
. 
Oxi4503 is a combretestatin-derived chemotherapeutic drug known as a vascular 
disrupting agent (VDA). It works by preventing the formation of microtubules within 
endothelial cells, which precipitates morphological abnormalities as the cells replicate. This 
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causes an increase in vascular permeability, leading to the collapse of the vascular wall. 
Ultimately, the tumour undergoes necrosis due to an acute reduction of its blood supply
[38]
. 
Oxi4503 has been shown in the literature to have a deleterious effect on a number of diverse 
tumour types
[38-40]
, including a preclinical model of colorectal liver metastases
[41, 42]
. It acts 
quickly within tumours, having a profound effect immediately after administration
[41]
. 
However, as with bevacizumab, its effects may not have an immediate impact on tumour 
morphology. Previously, the efficacy of Oxi4503 was assessed in CRLM by means of 
histology, stereology, and laser Doppler flowmetry, wherein it was shown that treated 
tumours displayed significant necrosis and a decrease in tumour blood flow relative to the 
surrounding tissue
[42]
.  
In the previous chapter, the response of colorectal liver metastases to hyperoxia was 
examined using QSM, and it was established that by altering the oxygen concentration of the 
blood, changes could be detected in the magnetic susceptibility of the tumours. Secondly, it 
was shown that the hepatic venous oxygen saturation of mice with liver tumours was 
significantly lower than that of healthy wild type mice, which was ascribed to the increased 
metabolic demands of the cancer. 
The aim of this chapter is to examine whether QSM can be used to assess the efficacy 
of the vascular disrupting agent Oxi4503. It was hypothesised that the change observed in the 
susceptibility of the tumours in response to hyperoxia necessitates a functioning tumour 
vasculature. As such, a disruption of the tumour vasculature by Oxi4503 will undermine the 
effect induced by the gas challenge to which QSM is sensitive. Furthermore, it was 
hypothesised that the destruction of the tumour vasculature would reduce the metabolic 
burden on the liver, and that this would be reflected in the oxygen saturation of the hepatic 
venous blood. 
 
                                                   5.2.2 Methods 
5.2.2.1 Animal Preparation 
All animal studies were performed in accordance with the UK Home Office Animals 
Science Procedures Act (1986). Severe combined immunodeficiency (SCID) mice (n = 10) 
were inoculated with 1x10
6 
SW1222 CRLM cells via intrasplenic injection
[25]
. A splenectomy 
was then performed immediately post-injection.  
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This was a longitudinal study during which data was acquired at 2 distinct time-
points. The cohort was divided into a treated (n = 5) and control (n = 5) group, and the initial 
scan took place 19 days post-surgery. Immediately after this, the treated group was 
administered 40 mg/kg of Oxi4503 via tail vein injection. Subsequently, all animals were 
rescanned 72 hours later. 
Hyperoxia was induced in all animals during both scan sessions via the administration 
of 100% O2, and data was acquired under hyperoxic and normoxic conditions, with 10 
minutes allowed between each gas to allow the animals to acclimatise. Gases were 
administered through a nose cone at a rate of 0.5 ltr/min. 
The data acquired during scan sessions 1 & 2 will be referred to as pre- and post-
treatment respectively for the treated group, and as control 1 and control 2 respectively for 
the control group. 
Otherwise, animal preparation (chap. 4A sec 4A.2.1), data acquisition (chap. 5A sec. 
5A.2.2), QSM processing (chap. 4 sec. 4A.2.3), region of interest identification (chap. 5A 
sec. 5A.2.3) and venous oxygen saturation calculation (chap. 4B sec. 4B.2.2) were performed 
as discussed previously. As in all experimental chapters, magnetic susceptibility 
measurements are quoted with respect to the external water reference that was included with 
each subject in the scanner. 
5.2.2.2 Histology 
Animals were culled immediately after the second scanning session. The livers were 
excised and stored in 10% neutral buffered formalin. Standard Hemotoxylin & Eosin staining 
was carried out on all livers from both the treated and untreated animals in order evaluate the 
morphological changes brought about by administration of the VDA. 
 
5.2.2.3 Statistical Analysis 
Parameter estimates were compared using either a Wilcoxon matched pairs signed 
rank test or a Mann-Whitney test for paired and unpaired data respectively. A difference was 
considered statistically significant for p < 0.05. 
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5.2.3 Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7 A - H: T2*-weighted magnitude (A,B), raw phase (C, D), frequency map (E, F), and 
susceptibility map (G, H) of single mouse from the treated cohort, acquired during scan sessions 1 (left) 
and scan session 2 (right) 
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Figure 5.8 A - H: T2*-weighted magnitude (A,B), raw phase (C, D), frequency map (E, F), and susceptibility 
map (G, H) of single mouse from the control cohort, acquired during scan sessions 1 (left) and scan session 2 
(right) 
143 
 
Figures 5.7 & 5.8 contain representative images from the treated (figure 5.7) and 
control (figure 5.8) groups. Images A, C, E, and G were acquired during the first scan 
session, and images B, D, F, and H are the images of the same subject from the second 
session in each. All images were subject to the same inspection that was detailed in 
previously (Chap. 5A sec. 5A.3). The raw phase data did not contain any obvious artefacts 
that could have confounded QSM processing, the SHARP algorithm successfully unwrapped 
and removed the background field from the raw phase data, and the susceptibility inversion 
was carried out successfully by the TKD algorithm in all cases.  
 
 
 
 
 
 
 
 
Figure 5.9: Magnetic susceptibility (ppb) of the healthy liver tissue and liver tumours in both 
groups, at both time-points, under normoxic conditions. The susceptibility of the liver 
tumours is significantly more diamagnetic than the liver tissue in all cases. 
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Figure 5.9 depicts the susceptibility of the liver tumours and healthy liver tissue under 
normoxic conditions for both groups at both time points. Results are summarised in table 1. 
In all cases, the susceptibility of the liver tumours was significantly more diamagnetic than 
the healthy liver tissue. This was as expected given the results of the previous chapter (5.1). 
There were no significant differences between any group for either region of interest. The 
susceptibility of the healthy tissue in the control group at the second time point is more 
paramagnetic than in the other groups, or in any other experiment that has been presented as 
part of this thesis. This measurement may be artefactual – the tumour burden of some of the 
animals in this group at this time-point was so large that selecting an ROI that contained only 
healthy liver tissue was extremely difficult. It is entirely possible that the region in some of 
the subjects contained large blood vessels, which would account for the relatively 
paramagnetic susceptibility. This is depicted in figure 5.10, which shows the T2*-weighted 
magnitude images of several mice from the control group acquired at the first time point (left) 
and the second time-point (right), under normoxic conditions. It is clear that the tumour 
burden increased to an extreme degree in some cases (e.g. image pair A). 
 
  
Healthy Tissue (ppb) 
 
Tumours   (ppb) 
 
Pre-treated 
 
-2.64005 ± 7.42 
 
-33.02± 21.32 
 
Post-treated 
 
-1.25544 ± 7.73 
 
-31.54 ± 23.16 
 
Control 1 
 
-0.50172 ± 7.16 
 
-34.17 ±26.41 
 
Control 2 
 
14.88 ± 17.76 
 
-17.5 ± 18.97 
Table 5.1: Summary of data presented in fig. 5.9 
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Figure 5.10 A- C: T2*-weighted magnitude images in axial (A & B) and saggital (C) orientation, showing 
extreme tumour burden of control group. Image pairs A, B & C are from 3 mice acquired during the scan 
sessions 1 & 2 
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Figure 5.11 A & B: 
(A) H & E stained histology of 
liver slice of treated mouse 
showing necrosis, viable tumour 
remnant, and tumours unaffected 
by treatment. Green Arrows: 
Successfully treated tumours, 
Yellow Arrows: Viable ring of 
tumour cells, Grey Arrows: 
Tumours unaffected by VDA 
(B): ) H & E stained histology of 
liver slice of untreated mouse 
shown for comparison 
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Figure 5.11 A shows a H&E stained histological image of one liver specimen from 
the treated group (A) and untreated group (B). As mentioned, the animals were culled 
immediately after the second MR acquisition. It can be seen from image (A) that the VDA 
has successfully acted on several of the large tumours (green arrows). The destruction of the 
tumours is incomplete however, and there is a ring of viable cells visible at their periphery 
(yellow arrows). This is well documented in the literature, and is attributed to the fact that the 
tumour periphery is fed by surrounding vessels of the host tissue, which are less susceptible 
to the effects of the drug 
[38]
. For comparison, image B shows a H&E stained histological 
image of a slice of liver from the untreated group. There is no evidence of the necrosis at the 
centre of advanced tumours that indicates the result of the administration of the VDA. 
Many of the smaller tumours appear unaffected by the treatment (grey arrows). The 
reason for this may be that the VDA selectively acts on tumour neo-vasculature, which is 
only necessitated by the tumour after it reaches a certain size 
[41]
. It is possible that the 
tumours which were micro-metastases at the time the drug was administered were sustained 
by the healthy vasculature of the liver tissue, and continued to grow until the animal was 
culled. Conversely, it is noted in the literature that the impact of the VDA is immediate, and 
its effect peaks at ~24 hours after administration, after which time the vasculature begins to 
regenerate
[41]
. The data acquired at the second time-point in this experiment was at 72 hours 
after the administration of the drug, which may have been enough time to abrogate some of 
the damage done by the drug. 
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 Hyperoxia  
(ppb) 
Normoxia   
(ppb) 
Difference 
(ppb) 
 
Pre-treated 
 
-13.26 ± 9.49 
 
-33.02± 21.32 
 
19.76 
 
Post-treated 
 
-25.55 ± 14.6 
 
-31.54 ± 23.16 
 
5.99 
 
Control 1 
 
-18.0 ± 12.44 
 
-34.17 ±26.41 
 
16.17 
 
Control 2 
 
-10.27 ± 20 
 
-17.5 ± 18.97 
 
7.23 
Figure 5.12 A - D: Susceptibility response of the tumours to hyperoxia and normoxia. Results from the first 
scan session are displayed on the left (A, C), and the corresponding results from the second session are on 
the right (B, D). 
Table 5.2: Summary of the results displayed in figure 6 & 7. 
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Figure 5.12 shows the susceptibility of the tumours in both groups at both time points 
under hyperoxia and normoxia. The data is summarised in table 2.  None of the differences 
brought about by the gases are significant in any group, however there are some interesting 
similarities and differences between the groups that merit some discussion. The susceptibility 
of the tumours calculated from data acquired during the first scan session (A, C) is more 
paramagnetic under hyperoxia in all cases. Again this is as expected, and it is hypothesised 
that this is due to the increased influx of paramagnetic, unbound O2 molecules that diffuse 
into the tumours from the hepatic artery.  
The measurements taken from the data acquired at the second time-point (B, D) are 
less clear. The mean shift in susceptibility in response to the gases was reduced in both cases 
by comparison to the first scan session, and the susceptibility of the tumours of the control 
group (D) was more paramagnetic under both gases than any of the other groups. 
 
 
 
 
 
 
Figure 5.13: Susceptibility response of the tumours to hyperoxia and normoxia displayed on one graph to 
allow direct comparison between groups. Error bars have been omitted in the interests of clarity. 
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In order to allow a direct comparison between the results of the gas challenge, the data 
is presented on a single graph showing the mean susceptibility of the tumours under both 
hyperoxia and normoxia (Figure 5.13). The mean susceptibility of the tumours under hyper- 
and normoxic states is similar for both groups at the first time-point (pre-treated, control 1). 
The susceptibility of each under normoxia is -33.02 ppb and -34.17 ppb for the pre-treated 
and control 1 subjects respectively, and the difference in susceptibility between hyper- and 
normoxia is 19.76 ppb and 16.17 ppb respectively. This suggests that the treatment and 
control groups were well matched during the first scan session. 
The paramagnetic shift in response to hyperoxia is reduced in the tumours of the post-
treated group. Again, the difference in susceptibility brought about by hyperoxia is not 
statistically significant, but the reduced response of the tumours may be indicative of the 
effects of the VDA. 
This response to hyperoxia is also reduced in control 2, and the susceptibility of the 
tumours under both normoxic and hyperoxic conditions is more paramagnetic than in the 
other mice. One possible reason is that the tumour burden in some of the mice was so 
extensive that the blood supply to the tumours was restricted (figure 5.10). This would have 
the effect of reducing the delivery of both oxyhaemoglobin and unbound oxygen, thus 
reducing the diamagnetism of the tumours under normoxic conditions, and undermining the 
effects of the gas challenge.  
Figure 5.14 shows the venous oxygen saturation calculated from the mean 
susceptibility measured in the hepatic vein of both groups at each time point. The differences 
between the groups are not statistically significant, but the data suggests that there is a slight 
increase in the oxygen saturation of the treated group after the drug has been administered. 
Again, the small size of the groups makes it difficult to draw any conclusion from the results. 
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5.2.4 Discussion   
The capacity of combretastatins to destroy tumour vasculature has been known about 
for some time. Oxi4503 is a second generation VDA that has repeatedly been shown to have 
a deleterious effect on the vasculature of a range of preclinical tumour models, including 
head and neck squamous cell carcinomas 
[39]
, KHT sarcomas 
[38]
, and colorectal liver 
metastases 
[41, 42]
. The efficacy of Oxi4503 has previously been assessed with a range of 
disparate imaging modalities, however each has drawbacks that may limit their use in various 
scenarios. 
For example, microvascular casting has been used to allow visualisation of the effect 
of the drug on the vasculature 
[42]
, but requires the tumours to be excised, usually post-
mortem, thus disallowing longitudinal assessment. Similarly, photoacoustic imaging has 
indicated necrosis at the centre of a treated subcutaneous xenograft 
[43]
, but the depth 
penetration currently available with photoacoustic imaging means its use is limited, 
particularly when attempting to image large, dense organs like the liver. Other studies have 
used bioluminescent imaging (BLI), or Gd-enhanced MRI to assess changes in tumour 
Figure 5.14: ShvO2 (%) calculated from the measured susceptibility of the blood in the hepatic vein under 
normoxic conditions. There were no significant differences between the groups or timepoints. 
152 
 
vascularity. Both of these require the use of exogenous contrast agents, rendering them 
unsuitable for certain cohorts of patients. The advantages offered by QSM are that functional 
information pertaining to the tumour vasculature can be obtained non-invasively through the 
effects of deoxyhaemoglobin. The use of an endogenous contrast agent makes it a viable 
option for a broader cohort of patients, and means that repeated scans can be carried out with 
little risk to the patient. 
The results of gas challenge were inconclusive. There were no significant differences 
in the susceptibility of the tumours under hyperoxia when compared to normoxia, and there 
were no significant differences in the susceptibility of the tumours between any group. It was 
assumed that the VDA would have destroyed the blood vessels supplying the oxygenated 
blood from the hepatic artery, thus affecting the normoxic susceptibility of the post-treated 
group, as well as reducing the paramagnetic shift caused by hyperoxia (as was observed). It 
was shown however that the normoxic susceptibility of the pre- and post- treatment tumours 
was very similar (table 2).  
A major limitation of this study was the fact that the mice were imaged at 72 hours 
after the administration of the drug. The results of the histology have confirmed the presence 
of necrosis in some of the tumours that were clearly affected by the administration of the 
VDA, however it also shows that the smaller tumours were unaffected, and, furthermore, that 
a peripheral ring of viable tumour remained where the drug did take effect. It is shown in the 
literature that the effects of the drug manifest most strongly 24 hours after administration 
[41]
, 
after which point the tumours can begin to regenerate as the drug affects less strongly the 
cells at the periphery of the tumours. This phenomenon is clearly visible in the fig 5.11. 
Furthermore, it is equally clear that some of the tumours were unaffected by the drug, which 
may be due to the fact that micrometastases will most likely be unaffected by the VDA due to 
the lack of neo-vasculature in small, young tumours. As such, it is possible that the 72 hour 
time window allowed these micrometastases to continue to grow. Both of these factors would 
have a negative effect on the experimental variable it was hoped to measure using QSM. The 
experimental protocol would be greatly improved by imaging the mice 24 hours after the 
drug was administered. 
The difference between the treated and control groups at the second time point (post-
treated and control 2) may have been undermined by the extreme tumour burden of the 
control group (figure 5.10). Chronic hypoxia limits the diffusion of oxygen to cells that are 
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distal from the blood vessels, and acute hypoxia restricts the flow of blood into the tumours. 
Both conditions are exacerbated by an increased tumour load, and could also have had the 
effect of confounding the results. Both of these situations could have been avoided if the 
second scan session had been performed at an earlier time-point. 
The differences between the groups in terms of ShvO2 were equally inconclusive. 
While the data suggests that there was some divergence between the pre- and post-treated  
animals, the underpowered nature of the study has limited the conclusions that can be drawn. 
Based on the results of the last experiment however it is entirely conceivable that ShvO2 
could be used as a metric to assess treatment efficacy, however as mentioned this would 
require more work to characterise the correlations of oxygen saturation with tumour burden. 
The treated cohort in this study were administered a single dose of 40 mg/kg of the 
drug. This is broadly in line with similar experiments 
[39, 42]
, though single doses range from 1 
– 100 mg/kg, and comparisons have been made between single doses and continuous, daily 
and intermittent dosing 
[42]
 where it was shown that intermittent dosing produced the greatest 
reduction in tumour growth. As such, an improvement to the experimental approach 
described in this chapter could be to recommend that the treated subjects receive intermittent 
doses of the drug, or that imaging take place 24 hours after the administration of a single 
dose. Furthermore, increasing the numbers is each group would have allowed a more 
powerful statistical analysis, such that the results could be expressed with a greater degree of 
confidence. 
A common metric used in similar studies has been to compare the mass of treated and 
untreated livers as a proxy for tumour burden, or to measure tumour necrosis via histology, 
however it has been suggested that a more accurate assessment of drug efficacy would 
measure the remaining viable tumour 
[41]
. While it was not possible in this instance, it is 
conceivable that using QSM to measure the response of a single tumour to a gas challenge 
could yield information regarding the amount of viable vasculature present after treatment 
without the use of exogenous contrast agents. 
The results of this experiment would benefit from the inclusion of more in-depth 
histopathological analysis. While the standard H & E stained images sufficiently showed the 
necrosis of the tumours that were affected by the VDA, more information could have been 
gleaned by the expansion of the imaging protocol. For example, intravenous injection of 
pimonidazole between the administration of the VDA and the second scanning session may 
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have confirmed hypoxia in tumours that were initially affected by the drug but then 
recovered. Equally, some of the mice could have been imaged using a dynamic contrast 
enhanced (DCE) protocol to discern changes in tumour blood flow caused by the VDA. It 
may then have been possible to compare DCE and QSM images of tumours, although, as 
already noted, drawing comparisons between individual tumours is extremely difficult in the 
liver due to the amorphous nature, and high degree of movement of the organ between scans. 
These limitations may be difficult to address however, as the mice under examination do not 
tolerate the administration of drugs, stains or anaesthetic well, and so the inclusion of 
additional imaging techniques may require redesigning the protocol of the entire experiment. 
 
 
5.2.5 Conclusions 
 Though not statistically significant the difference in hepatic venous blood oxygen in 
between the pre- and post-treated groups reflects the results presented in section 5.1. It is 
conceivable the measurement of ShvO2 with QSM could be used to assess the efficacy of the 
VDA, however further experimental work is required to confirm this. 
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Chapter 6 
 Chapter 6 details the application of QSM to a model of liver cirrhosis. Data was 
acquired from a cohort of rats in which cirrhosis had been induced by bile duct ligation, as 
well as a cohort that had been subject to a sham operation. Susceptibility was measured in the 
liver tissue and major blood vessels of both sets of animals. 
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Liver Cirrhosis 
6.1 Introduction 
 Liver fibrosis is characterised histologically by the presence of excess collagen caused 
by chronic inflammation 
[1]
. Early stage fibrosis is potentially reversible, and causes only 
minor clinical symptoms or disturbance of liver function. Liver cirrhosis occurs in the final 
stage of liver fibrosis. It is an irreversible development, the transition to which involves 
inflammation, activation of hepatic stellate cells, and parenchymal extinction due to vascular 
occlusion 
[2]
. Normal hepatic architecture is replaced with a spectrum of partially restorative 
nodules surrounded by fibrous bands, resulting in portal hypertension, hepatic perivascular 
shunting, and ultimately end-stage liver disease 
[3]
. Normal liver function and perfusion are 
increasingly compromised as fibrosis progresses 
[4]
. 
 The severity of liver fibrosis is gauged using a series of histological gradations 
ranging from 0 - 4, with stage 4 liver fibrosis being equivalent to cirrhosis 
[5]
. There are 
myriad factors that precipitate fibrosis, however all aetiologies of cirrhosis lead to the same 
pathology. Fibrosis and cirrhosis are often asymptomatic until patients present with 
ambiguous ailments, at which point blood testing may reveal abnormal liver function 
[3]
. The 
extent of fibrosis will strongly influence the treatment pathway embarked upon, so accurate 
estimation of its progression is an important facet of the initial diagnosis. 
Upon suspicion of cirrhosis there are numerous diagnostic procedures available to 
clinicians. Histological evaluation via liver biopsy remains the gold standard 
[3]
, but it is 
prone to sampling error, and the invasive nature of the procedure renders it unsuitable in 
many instances. Equally, there are a range of serum markers that are useful for differentiating 
between fibrosis and cirrhosis, but these often lack the accuracy required for differentiating 
between the early stages of fibrosis 
[6]
, particularly in cases of inflammation 
[7]
. Conversely, 
there are a number of imaging modalities that can provide non-invasive assessment, but 
traditionally the primary role of radiography is the determination and assessment of the 
complications that accompany cirrhosis e.g. ascites or hepatocellular carcinoma 
[3]
. 
In recent years, a number of novel imaging techniques have been developed that could 
allow accurate, non-invasive staging of fibrosis and cirrhosis. Magnetic Resonance 
Elastography (MRE) analyses the propagation of a mechanical wave generated by an external 
driver through the liver tissue. An overabundance of collagen will affect the stiffness of the 
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tissue, and subsequently the velocity and wavelength of the propagating wave. MRE has been 
shown to have a sensitivity of 98% and a specificity of 99% for diagnosing any grade of liver 
fibrosis 
[8]
, though it is noted in the literature that the MRE signal may be poor in patients 
with moderate to severe iron load, leading to failed examinations 
[6]
. This may prove 
problematic, as siderosis is a known facet of advanced liver fibrosis. 
Of particular interest in this instance are the phase based approaches to MRI imaging. 
One such technique is Susceptibility Weighted Imaging (SWI), the precursor to QSM. It too 
utilises the phase of a T2*-weighted signal, so is sensitive to compositional variations that 
affect magnetic susceptibility, however it uses this information to enhance its associated 
magnitude image. The accumulation of iron within reticuloendothelial cells is known to occur 
with the progression of fibrosis as ferritin is mobilised from damaged hepatocytes 
[9]
, and on 
this basis it has been shown that the detection and grading of liver fibrosis is feasible with 
SWI 
[7]
. Furthermore, cirrhotic liver iron can also accumulate in the regenerative nodules 
associated with the disease, and it has been shown that SWI can more accurately identify 
siderotic nodules in the cirrhotic liver than conventional magnitude-based MRI techniques 
[9, 
10]
. Susceptibility weighted imaging, while more sensitive to iron deposition than 
conventional techniques, is not, however, quantitative in nature, and is beset by the blooming 
artefacts that can also be detrimental to T2*-weighted imaging. The latter in particular could 
prove problematic when performing liver imaging due to the relative size of the blood 
vessels. 
The aim of this study was to apply QSM to a preclinical model of liver cirrhosis 
implemented in a cohort of Bile Duct Ligated (BDL) rats, and in doing so test three 
hypotheses. In the first instance, QSM overcomes the aforementioned quantification and non-
locality problems that are inherent to SWI, and it is though that the quantitative nature of the 
technique may allow a more accurate assessment of excess hepatic iron. To test this, the 
susceptibility of the liver tissue was measured under normoxic conditions, and compared to 
that of a sham cohort. Secondly, it has been shown that the livers of cirrhosis patients exhibit 
a significant enhancement of the T2* signal when administered pure O2 that was not observed 
in healthy volunteers 
[11]
. As such, the sensitivity of QSM to the changes in liver perfusion 
associated with advanced fibrosis was assessed by administering a hyperoxic gas challenge to 
the BDL rats, and comparing the change in susceptibility of the BDL and sham cohorts. 
Finally, it has been suggested in the literature that the progression of liver disease correlates 
inversely with tissue oxygen uptake 
[12]
. As such, the final hypothesis explored here is that a 
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reduction in oxygen extraction from the blood by the liver tissue will be reflected in the 
hepatic venous oxygen saturation (ShvO2) of the BDL cohort. To test this, ShvO2 was 
calculated from the measured susceptibility of the blood in the hepatic vein and was 
compared to that of the sham cohort. 
 
6.2 Theory 
6.2.1 Cirrhosis Model 
Cirrhosis in this instance was induced using via bile duct ligation (BDL) in order to 
implement obstructive cholestasis in the livers of the experimental subjects. Ligation of the 
duct is achieved via surgical means, and disrupts the secretion of bile causing it to accumulate 
in the liver tissue. The compounds of which bile is comprised e.g. bile salts, bilirubin, as well 
as the potentially toxic compounds that result from the clearance function of the liver result 
cause inflammation of the liver tissue, as well as the progressive development of fibrosis. The 
process ultimately results in liver failure, or progression to liver cancer 
[13]
. 
 
6.3 Methods 
6.3.1 Animal preparation 
Surgical preparations were performed as previously reported 
[14]
. Briefly, male 
Sprague-Dawley rats (body weight 350 – 400g) were obtained from Charles River 
Laboratories (Kent, UK). Under general anaesthesia (5% isoflurane in 100% O2 for 
induction, 2% in air for maintenance) 30 rats underwent triple ligation of the bile duct (via 
laparotomy) to induce chronic liver injury. A number of rats (n = 7) were randomly selected 
for inclusion in the experiment presented here, and were imaged approx.. 4 weeks after 
surgery.  
In addition to this, a number of rats that had undergone a sham operation (n = 3) were 
also selected for inclusion. However, one of these died while under anaesthetic in the scanner 
and was excluded from the study.  
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6.3.2 Data acquisition 
Data were acquired on a 9.4T MRI scanner (Agilent Technologies, Santa Clara, CA, 
USA) using a 72-mm-diameter bird cage coil for signal transmission and reception (RAPID 
Biomed, Rimpar, Germany). Subjects were anaesthetised using 5% isoflurane in 20% O2, 
80% medical air. During scanning, respiratory rate was monitored and maintained at ~60 - 70 
breaths per minute by varying isoflurane concentration between 1.5 and 3%. Rectal 
temperature was maintained at 37.5 ± 0.5
o
C using a warm water circulation system. 
Gases were administered through a nose cone at a rate of 1 ltr/min. Images were 
acquired under normoxic conditions as the subject was administered medical air (21% 
O2/balance Nitrogen), and again under hyperoxic conditions as the subject was administered 
100% O2. 10 minutes were allowed between gases to allow the animal to acclimatise.  
The acquisition parameters were as such: TR = 1000 ms, TE = 4 ms, FA = 70
o
, voxel 
size = 300 µm isotropic, acquisition bandwidth = 50 kHz, number of averages = 4. The FOV 
was adjusted such that the entire liver and water reference were imaged (see Chap. 4A sec. 
4A.1.1), and the matrix size was adjusted to maintain isotropic voxel size. 
Regions of interest were manually segmented on the magnitude images and 
transferred to QSM images after processing. ROIs included a large branch of the hepatic vein, 
which was segmented as discussed previously (see Chap. 4 sec. 4.1.2.5). In this instance, 
large regions of liver tissue were segmented because disruption to the liver architecture was 
not obvious from signal intensity changes in the magnitude image so as much tissue was 
included for examination as possible while avoiding large blood vessels (fig 6.1). 
QSM processing (chap. 4 sec. 4.1.2.3) and venous oxygen saturation calculations 
(chap. 4 sec. 4.2.2.2) were performed as discussed in previous chapters. 
 
 
 
 
 
163 
 
 
 
 
 
 
 
 
 
Figure 6.1: Slice showing liver tissue ROI on T2*- magnitude image (axial orientation). Due to the diffuse 
nature of the disease the ROI included as much liver tissue as possible, while avoiding any obvious blood 
vessels. As such, the tissue ROI included many slices in the liver volume. 
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6.3.3 Statistics 
The diminutive size of the sham cohort precluded any meaningful statistical 
comparison between the groups, or within the sham cohort brought about by means of 
intervention (i.e. the gas challenge).  
Where possible, parameter estimates were compared using a Wilcoxon matched-pairs 
signed rank test, in which a difference was considered statistically significant for p < 0.05.   
 
6.4 Results 
Figures 6.2 & 6.3 contain a T2*-weighted magnitude, raw phase, frequency map and 
susceptibility map of a subject each from the BDL (figure 6.2) and sham cohort (figure 6.3). 
Each image of every animal was subjected to the same visual inspections detailed elsewhere 
(chap. 5 sec 5.1.3), and all acquired data was deemed fit for inclusion in the study. As in the 
other experiments, frequency maps and subsequent susceptibility maps were calculated 
without issue. 
 Figure 6.2 A- D: T2*-weighted magnitude (A), raw phase (B), frequency map (C) and susceptibility map (D) 
of a single animal from the BDL cohort. 
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Figure 6.4 depicts the susceptibility (ppb) of the liver tissue in the BDL and sham 
animals under normoxic conditions. The mean values were -0.825 ± 5.97 ppb and -1.77 ± 
0.366 ppb for the BDL and sham animals respectively. The difference between the cohorts 
was not significant. 
 
 
 
 
 
 
Figure 6.3 A - D: T2*-weighted magnitude (A), raw phase (B), frequency map (C) and susceptibility map 
(D) of a single animal from the sham cohort. 
Figure 6.4: Magnetic susceptibility (ppb) of liver 
tissue of the BDL and sham animals. There was no 
significant difference between the cohorts. 
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Figure 6.5 is an image taken from the literature
[15]
 that shows segments taken from the 
livers of sham (a) and BDL model (b) rats, that have been histologically stained with Perl’s 
iron stain. There is a small build-up of iron in the Kuppfer cells of the BDL model animals, 
however it would appear from the images that the change in liver iron content may not be 
enough to have a significant impact on the QSM measurements of the liver tissue of similar 
animals. This may explain the lack of significant difference between the QSM measurements 
taken from either cohort. 
 
 
 
 
Figure 6.6 contains graphs showing the susceptibility measured in the liver tissue of 
the BDL (A) and sham (B) cohorts. The results are summarised in table 1. There was no 
significant difference in susceptibility brought about by the gas challenge, and there were no 
significant differences between the groups. The data suggests that the liver tissue of the BDL 
rats is slightly more paramagnetic than that of the sham cohorts, but low numbers of sham 
animals makes it difficult to draw any conclusion. 
 
 
 
Figure 6.5 A & B: Perl stained histological images of liver segments from a sham (a) and BDL model rat 
(b). (Taken from the literature) This shows the iron accumulated in the liver of each animal. There is a slight 
build-up of iron in the kupffer cells of the BDL rats that is not present in the sham cohort. 
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Figure 6.6 A & B: Susceptibility of liver tissue under norm- and hyperoxia measured in the BDL rats (A) 
and the sham rats (B) 
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Figure 6.7: Venous Oxygen 
Saturation calculated from the 
susceptibility of the blood 
measured in the hepatic vein. 
There was no significant 
differences between the groups, 
but the data suggests that there 
ShvO2 is higher in the BDL 
cohort.  
 
 
 
 
 
 
 
 
 
 
Figure 6.7 shows the venous oxygen concentration calculated from the measured 
susceptibility of the blood in the hepatic vein. The mean values were 48.87 ± 13.8% and 
29.17 ± 25.71% for the BDL and sham rats respectively. The difference between the cohorts 
was not significant but the data suggests that the oxygen saturation of the blood from the 
BDL cohort is the higher of the two. 
 
 
 
 
 
Normoxia (ppb) 
 
Hyperoxia (ppb) 
 
BDL (mean) 
 
-0.825 ± 5.97 
  
0.28 ± 5.14 
 
Sham (mean) 
 
-1.77 ± 0.36 
  
-0.77 ± 0.202 
Table 6.1: Summary data of the susceptibility of the liver tissue in either cohort under norm- and hyperoxia. 
Mean and SD displayed. 
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6.5 Discussion 
Liver disease is one of the largest causes of mortality in the UK, and is the only major 
cause of death still increasing year on year 
[16]
. Diagnosis is notoriously difficult as most 
patients don’t present until experiencing secondary symptoms such as ascites, sepsis, or 
encephalopathy, among others 
[2]
. While it is not possible to reverse the sclerosis of the liver 
tissue, it is often possible to delay its progression or prevent further damage, as well as treat 
other complications that may arise.  
It is increasingly accepted that cirrhosis is a dynamic process that is no longer a 
terminal condition 
[2]
. The standard METAVIR system used to gauge the severity of fibrosis 
does not have a grade past cirrhosis, and a new sub-classification system has been proposed 
to gauge the severity of cirrhosis and the likelihood of mortality at each stage. For patients in 
the advanced stages of cirrhosis, these further prognostic scores are widely used to predict 
survival and the need for transplant. As such, the development of accurate, non-invasive 
diagnostic modalities is becoming increasingly important. 
The susceptibility of the liver tissue measured in this experiment is consistent with the 
other experiments presented in this thesis, i.e. the susceptibility of the cirrhotic liver tissue as 
measured in QSM images is approximately the equal to that of the water reference, indicating 
no increase in hepatic iron in the BDL rats. In the previous mouse experiments it was shown 
histologically that the amount of iron present in the liver was minimal (chap. 4 fig. 4.10) , 
however it is known that the accumulation of excess liver iron is a facet of advanced liver 
diseases including cirrhosis. The findings in this experiment are in contrast with the expected 
results based on the findings of similar studies that have shown that shown that it is feasible 
to use changes in liver iron to accurately stage liver fibrosis such that susceptibility estimates 
correlate well with liver biopsies 
[17]
 and R2* measurements 
[18]
. The reasons for this are 
unclear, however it may be the case that iron over load is not as prevalent in this model as 
was assumed (fig. 6.5).  
Based on the results of a similar experiment 
[11]
, it was expected that a hyperoxic gas 
challenge would induce a meaningful shift in susceptibility from baseline (normoxic) 
conditions. This was not the case. In the experiment conducted by Patterson et. al., the 
significant increase in T2* observed in the livers of patients suffering from cirrhosis was 
hypothesised to be caused by a breakdown in the auto-regulatory mechanisms of the liver 
vasculature. The data suggests a paramagnetic shift in the susceptibility of almost all of the 
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animals in the BDL cohort (figure 6.6) in response to the gas challenge, but the difference 
was miniscule i.e. on the order of a few parts per billion. 
The difference in oxygen extraction between cirrhotic and healthy livers is the subject 
of conflicting reports in the literature. It has been shown previously that oxygen uptake in 
patients with liver cirrhosis had an inverse relationship with the severity of the disease (as 
determined by Pugh score) 
[19]
. One hypothesis to explain this was that this was due to an 
abnormal limitation of tissue extraction caused by the disease. Conversely, while it has been 
shown that ShvO2 reflects the hepatic oxygen supply/demand ratio 
[20]
, it has also been shown 
in several studies that, despite the disruption to liver perfusion, there is no difference between 
the hepatic venous oxygen content of healthy and cirrhotic livers as measured in both 
preclinical and clinical studies 
[21, 22]
. The data here would suggest that there is a reduction in 
the amount of O2 extracted from the blood in the BDL animals, but due to the low numbers of 
the sham cohort, no conclusion could be reached. 
This experiment encountered a number of limitations. Most importantly, the study is 
underpowered. More control animals are required to draw meaningful conclusions from the 
results. The reason the number of sham animals was so limited was that this experiment was 
outside of the initial scope of the project, which had originally intended to perform mouse 
experiments only. During the course of the PhD however, the opportunity presented itself to 
examine another disease model which had previously been unavailable. As the animals were 
intended for another study this resulted in a number of additional limitations. Firstly, 
obtaining the animals proved quite difficult due to clashes in the experimental calendars of 
this and the other study. Secondly, this precluded the possibility of further examination of the 
liver tissue (e.g. histological examination) which could have further informed the results of 
the QSM experiment, and thirdly, the animals had had a significant amount of time and effort 
invested by the group that owned them, and so obtaining the number of animals required for 
statistical validation was not possible.  In the future, if access to greater numbers was 
possible, a longitudinal study of changes in susceptibility and ShvO2 as cirrhosis progressed 
may yield interesting results. 
Despite the apparent usefulness of the measurement 
[20, 23, 24]
, ShvO2 has been the 
focus of very few studies, fewer still that focus on rats. Of the few studies that have examined 
rats, there are large variations in the measured ShvO2 values ranging from ~30% 
[25]
 to ~65% 
[20]
 in healthy and sham hepatectomy rats respectively. Further work on this topic could 
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include an in-depth characterisation of changes in ShvO2, as well as a comparison of invasive 
and non-invasive measurements under a variety of experimental conditions. 
In addition to the small cohort, the tuning rod of the transmit/receive coil used during 
scanning was broken at the time the data was acquired, so the signal intensity (and hence 
SNR) was reduced. As the animals that were the focus of this experiment were primarily 
being used in a separate study, the window of opportunity to acquire data was limited. This 
window coincided with a time during which the tuning rod on the transmit/receive coil was 
malfunctioning, thus undermining the quality of the acquired data. The data acquired from 
the BDL rats was more reliable as the cohort consisted of 7 animals, however the small size 
of the sham cohort disallowed meaningful statistical analysis of control data, as well as 
meaningful comparison between the two cohorts.  
The BDL model of liver cirrhosis is the most common model used to induce 
obstructive cholestatic injury to mice and rats 
[1]
. However, there are a number of methods 
available to inflict the same injury. Toxic models involve the administration of substances 
such as carbon tetrachloride or ethanol over roughly the same amount of time as the BDL rats 
examined here (~4 – 6 weeks), and it is noted in the literature that the administration of 
ethanol will decrease the response of the liver to hyper- and hypoxic challenges 
[26]
. This is 
most likely due to the presence of ethanol, rather than the manifestation of the liver’s 
response to the insult. This is somewhat representative of the clinical situation – the liver’s 
reaction to a wide variety of insults from hepatitis to drug and alcohol abuse is reasonably 
similar, and results in the same pathological characteristics. 
6.6 Conclusions 
In this work, I have demonstrated that it is possible to measure the susceptibility, and 
to calculate the SvO2 in the major blood vessels of a cirrhotic liver. The susceptibility of the 
liver tissue as measured with QSM did not reflect the expected increase in iron deposition in 
the disease cohort, and administration of pure oxygen did not seem to reflect the vascular 
disruption that is characteristic of liver fibrosis. These results were unexpected, and most 
likely reflect the limited number animals studied and hardware problems that were present at 
the time of data acquisition. Nevertheless, the data presented here provide a proof of principle 
for the application of QSM to animal models of liver cirrhosis, and also provide motivation 
for a follow-up study to investigate the usefulness of QSM for diagnosing and staging the 
disease. 
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Final Discussion 
The primary aim of this thesis was to investigate novel applications of Quantitative 
Susceptibility Mapping (QSM). The work focussed specifically on the liver, as this is a niche 
area that has so far been almost entirely unexplored otherwise, but one which could provide a 
rich area for improving the diagnosis and understanding of disease. The experiments 
performed represent the development and implementation of QSM in the rodent (mouse and 
rat) liver for the first time, and, furthermore, demonstrate the first instances in which QSM 
has been applied to a diverse range of liver pathologies. While preliminary in nature, the 
undertaking has resulted in a viable paradigm within which future experiments can be carried 
out, and has laid the groundwork for further avenues of study. 
QSM is an exciting field that has given researchers a novel way to explore tissue 
composition and microstructure. Initial applications focussed on quantifying the changes in 
tissue iron content that are indicative of neurological disorders, but the field has grown 
rapidly to give rise to a diverse range of clinically relevant applications, many of which have 
been discussed during the course of this thesis. A number of clinical trials are currently 
ongoing 
[1-3]
 , including one that aims to evaluate regional gadolinium (Gd) retention in 
patients that have undergone Dynamic Contrast Enhanced (DCE) MRI 
[1]
. This is of 
particular relevance, as at time of writing the issue of toxicity caused by residual Gd is a 
highly contentious one in the MR community 
[4]
, and the results may have significant 
implications for diagnostic MR in clinical practice. 
Applications of QSM in organs outside the brain are still relatively few in number, 
and some of the reasons for this may be due to the relative simplicity of acquiring images of 
the brain. For example, the lack of organ motion is advantageous, as it allows the acquisition 
of repeatable images with relative ease, and the comparably small air/tissue interfaces in the 
head require the removal of less information during processing. Secondly, the consistent 
architecture of the brain allows more robust comparisons between subjects, or in the same 
subject longitudinally. Similarly, the wide availability of brain masks and atlases means that 
processing the images is far less cumbersome, allowing segmentation to be performed 
automatically in seconds, as opposed to the hours required to do so manually. This has the 
added advantage of reducing the error that could be caused by human intervention. Thirdly, 
while it has been shown that there is a negligible amount of fat in the animals examined here 
175 
 
(chap. 3A. sec. 3.4.1), this will be a challenge in clinical imaging, requiring a reasonably 
complex augmentation of the processing protocol 
[5]
. 
A significant amount of experimental work was dedicated to addressing the obstacles 
encountered during the implementation phase of the project, and there is still scope for 
further improvement. For example, respiratory gating was used during the all of the 
acquisitions, necessitating a regular respiratory rate. While this was not an issue when 
imaging healthy subjects, controlling by means of anaesthetic the respiratory rate of animals 
that were at an advanced stage of disease required a considerable level of skill and patience. 
In some instances the animals would periodically hyperventilate, resulting in ghosting and 
increased image noise. Another solution to this problem could be to implement retrospective 
gating, meaning that data is acquired throughout the entire respiratory cycle. Slices acquired 
during motion could then be identified during processing and removed from the dataset 
[5]
. 
The trade-off between prospective and retrospective gating is a complex one – the data may 
be acquired at a faster rate, as the sequence doesn’t require a trigger from the respiratory 
cycle and instead acquires data constantly. Conversely, retrospective gating necessitates an 
increased number of signal averages to ensure the missing data is adequately compensated 
for, and so may increase acquisition time, and subsequently the risk of subject mortality.  
Some of the difficulties encountered during implementation however gave rise to 
novel solutions that may benefit the field of QSM imaging as a whole. As discussed in 
chapter 4 sec. 4.1.2.4, the reference against which QSM values are measured can easily be a 
source of systematic error when taken from an internal region (e.g. CSF, white matter). The 
inclusion of a sample of distilled water to act as an external reference is an entirely novel 
solution to the problem, and elegantly addresses a number of known issues, such as 
standardisation, and ensuring easy identification in all images. Selection of a suitable 
reference has been a point of contention for some time in the QSM community 
[6]
, and it is 
hoped that this may go some way to settling the argument. 
Similarly, the TKD algorithm selected to perform the QSM inversion is well-suited to 
the exploration of novel applications. As mentioned, the speed with which it can carry out the 
calculation is extremely advantageous, as empirically optimising an image processing 
protocol requires repeatedly performing the same calculation while incrementally adjusting a 
variety of parameters. The drawback of the algorithm is the trade-off between image quality 
and fidelity, and is most likely the reason it is underused in the literature. The solution (chap 
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3 Sec 3.2.4) presented here to the systematic underestimation of susceptibility values inherent 
in the algorithm is also entirely novel. As discussed, the correction curve presented in the 
literature was derived experimentally, specifically for images of the brain acquired at 3T. The 
solution proposed here allows a correction curve to be calculated from a single data set 
(negating the need for multi-orientation acquisitions and the requisite processing thereof), in 
any organ, at any field strength.  
The main experimental chapters detailed the application of QSM to a diverse range of 
hepatic scenarios. A hyperoxic gas challenge was utilised in all experiments, as it was 
thought that controlled modulation of the deoxyhaemoglobin content of the blood would 
impart information regarding blood oxygenation (chapter 4) and vascular status (chapter 5 & 
6). 
Chapter 4 detailed the first attempt at using QSM measurements to calculate the 
venous oxygen saturation in large branches of liver vasculature. Data was acquired under 
normoxic and hyperoxic conditions, and susceptibility was measured in both the portal and 
hepatic veins.  SvO2 was then calculated in each under both conditions. This was validated by 
means of invasive measurement, and it was found that there was excellent agreement between 
the calculated and directly measured values under both norm- and hyperoxic conditions. 
It was not possible to obtain susceptibility measurements from the hepatic artery with 
the imaging protocol used here. However, susceptibility measurements from all three hepatic 
blood vessels at once would be extremely useful. For instance, it has been shown previously 
that it is possible to measure the blood flow in each vessel in rats using phase contrast MRI 
[7]
. If one could measure both blood flow and oxygen saturation in all three major hepatic 
vessels, it would be entirely possible to calculate the hepatic metabolic rate of oxygen 
consumption. The cerebral metabolic rate of oxygen consumption has proved to be an 
extremely useful marker when assessing a variety of brain insults, and is thought to be a 
direct index of energy homeostasis and brain health 
[8]
. The ability to non-invasively measure 
oxygen metabolism in the liver could prove equally useful for a wide variety of applications. 
Chapter 5 describes the first application of QSM to a pre-clinical model of colorectal 
liver metastases, or, indeed, any cancer outside of the brain. In sec. 5.1 susceptibility was 
measured in the tumours and healthy liver tissue, and it was found that the tumours were 
significantly more diamagnetic than the surrounding tissue. Hyperoxia was induced in order 
to assess the vascularity of the tumours, and it was found that the susceptibility of the 
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tumours was significantly more paramagnetic during the administration of pure O2. This is in 
contrast to a number of similar experiments contained within the body of literature on the 
subject, and it is hypothesised that this is due to an increased influx of unbound paramagnetic 
O2 molecules dissolved in the blood plasma. In addition, susceptibility was measured in the 
portal and hepatic veins, and the calculated oxygen saturation in each was compared to that of 
a healthy cohort under the same conditions. It was found that there was significantly less 
oxygen in the hepatic venous blood of the animals that had tumours when compared to the 
healthy cohort. This was ascribed to the increased metabolic demands of the cancer.  
Chapter 5 sec 5.2 outlined the first attempt at using QSM in conjunction with a gas 
challenge to assess the efficacy of a Vascular Disrupting Agent (VDA). Currently, there is a 
critical need for noninvasive imaging biomarkers of the response of cancer to therapy, and 
the aim of this chapter was to evaluate hepatic QSM in this context. The study examined 10 
mice that had been inoculated with cancer. Half were administered the drug, and half were 
not in order to act as a control. The mice were scanned immediately before and 72 hours after 
the VDA was given to the treated cohort, and hyperoxia was induced during both sessions. 
Susceptibility was measured in tumours under both hyper- and normoxic conditions at both 
time points. It was found that, as in sec. 5.1, the susceptibility of the tumours was more 
paramagnetic under hyperoxic conditions, however the response of the tumours to the gas 
challenge was reduced after the administration of the VDA, possibly indicating a reduction in 
tumour blood supply caused by the denigration of their vasculature. The effect of the drug 
was confirmed by histology. 
The cancer studies discussed in chapter 5 were extremely technically challenging, and 
took roughly two years to complete. It proved extremely difficult to cultivate tumours in the 
animals, and attempts to implement the model in several strains of mice using a number of 
different cell lines repeatedly failed, or met with very limited success. When the model was 
implemented successfully, it was found that the animals did not tolerate anaesthetic very 
well, which somewhat precluded cross validation with other MRI techniques. 
While in contradiction to the existing literature, the reaction of the tumours to 
hyperoxia as measured via susceptibility was consistent across a number of experiments. It 
could be argued that this study may have benefited from invasive measurement of tumour 
oxygenation, although the tumours were extremely small and diffuse, and the measurements 
taken from the susceptibility maps encompassed all the tumours en masse by necessity. 
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Invasive measurements would have had to have been made in several tumours in each animal 
in order accurately assess changes in the changes in oxygenation status. The difficulty of 
ensuring the sample was actually taken from a tumour notwithstanding, it is unlikely that the 
mice could have tolerated the severity of the protocol. 
The reduced reaction of the tumours to the gas challenge after the administration of a 
VDA in sec. 5.2 is encouraging, though there is scope for improvement in the experimental 
design. For example, one obvious improvement is to increase the numbers in each cohort to 
10 animals each. This would allow a more rigorous statistical analysis, allowing the results to 
be discussed with greater confidence. Conversely, administering the drug to half of the 
animals, but scanning once, at an earlier timepoint (i.e. 24 hours after the drug was 
administered) may have meant that the animals could have better tolerated the anaesthetic, 
and would have eliminated the need to ensure the animals survived the entirety of a 
longitudinal study. This may have allowed their time in the scanner to be extended, 
potentially allowing cross-validation with other MRI techniques (e.g. R2* or ASL). 
The experiment described in chapter 6 was the first instance in which QSM had been 
applied to a model of liver cirrhosis. As mentioned, the experimental work was carried out as 
part of a broader experiment to study hepatic encephalopathy. As such, priority was placed on 
ensuring the survival of the animals by minimising their time in the scanner. Furthermore, 
there were some technical difficulties which have already been outlined (chapter 6). While 
the results of this experiment are limited, it is reasonably apparent that QSM cannot detect 
changes in liver iron deposition that are associated with liver cirrhosis. The precise reasons 
for this remain unclear, particularly as it has been shown in the literature that it is possible 
with SWI. It may be the case that the iron distributed through the liver tissue is too diffuse to 
have a noticeable effect on the bulk susceptibility of the liver that is measureable by QSM. 
This is unlikely however, as it has been shown in the experiments presented here that QSM is 
sensitive to changes in susceptibility of the order of part per billion. Conversely, it may be the 
case that, as is shown in fig 6.4, the accumulation of iron in this model may be so limited as 
to not have a significant effect on the QSM measurement. 
In general, the mechanisms underpinning changes (or lack thereof) in susceptibility of 
rodent liver tissue, as measured with QSM in all of the above experiments, remain somewhat 
mysterious. Upon commencement of the project, it was thought that the variation of iron 
throughout the liver tissue would have been obvious, particularly so as iron delineation and 
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quantification was the initial focus of QSM experiments in the brain. Furthermore, it was also 
assumed that hyperoxia would have had a measureable effect on the susceptibility of the liver 
tissue, due to the fact it is a highly vascularised organ with a relatively high throughput of 
blood. This was not the case, although changes in blood oxygen status were apparent.  
One challenge throughout the course of this project has been the lack of literature on 
the subject. While liver susceptometry has been carried out clinically to assess iron overload 
for a number of years, very little work has been performed in rodents. As such, it is very 
difficult to find any experiments that have examined venous blood oxygen saturation in either 
the rodent or human liver, or changes therein associated with gas challenges. Furthermore, 
the existing literature values vary wildly from one experiment to the next, so comparing 
experimental results to literature values was extremely difficult. As such, future work could 
involve cannulating the major hepatic blood vessels and characterising changes in blood 
oxygen saturation brought about by various gas challenges or disease states. This would most 
likely be carried out in rats due to the size of the blood vessels in mouse livers. 
The novelty of the work also made validating the experimental results extremely 
difficult, as there is no “gold standard” to compare results to. This is partially due to the semi-
quantitative nature of QSM (see chapter 4 sec. 4.1.2.4 – water reference), but also because 
performing susceptometry is a difficult endeavour. For example, validation of susceptibility 
values could be sought by comparing QSM results to those obtained from a Superconducting 
Quantum Interference Device (SQUID). Examining samples on a SQUID however is by no 
means a trivial process, requiring rigorous preparation of the sample. Equally, validating 
results with similar MRI techniques may not be suitable in all instances. R2* for example, 
while related to susceptibility, effectively gives proxy measurements of susceptibility via 
local field inhomogeneities. As such, validation of the results in the above experiments was 
done where possible by invasive, direct measurements (chapter 4), or by histology (chapter 4 
& 5). 
The combination of QSM and a hyperoxic gas challenge puts to good use its ability to 
exploit dHb as an endogenous contrast agent, and is potentially quite a useful technique. The 
assessment of tumour vasculature and oxygenation is an important component of oncologic 
diagnostic procedure, particularly when deciding a treatment pathway. It is thought that the 
administration of O2 could be well tolerated by the vast majority of patients, and so could 
easily be integrated into clinical protocol. The added advantage of performing measurements 
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in the blood vessels is that fat does not need to be accounted for during processing. ShvO2 is 
an underutilised measurement, and it would appear that it can tell a lot about the health of the 
liver. Its underuse may be because, currently, it can only be measured invasively. The ability 
to perform the measurement non-invasively may allow more in-depth diagnoses or post-
operative monitoring at very little cost in terms of morbidity.  
Susceptibility mapping has the potential to be a powerful diagnostic tool, however 
currently much of the work in the field is focussed on improving the processing techniques as 
opposed to investigating novel applications. It is hoped that the work put forward in this 
thesis will go some way to opening new avenues of research, and stimulating a discussion 
that will encourage the exploration of new clinical applications and diagnostic perspectives. 
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